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ABSTRACT 
Aeromonas hydrophila is an opportunistic pathogen that causes a wide range of 
symptoms and diseases in fish. Development of a commercial vaccine has been 
problematic due to the heterogenicity between isolates of A. hydrophila. A new 
approach using immunoproteomics was used in this study to try to develop a 
vaccine that would protect against a wide range of A. hydrophila strains. 
 
The virulence of 14 isolates of A. hydrophila from different geographical regions 
was determined in common carp (Cyprinus carpio) indicating that 6 isolates were 
virulent, while 8 isolates were avirulent. Expression of cellular and extracellular 
products (ECP) of six of these isolates (4 virulent and 2 avirulent isolates) were 
examined following culture of the bacterium in vitro, in tryptic soy broth, and in 
vivo, in dialysis tubing placed within the peritoneal cavity of carp. Two types of 
molecular weight cut off tubes (25 and 100 kDa) were used for the implants. 
Whole cell (WC), outer membrane protein (OMP) and ECPs of the bacteria grown 
in vitro and in vivo were analysed by 1 dimensional sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (1D SDS-PAGE). Additionally, 2D SDS-PAGE 
was used to analyse WC preparations of A. hydrophila grown in vitro and in vivo. 
The production of unique proteins and up and down-regulation of protein 
expression were observed in all the preparations of bacteria grown in vitro and in 
vivo. Unique bands were seen in the 1D SDS-PAGE at 58 and 55 kDa for WC and 
OMP preparations, respectively, for all the isolates cultured in vivo. Bands of 
increased intensity were observed at 70, 55, 50 and 25 kDa with WC preparations 
for the virulent isolates cultured in vivo. Analysis of WC preparations by 2D SDS-
PAGE indicated differences in the expression of spots between bacteria cultured 
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in vitro and in vivo. A number of unique spots, mostly between 30 and 80 kDa with 
pI values ranging from 5.0-6.0 were observed in the bacteria grown in vivo. 
 
The protein profiles of different preparations (WC, OMP, ECP) of bacteria cultured 
in vitro and in vivo were screened by 1D Western blot using antibodies from carp 
artificially infected with different isolates of A. hydrophila to identify potential 
vaccine candidates. The WC preparations of A. hydrophila (T4 isolate) grown in 
vitro were also analysed by 2D Western blot. A 50 kDa protein of A. hydrophila 
was found to be the most immunogenic molecule in both WC and OMP of bacteria 
grown both in vitro and in vivo. The protection efficacy of this protein was 
determined in goldfish by vaccinating fish with electro-eluted 50 kDa protein then 
challenging the fish with A. hydrophila. Fish were also passively immunised with 
fish sera raised to the 50 kDa protein and then challenged. The relative 
percentage survival (RPS) was 67 % in the vaccination trial, while the results were 
inconclusive for the passive immunisation trial. 
 
The 50 kDa protein was confirmed to be the S-layer protein of A. hydrophila 
following identification using matrix-assisted laser desorption ionisation time-of-
flight mass spectrometry (MALDI-TOF MS). Recombinant S-layer protein was then 
produced and the cross-protection efficacy of this protein against six virulent 
isolates of A. hydrophila was confirmed in a large scale vaccination trial using 
carp. The RPS value for the 6 isolates of A. hydrophila ranged from between 56 
and 87 %. The results of this project suggest that the immunogenic S-layer protein 
of A. hydrophila could be used as a common antigen to protect fish against 
infection by different isolates of this pathogenic bacterium. 
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1.1. Introduction 
Aeromonas hydrophila is a primary (Esteve et al., 1993), secondary (Joice et al., 
2002) and opportunistic pathogen (Dooley and Trust, 1988; Lio-Po et al., 1996) of 
a variety of aquatic and terrestrial animals, including humans. It is a ubiquitous, 
free living, Gram-negative bacterium, mainly found in water and water-related 
environments and causes a wide variety of symptoms (Hazen et al., 1978a). The 
disease caused by A. hydrophila is called motile aeromonad septicaemia (MAS) 
and this pathogen is associated with number of other diseases in fish, for 
example, epizootic ulcerative syndrome (EUS) as a secondary pathogen (Roberts, 
1993; Pathiratne et al., 1994; Lio-Po et al., 1998). The clinical signs in fish vary 
from tissue swelling, necrosis, ulceration and haemorrhagic septicaemia (Hazen et 
al., 1978a; Karunasagar et al., 1986; Angka, 1990; Aguilar et al., 1997; Azad et al., 
2001). 
 
Aeromonas hydrophila is associated with disease in humans and domestic 
animals including sheep, dogs and cats, especially when exposed to periods of 
stress (Burke et al., 1984; Howard and Buckley, 1985a; Janda and Duffey, 1988; 
Ghenghesh et al., 1999; Ilhan et al., 2006). It is reported to contribute to intestinal 
and extra-intestinal infections including diarrhea in humans and other animals 
(Agarwal et al., 1998; Guimaraes et al., 2002). It has also been found in a variety 
of food products producing a range of toxins such as haemolysin, enterotoxin and 
cytotoxin (Callister and Agger, 1987: Yucel et al., 2005; Daskalov, 2006). 
 
 Chapter 1  Page 3 
1.2. Historical background and taxonomy 
The genus Aeromonas was first described by Zimmermann (1890), who isolated 
the bacterium from the drinking water supply of Chemnitz in Germany using 
gelatine agar. He named the bacterium “Bacillus punctatus”. Sanarelli (1891) 
isolated a similar bacterium from the blood and lymph of frogs, which he called 
“Bacillus hydrophilus fuscus”, but in 1901 Chester proposed a name change to 
“Bacterium hydrophilium” (Caselitz, 1966). In the first edition of the Bergey´s 
manual, this species was erroneously designated as “Proteus hydrophilus”. 
However, in the Sixth Edition the genus Proteus was reclassified as Pseudomonas 
(Speck and Stark, 1942; Rustigan and Stuart, 1943). The genus Aeromonas was 
finally adopted in the Seventh Edition of Bergey´s manual (Stainer, 1943), and this 
particular organism was classified as A. hydrophila. 
 
According to molecular genetic studies, Messner and Sleytr (1992) proposed that 
the genus Aeromonas might be placed in a new family, the Aeromonadaceae. 
This genus was previously placed in the family, Vibrionaceae (Farmer, 1992) 
based on its phenotypic expression. Sakazaki & Shimada (1984) serotyped strains 
of Aeromonas on the basis of its O-antigen lipopolysaccharide (LPS). The genus 
Aeromonas has been shown to be antigenically diverse with over 90 established 
or possible serogroups described within this genus (O'Farrell, 1975; Frerichs, 
1989). 
 
The family is sub-divided into psychrophilic and mesophilic species. The 
psychrophilic   group   is   non-motile,  does  not  grow  at  37°C  and  is   therefore  
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unimportant to clinical microbiology. Members of the mesophilic group grow at 
37°C and are motile using polar flagella. This group is divided into three principal 
groups, A. hydrophila, A. caviae and A. sobria (Korbsrisate et al., 2002). 
 
1.3. Characteristics of A. hydrophila 
1.3.1. Growth characteristics 
Aeromonas hydrophila is a fermentative rod approximately 0.8-1.0 × 1.0-3.5 µm in 
size, that is motile via a single polar flagella (Austin and Austin, 1999). It is able to 
produce two distinct types of flagella; polar flagella for swimming in liquids and 
lateral flagella for swarming over surfaces (Altarriba et al., 2003). The bacterium 
can be isolated on non-selective media such as nutrient agar or tryptone soy agar 
(TSA), or on selective media such as Rimler-Shotts medium (Zimmermann, 1890) 
or peptone beef-extract glycogen agar (Sanarelli, 1891) by incubating at 20-30°C 
for 18-36 h. Colonies of A. hydrophila that are grown on TSA at 28°C for 18-24 h 
usually appear round, creamy to light yellow in colour, raised, and 2-3 mm in 
diameter. Most selective media use carbohydrate and ampicillin or penicillin as the 
selective agent (Palumbo et al., 1985). Kay et al. (1985) recommended using 
sheep blood agar with 10 µg ml-1 ampicillin preceded by overnight enrichment in 
alkaline peptone water (APW) for the isolation of A. hydrophila from humans. 
Cepahlothin has been reported as the best enrichment agent in APW for A. 
hydrophila isolation owing to its greater selectivity and efficiency in recovering 
stressed or low concentrations of bacteria (Sachan and Agarwal, 2000). 
 
The culture environment plays a major role in the growth and virulence of the 
bacterium, especially with respect to available nutrients, temperature and pH. 
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Sautour et al. (2003) proposed a model for describing the effects of temperature, 
water activity (aw) (ratio between vapour pressure of water and that of pure water 
at the same temperature) and pH on the growth of A. hydrophila, and showed that 
temperature and aw are the main influences on the bacterium’s growth, while no 
significant influence of pH was seen. Incubation of A. hydrophila at different pH 
values, i.e. 6.0, 6.5, 7.0 and 7.5 did not significantly affect the growth rates, but lag 
phases were shorter at pH 6.0 than pH 7.0 (Buncic and Avery, 1995). 
 
Although A. hydrophila can be grown at a wide range of temperatures, many 
researchers claim that the most suitable temperature for culturing the bacterium is 
between 25 and 35°C, while some researchers have found 20°C as an optimal 
temperature for its growth (Popoff, 1984). However, Uddin et al. (1997) found that 
the optimum temperature for growth of A. hydrophila was 34.5 ± 1.0°C, while 
protease production was greatest at 27.6 ± 4.9°C. It is neither salt (<5%) nor acid 
(min. pH∼6) tolerant, and has the ability to grow at temperatures as low as –0.1°C 
for some strains (Daskalov, 2006). The growth of A. hydrophila at different 
temperatures ranging from 4 to 42°C and 5 to 35°C have been reported by 
Palumbo et al. (1985) and Callister and Agger (1987), respectively. 
 
1.3.2. Biochemical Characteristics 
The biochemical characteristics of the A. hydrophila are very complex and 
researchers have found it hard to relate these activities with a particular function. 
For example, biochemical reactions of A. hydrophila have not been correlated with 
either toxin production or plasmid profiles of the bacteria (Kindschuh et al., 1987; 
Noterdaeme et al., 1991). However, a high degree of similarity was found in the 
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biochemical traits of A. hydrophila isolated from water and sediment at different 
sites and during different seasons along the river Porma, in Spain, although the 
isolates displayed different degrees of virulence in fish (Paniagua et al., 1990). De 
Figueiredo and Plumb (1977) previously reported that A. hydrophila isolated from 
water was not as virulent as those isolates obtained from fish, despite isolates 
from both sources having similar biochemical characteristics. 
 
Biochemical factors such as production of high affinity iron uptake systems (e.g. 
siderophores) have been correlatated with virulence, although the bacteria have 
evolved many other factors for infecting fish (Ellis, 1999). There are two iron-
transporting siderophores, amonabactin and enterobactin in mesophilic 
Aeromonas, but production of amonabactin is predominant in A. hydrophila. The 
type of siderophore produced by different strains might be a useful tool for 
subdividing the motile aeromonads (Barghouthi et al., 1989). Barghouthi et al. 
(1991) suggested that amonabactin could be a virulence factor of aeromonads. 
This was supported by the work of Naidu and Yadav (1997), in which production of 
amonabactin was found to be greater in clinical isolates than in environmental 
isolates of A. hydrophila. 
 
Merino et al. (2001) suggested that Mg2+ and possibly Co2+ have some role in A. 
hydrophila’s ability to swarm and may be related to processes such as adherence 
and biofilm formation. N-acylhomoserine lactone-dependent quorum sensing has 
also been reported to be involved in biofilm formation by A. hydrophila (Lynch et 
al., 2002). Quorum sensing is a form of cell-to-cell communication employed by 
many Gram-negative bacteria to regulate a diverse array of characteristics 
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including bioluminescence, antibiotic production, swarming motility and production 
of extracelluar virulence factors (Kirke et al., 2004). Aeromonas hydrophila from a 
variety of different sources have been shown to have different chemotactic 
responses to the mucus of freshwater fish, amino acids and carbohydrates (Hazen 
et al., 1982 and 1984). The authors found a significantly higher chemotactic index 
with clinical isolates compared to the environmental isolates, and suggested that 
this factor might contribute to the virulence of the pathogen. 
 
1.4. Epizootiology 
1.4.1. Distribution of A. hydrophila and susceptible fish species 
The distribution of A. hydrophila in many aquatic systems globally indicates the 
successful adaptation of the bacterium to such environments (Hazen et al., 1978b; 
Williams and LaRock, 1985). It is a common contaminant of fresh foods, including 
fish and other seafood (Rustigan and Stuart, 1943; Amend and Fender, 1976; 
Daskalov, 2006). The occurrence of A. hydrophila is higher in lotic systems 
compared with lentic systems, and saline environments have higher levels of A. 
hydrophila than fresh water environments (Hazen et al., 1978b). 
 
Fish disease is a major risk factor in commercial aquaculture with millions of 
dollars lost annually (Boulanger et al., 1977; Fang et al., 2000 and 2004). 
Aeromonas hydrophila infection is the scourge of fresh and warm water fish 
farming worldwide and is considered as a significant economic problem ( Torres et 
al., 1990; Rahman et al., 2001a; Hu et al., 2005), particularly in China and India 
over the past decade (Karunasagar et al., 1989; Chang et al., 1992). It is also 
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believed to be a pathogen of emerging importance for humans through consuming 
fish and shellfish contaminated with A. hydrophila (Vivekanandhan et al., 2005). 
 
Aeromonas hydrophila are psychrotrophic in nature with a multiplicity of virulence 
factors. They are commonly isolated from normal healthy fish, with only certain 
strains possessing the virulence factors necessary to induce disease (Cahill, 1990; 
Vivekanandhan et al., 2005). There are many combinations of factors involved in 
host susceptibility to A. hydrophila infections. For example, environmental stress 
and injury, which precipitate infection, have been reported in common carp 
(Cyprinus carp) (Pai et al., 1995). Similarly, warmer water temperatures in the 
summer have been shown to increase the susceptibility of goldfish (Carrassius 
auratus) and koi (C. auratus × C. carpio) to infection by A. hydrophila, with 
secondary infections resulting from high parasite loads (Dixon and Issvoran, 
1993). 
 
A wide variety of fish and shellfish has been reported to be susceptible to A. 
hydrophila by a number of authors (Table 1.1). Esteve et al. (1994) reported that 
European eel, Anguilla anguilla were particularly susceptible and might be specific 
hosts for A. hydrophila due to dominance of this pathogen in diseased eel at 
different eel farms in Valencia (Spain) during various seasons. Rainbow trout 
(Oncorhynchus mykiss), on the other hand, were shown to be less susceptible 
than European eel to A. hydrophila (Esteve et al., 1993). 
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Table 1.1: Fish and shellfish species susceptible to A. hydrophila 
infection 
Fish species 
Scientific name Common name 
Authors 
Anabas testudineus Climbing perch Ansary et al., 1992 
Anguilla anguilla Eel Esteve et al., 1993 
Argopecten purpuratus Scallops Riquelme et al., 1996 
Carrassius auratus Goldfish Maji et al., 2006  
Carassius carassius Crucian carp 
Channa striatus Chevron snakehead 
Clarias batrachus catfish 
Llobrera and Gacutan, 
1987 
Clarias gariepinus African catfish Angka et al., 1995 
Cyprinus carpio Common carp Farkas and Olah, 1982 
Etroplus suratensis Pearl spot Pathiratne et al., 1994 
Glossogobius giurus goby Llobrera and Gacutan, 
1987 
Ictalurus punctatus Channel catfish Ventura and Grizzle,1988 
Macrobrachium 
rosenbergii 
Giant freshwater prawn Tonguthai, 1992 
Megalobrama 
amblycephala 
Wuchang bream Nielsen et al., 2001 
Micropterus salmoides Largemouth bass Huizinga et al., 1979 
Neoceratodus forsteri Australian lungfish Kemp, 1994 
Ophiocephalus striatus Snakehead Llobrera and Gacutan, 
1987 
Oreochromis niloticus Nile tilapia Yambot, 1998 
Osphronemus gourami Giant gourami Supriyadi, 1986 
Pangasius pangasius Catfish Tanasomwang and 
Saitanu, 1979 
Puntius sarana Barb 
Rasbora danicornius Rasbora 
Pathiratne et al., 1994 
Silurus glanis Sheatfish Farkas and Olah, 1982 
Trichogaster pectoralis Snakeskin gourami 
Tor khudreelongispinnis Mahseer 
Wallago attu Catfish 
Pathiratne et al., 1994 
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1.4.2. Pathogenicity 
Aeromonas hydrophila mainly causes motile aeromonad septicemia (MAS) and 
has also been reported to cause secondary infections associated with EUS 
outbreaks (Roberts, 1993). The disease caused by A. hydrophila has also been 
called ‘Red-sore’ disease (Huizinga et al., 1979). It does not usually cause 
problems in fish populations under normal conditions, but when fish are under 
environmental or physiological stress or infected by other pathogens, A. 
hydrophila is a potential pathogen (Plumb et al., 1976; Fang et al., 2000). 
Generally, it has become an increasingly important pathogen in intensive fish 
culture due to increased environmental and physiological stress experienced by 
reared fish (Shaw and Squires, 1984). Under favourable environmental conditions, 
this pathogen seems to multiply and produce higher levels of ECP toxins in fish, 
which can cause sudden disease outbreaks and mortalities (Allan and Stevenson, 
1981; Yadav et al., 1992; Vivas et al., 2004a). 
 
Several studies have described a wide variation in the pathogenicity of A. 
hydrophila in different fish species. This is mainly due to the heterogenicity of 
strains and differences in the adhesive and enterotoxic mechanisms responsible 
for causing infection in fish (Fang et al., 2004). A natural infection model 
(immersion challenge) in a genetically stable inbred strain of southern platyfish, 
Xiphophorus  maculates,  was used to  study  the  pathogenesis of the bacterium 
(Kawula et al., 1996). They showed that the mortality was dependent on the 
concentration of bacteria and the appearance of clinical signs in fish that 
eventually died. In another study, haemolytic toxin of A. hydrophila reported to be 
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a major virulent factor, when its pathogenicity was studied using a suckling mice 
model infection (Heuzenroeder et al., 1999). 
 
1.4.2.1. Clinical signs of infection 
The clinical signs of disease caused by A. hydrophila have been classified into 
four categories; acute, rapidly fatal septicaemia, with few gross symptoms; an 
acute form with dropsy, blisters, abscesses and scale protrusion; chronic ulcerous 
form with furuncles and abscesses; and a latent form with no symptoms 
(Karunasagar et al., 1989). Clinical signs of infection have also been classified into 
three groups by other workers using an artificial challenge model in channel 
catfish: viz (1) MAS (systemic infection and signs of disease), (2) cutaneous 
(infection limited to skin and the underlying muscle) and (3) latent (systemic 
infection but no external signs of disease) (Grizzle and Kiryu, 1993). 
 
The basic clinical signs of the pathogenesis of A. hydrophila are the presence of 
small surface lesions (which lead to the sloughing-off of scales), local 
haemorrhages particularly in the gills and vent, ulcers, abscesses, exophthalmia 
and abdominal distension, and moreover, it is often associated with abdominal 
oedema or dropsy (Jeney and Jeney, 1995). Azad et al. (2001) observed external 
signs, such as necrotic and oedematous changes in tilapia, Oreochromis niloticus 
infected with A. hydrophila. As well as the external clinical signs described, various 
signs of disease have been reported in the internal organs of different fish species. 
For example, liver and kidneys were found to be completely destroyed in 
largemouth bass, Micropterus salmoides infected with A. hydrophila (Huizinga et 
al., 1979). Similarly, A. hydrophila infection in goldfish resulted in liver 
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degeneration and mild necrosis of the kidney (Tafalla et al., 1999). Diffused 
necrosis in several internal organs and the presence of melanin-containing 
macrophages in the blood was also observed during a systemic A. hydrophila 
infection in channel catfish (Ventura and Grizzle, 1988). 
 
Apart from external and internal clinical signs, immunological and biochemical 
parameters are also affected by A. hydrophila infection. For example, septicaemia 
in Indian major carp, catla (Catla catla), rohu (Labeo rohita) and mrigal (Cirrhinus 
mrigala) has been reported by Karunasagar et al. (1986 and 1989). Similarly, an 
increase in plasma glucose and leucocyte volume was noted in subordinate fish 
compared with dominant fish when juvenile rainbow trout were exposed to social 
stress following challenge with A. hydrophila (Peters et al., 1988). Biochemical 
signs, especially accumulation of lipofuscin (a peroxidation product of lipid 
catabolism) together with tissue destruction in the fish, have also been observed 
(Ventura and Grizzle, 1988). 
 
Toxin induced changes in the host have been reported by Rodriguez et al. (1993), 
who demonstrated that the acetylcholinesterase of A. hydrophila was found in the 
brain of infected rainbow trout which caused the fish to lose their “flight” reaction 
and then their equilibrium, leading to spasmodic swimming followed by death. The 
symptoms suggest that the toxin may be acting on the central nervous system. 
Endotoxins produced by A. hydrophila have been found to initiate febrile 
responses in the fish and other animals (Reynolds et al., 1978). According to Ko et 
al. (2005), mice artificially infected with A. hydrophila can evoke a pronounced pro-
inflammatory cytokine response. 
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In vitro assays have also been used as models to predict clinical changes in fish 
caused by A. hydrophila. In these experiments, the pathogen was seen to produce 
severe morphological changes in the first 2 h of incubating common carp epithelial 
monolayers in vitro with the bacterium, and changes could even been seen after 
30 min incubation with one strain (Leung et al., 1996). Apoptosis of lymphocytes 
by A. hydrophila in goldfish has also been reported in vitro (Shao et al., 2004). 
 
1.4.3. Factors involved in pathogenicity 
It has been reported that environmental factors (Pansare et al., 1985; Kobayashi 
et al., 1993; Rahman et al., 1997; Tsai et al., 1997) such as culture temperature, 
time of incubation (Khalil and Mansour, 1997) and medium (Vivas et al., 2005) can 
alter the expression of different virulence factors of A. hydrophila. For example, 
the expression of surface haemagglutin (s) appears to be medium-dependent, as 
A. hydrophila strains grown in liquid medium show enhanced haemagglutination 
activity compared to those grown on solid medium (Del Corral et al., 1990). 
Increased/decreased water temperatures have been reported to cause increased 
pathogenicity of the bacterium in cultured fish (Ventura and Grizzle, 1987; 
Yambot, 1998). These authors found that changes in water temperature, along 
with the increased stocking density, act as major factors in the occurrence of 
disease outbreaks by A. hydrophila in fish. Other possible factors reported to 
contribute to outbreaks of A. hydrophila infections in cultured fish include 
overfeeding and a drop in salinity (Doukas et al., 1998). Carriers of A. hydrophila 
has also been reported to play a role in infection, when Gatesoupe (1991) 
observed the infection in fish fed with rotifers carrying the bacteria. In addition, 
starved A. hydrophila (bacteria cultured in distilled water containing  0.60 % NaCl, 
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0.50 % KCl, 0.10 % CaCl2 2H2O and 0.20 % MgCl2 6H2O) were shown to be 
highly virulent in cyprinids (common carp and goldfish) compared to bacteria 
cultured in nutrient broth (Rahman et al., 1997). 
 
With regard to its pathogenesis, differing views have been expressed on whether 
A. hydrophila is a primary or secondary opportunistic pathogen of compromised or 
stressed hosts (Jeney and Jeney, 1995). Primary infection by other pathogens 
seems to assist in the infection of fish by A. hydrophila as a secondary pathogen. 
For example, mechanical trauma caused by Ichthyophthirius multifiliis acts as a 
portal entry for A. hydrophila present in the water, thereby facilitating the invasion 
of the bacterium (Liu and Lu, 2004). Similarly, when channel catfish (Ictalurus 
punctatus) were artificially infected with Edwardsiella ictaluri, the infection by A. 
hydrophila as a secondary pathogen was enhanced. In this example, A. hydrophila 
was present in the water, although the fish were capable of clearing E. ictaluri 
(Nusbaum and Morrison, 2002). 
 
Other factors have been reported to be involved in the pathogenicity of the 
bacterium. For example, serum resistance is considered a good indicator of the 
virulence of A. hydrophila associated with the pathogenicity (Leung et al., 1995). It 
seems virulent strains of A. hydrophila are able to survive within macrophages 
even when they are treated with specific antiserum (Yin et al., 1996). It had been 
previously suggested that the resistance of A. hydrophila to intracellular enzymatic 
digestion by macrophages of channel catfish may be due to an intrinsically 
resistant character of the bacterial envelope (Bach et al., 1978). This resistance is 
achieved by A. hydrophila in vivo by producing a serum-resistant capsule, 
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however, it has been shown that the bacterium can also produce such capsules 
when grown in either synthetic medium or an autolysate of fish viscera (Merino et 
al., 1994; Aguilar et al., 1999). 
 
1.4.3.1. Extracellular products 
Extracelluar products of A. hydrophila are considered to be major virulent factors 
of the bacterium (Allan & Stevenson, 1981; Ruangapan, 1986). However, the 
importance of each individual virulence factor in the pathogenicity of the bacterium 
in the various stages of infection remains unclear (Handfield et al., 1996). 
Aeromonas hydrophila is very well known for producing a wide range of 
extracellular toxins such as enterotoxin (Ljungh et al., 1981; Chakraborty et al., 
1984), aerolysin (Howard and Buckley, 1985c; Chakraborty et al., 1986), cytotoxin 
(Boulanger et al., 1977), haemolysin (Allan and Stevenson, 1981; Rodriguez et al., 
1992), protease (Leung and Stevenson, 1988a; Rodriguez et al., 1992), amylase 
(Gobius and Pemberton, 1988), acetylcholine esterase (Nieto et al., 1991), 
lipase/acyltransferase (Munn et al., 1982; Buckley, 1982), leucocidins (Caselitz, 
1966; Scholz et al., 1974), enolase (Sha et al., 2003), nucleases (Chang et al., 
1992; Favre et al., 1993), chitinases (Ueda et al., 1994) and unknown heat-stable 
virulence factors (Khalil and Mansour, 1997). Strains of A. hydrophila also produce 
gelatinase, caseinase, elastase, lipase, lecithinase and deoxyribonuclease (Favre 
et al., 1993). The role of these enzymes is to provide nutrients to the bacterium by 
breaking down host proteins into smaller molecules which are then capable of 
entering into the bacterial cell (Cicmanec and Holder, 1979; Sakai, 1985). 
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Although A. hydrophila tend to produce a wide range of toxins, proteases are 
considered to be the main virulence factors in ECPs implicated in the 
pathogenicity of fish. For example, it has been suggested that production of 
proteases by A. hydrophila may initiate the disease by degenerating 
tissues/organs in fish (Howard and Buckley, 1982; O'Reilly and Day, 1983; Sakai, 
1985). This was confirmed when elevated pathogenicity appeared to correlate with 
elevated protease activity (Khashe et al.,1996; Vivas et al., 2004a). Similarly, a 
higher proteolytic activity was found in A. hydrophila derived from humans, fish 
and other animal sources than those from water environments, confirming the 
involvement of the proteases in the pathogenicity of the bacteria from different 
hosts (Shotts et al., 1985). In contrast, Allan and Stevenson (1981) observed 
increased toxic effects in fish by the ECP of a protease-negative mutant of A. 
hydrophila in comparison to the parent strain (with protease activity), and 
suggested that proteases may not be contributing to virulence. 
 
The haemolysin toxin of A. hydrophila has been considered as one of the major 
virulence factors in the ECP of this bacterium. For example, Khalil and Mansour 
(1997) observed that the virulence of ECPs was closely associated with 
haemolysin activity, although Lallier et al. (1984) had previously suggested that 
haemolysis is not the principle toxic effect of the bacterium in fish. The response of 
speckled trout, Salvelinus fontinalis injected intraperitoneally (IP) with ECP from A. 
hydrophila suggested that the haemolytic activity is a significant lethal factor of the 
bacterium (Allan and Stevenson, 1981). This was confirmed when breakdown of 
haemoglobin (hemosiderosis) was observed in channel catfish infected by A. 
hydrophila, due to the haemolytic activity of virulent A. hydrophila (Ventura and 
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Grizzle, 1988). However, the activity of hemolysin produced by different A. 
hydrophila isolates is variable due to the heterogenicity of isolates. For example, 
differences were found in the activities of haemolysins expressed from cloned 
genes of two different A. hydrophila isolates in medium containing various 
erythrocytes from sources such as bovine, horse, rabbit and sheep (Hirono et 
al.,1992). Authors have also shown that the haemolytic activity of A. hydrophila 
has antibacterial activity against some other bacterial species (e.g. 
Staphylococcus spp) (Messi et al., 2003). 
 
One other exatracelluar toxin thought to be involved in the virulence of A. 
hydrophila is aerolysin. It binds to specific glycoprotein receptors on the surface of 
eucaryotic cells, and inserts itself into the lipid bilayer forming holes approximately 
3 nm in diameter (Karunasagar et al., 1986). This in turn leads to destruction of 
the permeability membrane barrier and ultimately cell death (Howard and Buckley, 
1985c). Thus, aerolysin kills cells by forming discrete channels in their plasma 
membranes (Buckley and Howard, 1999). Sirirat et al. (1999) found that aerolyin is 
expressed in greater amounts in the ECP of virulent isolates A. hydrophila than in 
avirulent isolates. 
 
Expression of specific virulence factors, in the ECP, seems to be dependent on 
the availability of nutrients (Gonzalez-Serrano et al., 2002). For example, Esteve 
and Birbeck (2004) showed that the amount of haemolytic and proteolytic activity 
of A. hydrophila is dependent on the culture media used, as differences in the 
expression of these activities was noted between bacteria grown in brain-heart 
infusion broth or tryptone soya yeast extract broth. Similarly, the differential up-
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regulation of the enolase enzyme of A. hydrophila was observed with bacteria 
grown in vivo in mice compared with those grown in vitro in broth (Sha et. al., 
2003). 
 
The production of components within the ECP have been shown to be affected by 
culture temperature, as Merino et al. (1992) found A. hydrophila to be more 
virulent for fish and mice when grown at 20°C than 37°C due to increased levels of 
ECP activity at lower temperature. O'Reilly and Day (1983) found higher 
proteolytic activity at 28°C than at 37°C, while Khalil and Mansour (1997) found 
increased production of protease at 30°C compared to 25°C in strains of A. 
hydrophila. Similarly, the highest production of the haemolysin was noted when A. 
hydrophila was grown at 35°C rather than 25 or 30°C (Khalil and Mansour, 1997). 
Aeromonas hydrophila can produce haemolysin and cytotoxin at 37, 28 and 5°C, 
however, toxins are produced faster and are more stable at 28°C than at 37°C 
(Tsai et al., 1997). 
 
1.4.3.2. The outer membrane and other surface components 
The outer membrane is the outermost structure on the surface of Gram-negative 
bacteria. Generally, Gram-negative bacteria are characteristically surrounded by a 
double membrane: the cytoplasmic or inner membrane, which is a phospholipid 
bilayer, and the asymmetrical outer membrane, which holds phospholipids and 
lipopolysaccharides (LPS) in its inner and outer layers, respectively (Figure 1.1) 
(Bos and Tommassen, 2004). Phospholipids are major structural and functional 
components of the cell envelop of all bacteria (Howard and Buckley, 1985b). The 
outer membrane  assembly  and the  extracellular protein secretion are reported to  
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be regulated by the expression of many genes such as exe genes (Howard et al., 
1993). Proteins present in the outer membrane are composed of two classes: 
lipoprotein, which are anchored into the outer membrane via a N-terminal lipid tail, 
and integral proteins that contain membrane-spanning regions. All proteins 
destined for the outer membrane are synthesized in the cytoplasm as precursors 
with N-terminal signal sequences, which are essential for translocation across the 
inner membrane (Bos and Tommassen, 2004). 
 
 
Figure 1.1: Structure of the outer membrane 
 
The OMP are believed to be a primary factor involved in the attachment 
(adhesion) of A. hydrophila to various host tissues, as this is a prerequisite to 
initiate infection (Del Corral et al., 1990). Quinn et al. (1994) isolated pore-forming 
OMP from A. hydrophila and suggested that it may be involved in the initial 
colonization of the bacterium on its host. Similarly, it was suggested that the 43 
kDa porin may be an important adhesin with regard to entry into common carp 
epithelial cells because of an abundance of this particular receptor on the cell 
surface (Lee et al., 1997). 
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The LPS is an important component of the outer membrane of Gram-negative 
bacteria (Howard and Buckley, 1985b), which consists of a hydrophobic 
membrane anchor, lipid A, substituted with an oligosaccharide core region that 
can be extended in some bacteria by a repeating oligosaccharide, the O-antigen 
(Bos and Tommassen, 2004). It plays an important role in the pathogenesis of the 
bacterium including having a role in adhesion and its ability to cause 
gastroenteritis (Merino et al.,1996a; Knirel et al., 2002). Shaw and Squires (1984) 
found an involvement of A. hydrophila LPS in bacteriophage attachment and other 
virulence properties such as serum resistance. It has been confirmed that A. 
hydrophila strains lacking a defined LPS are susceptible to killing by human serum 
(Janda et al., 1994a). Similarly, Mittal et al. (1980) reported that virulent strains of 
A. hydrophila express a unique O-antigen, and were able to differentiate between 
virulent and less virulent strains on the basis of serogrouping and cell surface 
characteristics. 
 
Many of the properties which facilitate the colonisation of the bacterium on its host 
are associated with the cell surface of A. hydrophila, and are very important in  
host-pathogen infection (Dooley and Trust, 1988). Cell surface structures enable 
this pathogen to bind to a large number of cells and biomolecules in host tissues 
(Janda and Duffey, 1988; Ascencio et al., 1991a and 1998). These cell surface 
receptors can bind with iron-containing proteins of the host and may be involved in 
the acquisition of iron by the bacterium (i.e. the siderophores mentioned earlier) 
(Ascencio et al., 1992). However, environmental factors such as temperature play 
a significant role in regulating virulent factors, including the biochemistry of the cell 
surface of A. hydrophila (Merino et al., 1992). 
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The S-layer proteins are considered to play a major role in infection for a number 
of bacteria (Boulanger et al., 1977; Dooley and Trust, 1988; Messner and Sleytr, 
1992). The S-layer or paracrystalline surface layer was first described in Spirillum 
using electron microscopy (EM) by Houwink in 1953. Thereafter it has been 
reported in nearly every taxonomic group of walled eubacteria, and is a feature of 
most archaebacterial cell envelops (Sleytr and Messner, 1983 and 1988; Messner 
and Sleytr, 1992). Pathogenic bacteria such as Clostridium botulinum, A. 
salmonicida, Campylobacter fetus subsp. fetus, C. rectus and Mycobacterium 
bovis have all been reported to possess S-layers (Boulanger et al., 1977; Messner 
and Sleytr, 1992). 
 
Using a laboratory challenge model, Thune et al. (1986) showed the S-layer of A. 
hydrophila to correlate with virulence. It is believed to influence the interaction 
between the bacterial cell and its environment (Austin and Austin, 1999). The 
localisation of the S-layer on the surface of the cell suggests it has an important 
role in the growth and survival of bacteria, and is the site of interaction between 
the bacteria and the external environment. It possesses anti-phagocytic activity 
which may aid in the systemic dissemination of bacteria once invasion through the 
gastrointestinal mucosa has occurred (Janda et al., 1994a). However, the degree 
of antigenicity of S-layer proteins varies among bacterial species (Kobayashi et al., 
1993). The S-layer in conjunction with LPS has been shown to play an integral 
part in the overt resistance of A. salmonicida to complement-mediated lysis 
(Chang et al., 1992). 
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1.5. Diagnostics 
Diagnosing disease and identifying the infectious agents included are important for 
managing any disease. Visible internal and external clinical signs indicating 
disease caused by A. hydrophila are discussed in the Section 1.4.2.1. However, 
diagnosis can be very difficult, since the progress of infection by A. hydrophila is 
rapid in the fish under favourable conditions for the bacterium (Jeney and Jeney 
1995), and other pathogens such A. salmonicida and Vibrio species could also 
possibly cause similar signs. Confirming the association of A. hydrophila with 
disease/infection is important before treating the disease. A number of methods 
have been reported for the detection and identification of this pathogen, including 
traditional (phenotypic and biochemical characteristics), immunological and 
molecular techniques. 
 
Traditional methods to detect and identify A. hydrophila include examination of the 
shape and colour of colonies on nutrient agar, Gram staining, morphology and 
motility of the bacterium and various biochemical analyses (Altwegg et al., 1990; 
Chaudhury et al., 1996; Yambot, 1998). A rapid method based on biochemical 
analysis using an API strip containing premixed chemicals has been routinely 
used for the identification of A. hydrophila (Dixon et al., 1990; Gatesoupe, 1991; 
Hettiarachchi and Cheong, 1994; Noterdaeme et al., 1991). However, traditional 
methods are not fully reliable for the identification of A. hydrophila to species level 
due to similarity in some phenotypic and biochemical characters with other 
species (A. caviae and A. sorbia). In addition, the biochemical characteristics 
expressed between different isolates of A. hydrophila are not always same (De 
Figueiredo and Plumb, 1977). 
 Chapter 1  Page 23 
Immunological detection methods such as enzyme linked immunosorbent assay 
(ELISA) were developed for the detection of A. hydrophila by Merino et al. (1993) 
and Sendra et al. (1997). Korbsrisate et al. (2002) produced polyclonal antibodies 
against A. hydrophila for use in a specific direct agglutination test to identify A. 
hydrophila. Monoclonal antibodies (Mabs) have also played a vital role for the 
identification of fish pathogens (Adams and Thompson, 2006), and Mabs that 
recognise a particular serotype O side-chain core oligosaccharide of A. hydrophila 
have been developed (Cartwright et al., 1994). Chanphong et al. (1999) developed 
Mabs against a 41 kDa protein of A. hydrophila, while Mabs were also produced 
against A. hydrophila that recognised a 110 kDa polypeptide on the bacterium 
(Delamare et al., 2002). Although immunological methods have been useful in the 
identification of A. hydrophila, it might only be possible to identify particular 
isolates/serotypes with the specific antibodies developed due to heterogenicity of 
isolates (Merino et al., 1993). 
 
Molecular methods have been recommended for the identification A. hydrophila to 
overcome possible problems encountered with traditional or immunological 
methods. Sugita et al. (1994) suggested a deoxyribonucleic acid (DNA) based 
hybridisation method for the identification of A. hydrophila, while amplification of 
specific genes (e.g. haemolysin) of A. hydrophila by polymerase chain reaction 
(PCR) has been recommended for detection of the bacterium (Xia et al., 2004). In 
addition, a rapid identification method was developed by sequencing 16s 
ribosomal DNA (rDNA) regions of A. hydrophila (Dorsch et al., 1994). More 
recently, Chu and Lu (2005) developed a multiplex PCR method to amplify the 16s 
rDNA gene and the aerolysin gene of A. hydrophila to detect pathogenic strains of 
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A. hydrophila. A method combining immunological and molecular techniques 
(immuno-capture assay with PCR) has also been developed to provide a quick, 
sensitive and reproducible way of detecting A. hydrophila (Peng et al., 2002). 
 
1.6. Treatments and control 
1.6.1. Antibiotics 
Antibiotics are the major agents for controlling A. hydrophila (Fang et al., 2004). 
Those described as being effective include furance (Mitchell and Plumb, 1980), 
sulfonamide (Bowser et al., 1987), chloramphenical, neomycin, sulfamethoxazole-
trimethoprim, streptomycin, naladixic acid, oxolinic acid, neomycin and 
sarafloxacin (Krovacek et al., 1989; Dixon et al., 1990), rifampicin (Ansary et al., 
1992), oxytetracycline (Tafalla et al., 1999), cephamycins and moxalactam 
(Zervosen et al., 2001), ciprofloxacin (Ko et al., 2003), amoxycillin and 
enrofloxacin (Ilhan et al., 2006). Aeromonas hydrophila is also found to be 
sensitive to other chemotherapeutants such as amino acid-derived hydroximates 
(Walter et al., 1999) and hydrogen peroxide (H2O2) (Landre et al., 2000). 
 
Although antibiotics control A. hydrophila to a certain extent, it has been observed 
that bacterial pathogens become resistant to chemotherapeutants when they are 
used over an extended period of time (Mitchell and Plumb, 1980; Vivekanandhan 
et al., 2002). Different isolates of A. hydrophila are reported to have resistance to 
the following antibiotics; ampicillin, carbenicillin, erythromycin, gentamicin, 
penicillin, tetracycline, nitrofuradantoin, ormetoprim-sulfadimethoxine, 
sulfamethoxazole-trimethoprim and triple sulfa (Dixon et al., 1990; Ansary et al., 
1992; Dixon and Issvoran, 1993; Ilhan et al., 2006). 
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The high incidence of antibiotic resistance in A. hydrophila isolated from cultured 
fish is assumed to be due to selective pressure exerted by the use of 
chemotherapeutics in aquaculture, since such resistance has not been found in A. 
hydrophila isolated from wild fish (Aoki et al., 1971; Radu et al., 2003). Moreover, 
the majority of researchers have found that resistance plasmids play a major role 
in the development of antibiotic resistant strains (Chang and Bolton, 1987; 
Choudhury et al., 1996; Son et al., 1997). It has also been found that the 
molecular size of the drug resistance plasmids in A. hydrophila range from 
approximately 3 to 150 kb (Chang and Bolton, 1987; Choudhury et al., 1996; Son 
et al., 1997). Restriction in the use of drugs to bacterial pathogens of fish will aid in 
minimising the development and spread of resistance plasmids in bacteria (Son et 
al., 1997). However, some other factors are suspected of playing a role in the 
antibiotic resistance, since Ansary et al. (1992) found no plasmids in A. hydrophila 
which are resistant to antibiotics (ampicillin and carbenicillin). 
 
Due to high resistance to some antibiotics applied in clinical practice, it is difficult 
to control A. hydrophila present in aquaculture systems (Riquelme et al., 1996; 
Daskalov, 2006). The development of antibiotic resistant strains is making the use 
of drugs more and more ineffective. In addition, transmission of resistance from 
resistant bacteria from aquaculture farms to bacteria of human and/or veterinary 
significance remains a major public health concern (Shariff, 1998). Thayumanavan 
et al. (2003) warned that the increasing population of multiple drug-resistant A. 
hydrophila in fish and prawns may become a potential human health hazard. Also 
the use of antibiotics can considerably increase the production cost to the 
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aquaculture industry, so, it is essential that losses caused by diseases and the use 
of antibiotics be kept at a minimum (Gudding et al., 1999). 
 
Apart from antibiotic resistance, a number of authors have reported that the use of 
antibiotics has adverse effects, such as accumulation of tissue residues and 
immunosupression of natural immunity in fish (Van Muiswinkel et al., 1985; Ellis, 
1988; Thompson and Adams, 2004). In contrast, other researchers reported that 
the use of certain antibiotics, such as sulfonamide and oxytetracycline, does not 
have adverse effects in fish (Bowser et al., 1987; Tafalla et al., 1999). The use of 
antibiotics and chemotherapeutics have been shown to evoke toxic effects in 
animals (Martin, 1973), and can interfere with certain steps in protein synthesis 
(Watson, 1975). It is also believed that mitochondrial protein synthesis might be 
inhibited by some antibiotics (De Vries and Kroon, 1970). Humoral and cellular 
immune responses of common carp have been shown to be suppressed during 
treatment with oxytetracycline, and an increased number of granulocytes were 
observed in the spleen of treated fish (Rijkers et al., 1980). 
 
The use of other chemicals in the aquaculture industry to kill ectoparasites, insects 
and weeds could also be immunosuppressors in fish. The reduction of several 
non-specific immune responses and serum enzymes were found, when Indian 
major carp (rohu) were exposed to the pesticide, α-permethrin (Nayak et al., 
2004a). These fish were found to be more susceptible to A. hydrophila challenge. 
Fish exposed to high levels of copper were also immunosupressed, with a change 
in various immunological parameters occurring (Ellis, 1981; Shariff et al., 2001). 
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1.6.2. Immunostimulants 
A variety of immunostimulants have been reported to enhance immunity against A. 
hydrophila, these being mainly herbal extracts, glucans and vitamin C, although a 
number of other immunostimulants also have been reported to have promising 
effects. For example, increased immunity in blue gourami, Trichogaster 
trichopterus against a virulent strain of A. hydrophila was reported, when the fish 
was treated IP with an extract from marine algae, laminaran (Samuel et al., 1996). 
An increase in serum glucose, cholesterol, total protein, red blood cell counts, 
hemoglobin and hematocrit/packed cell volume was found in A. hydrophila-
infected common carp after treating them by immersion with a leaf extract of 
Azadirachta indica (Harikrishnan et al., 2003). Similarly, herbal seed powder 
(Achyranthes aspera) in the diet increased innate immunity and resistance of rohu 
to A. hydrophila when experimentally infected with the bacterium (Vasudeva Rao 
et al., 2006). 
 
Other extracts from marine animals such as tunicate (sea squirt), Ecteinascidia 
turbinate enhanced both the humoral and the cellular immunity of American eel, A. 
rostrata against A. hydrophila (Davis and Hayasaka, 1984). It has been reported 
that glucans could also increase the immunity of fish against A. hydrophila as 
increased survival of tilapia and grass carp infected with A. hydrophila was 
observed when the fish were injected with glucans such as bar, krestin, 
scleroglucan and zymosan (Wang and Wang, 1997). Similarly, common carp 
injected IP with glucan showed an increase in their leucocyte counts (neutrophils 
and monocytes) and resistance to A. hydrophila challenge (Selvaraj et al., 2005). 
 Chapter 1  Page 28 
An adjuvant effect by the glucan was observed, since fish injected with glucan 
resulted in the highest antibody titer against A. hydrophila following vaccination. 
 
Humoral and cell mediated immune responses were found be increased in vitamin 
C supplemented catfish, Mystus gulio (Anbarasu and Chandran, 2001). The 
authors found a higher relative percentage survival (RPS) value in the vitamin C 
supplemented fish compared with the non vitamin C supplemented fish, when 
challenged with A. hydrophila following vaccination. Sobhana et al. (2002) found 
the infiltration of phagocytic cells into the injection site in mrigal (i.e. fish were 
injected with A. hydrophila IP) was quicker when their diet were supplemented 
with vitamin C, and the bacteria were cleared from the fish by Day 9 post-infection 
compared with vitamin C non-supplemented group. 
 
Hormones such as human lactoferrin (HLF) have been found to have 
immunomodulatory activities, as Weifeng et al. (2004) observed the development 
of resistance to A. hydrophila in HLF-transgenic grass carp, Ctenopharyngodon 
idella. Supplementation of diets with yeast ribonucleotides (RNA) also resulted in 
an improved resistance of rohu to A. hydrophila infection (Choudhury et al., 2005). 
Probiotics have been reported to increase the specific immune response, for 
example Ramadan et al. (1994) noted that supplementing the diet of tilapia with 
ascogen resulted in an increased antibody response in fish vaccinated with a 
formalin-killed preparations of A. hydrophila. Also, the dietary administration of 
hormones (triiodothyronine) in rohu enhanced the immune response of the fish 
vaccinated with formalin-killed A. hydrophila, which in turn conferred protection 
against an A. hydrophila challenge (Sahoo, 2003). 
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1.6.3. Vaccines 
Vaccination of humans and other animals, including fish, is one of the major 
methods for preventing infectious disease (Potter and Baiuk, 2001). Immunisation 
primes the immune system of the host against pathogens encountered during 
infections (Thompson and Adams, 2004). Fish vaccination in the aquaculture 
industry has been considered to be very important in reducing economic losses 
caused by disease (Ellis et al., 1997; Rahman and Kawai, 2000; Ebanks et al., 
2004). Several different kinds of vaccines have been investigated/developed 
against A. hydrophila including whole cell (WC), OMPs, ECPs, LPS and biofilms, 
although currently no commercial vaccine exists. 
 
1.6.3.1. History of A. hydrophila vaccine development 
Aeromonas hydrophila is an important pathogen that has caused major loss in the 
aquaculture industry for decades (Shotts et al., 1972; Olivier et al., 1981; Esteve et 
al., 1995). Many attempts have been made to develop an effective vaccine against 
A. hydrophila (Lamers et al., 1985; Baba et al., 1988b; Leung et al., 1997; 
Rahman and Kawai, 2000). The effects of number inactivated WC vaccines have 
been reported. For example, an increase in serum antibody levels against A. 
hydrophila was showed in common carp immersed in a preparation of heat 
inactivated A. hydrophila (Lamers et al., 1985). Later, Kusuda et al. (1987) also 
found an increase in the concentration of total serum proteins, when common carp 
were immunised with formalin killed A. hydrophila. Rainbow trout, immunised by 
injection, immersion and oral administration of killed A. hydrophila, have been 
shown to produce antibodies in their serum, bile, skin and gut mucus, and skin 
and muscle extracts (Loghothetis and Austin, 1994). A polyvalent vaccine 
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containing heat killed WC and formalin inactivated ECP of A. hydrophila has also 
been tested in two Indian major carp species (rohu and mrigal), but it failed to 
protect the fish against bacterial challenge (Chandran et al., 2002a). However, 
these authors observed relatively high antibody titres in immunised fish suggesting 
that the low survival in the vaccinated group may be due to an impact of unknown 
stress on the fish in the pond, or maybe the antibodies induced by the vaccine 
were not protective. 
 
Thin layers of bacteria (biofilms) grown on the surfaces of nutrient flakes (chitin) 
have been used as heat inactivated biofilm vaccines against A. hydrophila, by oral 
administration. For example, bacteria harvested from chitin flakes suspended in 
TSB have been reported to elicit a protective response in Indian major carp (catla 
and rohu) and common carp (Azad et al., 1999). These biofilm vaccines have 
been found to be retained for longer than free cell vaccines  in the tissues of gut, 
spleen and kidney in Indian major carp (Azad et al., 2000a). Catfish, fed with such 
biofilm vaccines, showed significantly higher serum agglutinating antibody titres 
and RPS compared to those fed with free cells, after subsequently challenging fish 
with A. hydrophila (Nayak et al. 2004b). A change in antigenic expression was 
noticed in A. hydrophila grown on a biofilm (Asha et al., 2004). The authors found 
that the S-layer proteins were lost and the LPS of the bacteria contained an 
additional high molecular weight band in biofilm-cultured cells compared with 
planktonic cells. Asha et al. (2004) suggested that this high molecular weight LPS 
band might elicit a protective immune response when the biofilm was 
administrated as an oral vaccine. 
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Considerable interest has been shown in bacterial OMP vaccines since these 
were thought to contain some of the major antigens responsible for inducing an 
immune response in the host (Aoki and Holland, 1985; Fang et al., 2004). Rahman 
and Kawai (2000) found that the OMPs of A. hydrophila elicited protection against 
an A. hydrophila challenge, and suggested that a vaccine based on selected OMP 
antigens may be effective. Munn (1994) suggested outer membrane components 
such as LPS could represent protective vaccine candidates for Gram-negative 
bacteria, while Dooley et al. (1986) reported that LPS of A. hydrophila possess 
highly immunogenic O polysaccharide chains of homogeneous length, and these 
were conserved both morphologically and antigenically in virulent isolates. The 
role of LPS in protection was also shown, in common carp vaccinated with crude 
LPS compared with a formalin-killed WC vaccine (Baba et al., 1988b). This 
protection appears to be based on cellular immunity, particularly thymus cells and 
macrophages rather than humoral immunity (Baba et al., 1988a). Similarly, 
Loghothetis and Austin (1996b) reported that LPS could be a major antigenic 
component of A. hydrophila. 
 
Live WC cell vaccines have also been found to increase antibody responses in 
fish (Loghothetis and Austin, 1994). Other live vaccines, such as live attenuated 
(mutant) vaccines have also been explored for A. hydrophila. For example, 
growth-deficient mutants of A. hydrophila have been found to be promising live 
vaccine candidates in fish (Leung et al., 1997). An AroA mutant A. hydrophila 
strain was also investigated and found to be protective in rainbow trout (Moral et 
al., 1998). The aromatic amino acid pathway is blocked in this mutant with the 
result that its growth in fish tissues is prevented. The vaccine was also found to 
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elicit significant protection against A. salmonicida (Vivas et al., 2004b). Vivas et al. 
(2004c) suggested that this live aroA attenuated vaccine had a high level of safety 
compared with normal strains as it has a lower potential to survive in water. Other 
live vaccines have also been investigated, for example Catfish, Clarias batrachus 
immunised with plasmid free A. hydrophila mutants, showed an increased survival 
rate following challenge with wild bacteria compared to the control group 
(Majumdar et al., 2006). Mutant strains of A. hydrophila with a highly attenuated 
exoenzyme were also shown to confer protection in swordtail fish, Xiphophorus 
helleri (Liu and Bi, 2006). 
 
Although all the vaccines reported have shown varying degrees of increased 
immunity and protection, no commercial vaccine is available for A. hydrophila 
(Loghothetis and Austin, 1996b; Rahman and Kawai, 2000; Fang et al., 2004; 
Vivas et al., 2005). This could be due to reduced efficacy of the vaccines against 
different isolates or serogroups of A. hydrophila, due to the heterogenicity of this 
bacterium (Stevenson, 1988; Janda et al., 1996; Merino et al., 1997; Aguilar et al., 
1999; Chandran et al., 2002a). Over 90 established or provisional serogroups 
within the genus Aeromonas have been described, and the heterologous nature of 
A. hydrophila, both biochemically and serologically are still the greatest concern 
for developing an effective vaccine against A. hydrophila (Sakazaki and Shimada 
1984; Stevenson, 1988; Khashe et al., 1996; Newman, 1993; Janda et al., 1994b; 
Leung et al., 1995). 
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1.6.3.2. Approaches for developing an effective A. hydrophila vaccine 
Many factors must be considered for developing an effective vaccine. The vaccine 
produced should be protective and should not cause any adverse effect in the host 
(Makela, 2000; Potter and Babiuk, 2001; Schuijffel et al., 2005). In addition, the 
vaccine should be cost effective for global use in the aquaculture industry (Leong 
and Munn, 1991; Munn, 1994; Naidu and Yadav, 1997). The vaccines already 
developed by a number of research groups for A. hydrophila do not appear to be 
fully effective due to heterogenicity of the challenge isolates. Therefore, authors 
have recommended identifying common antigens between different isolates of A. 
hydrophila as vaccine candidates (Dooley et al., 1988; Leung et al., 1997). The 
protective nature of such antigens then needs to be established. 
 
Understanding host-pathogen interactions, especially the host immune response 
to the pathogen, might offer important clues about potential protective antigens for 
vaccine development (Ellis, 1999). Such molecules tend to be ECP toxins and 
proteins located on the surface of pathogens. For example, the ECP of A. 
hydrophila has been reported to contain the antigens necessary for a successful 
vaccine against MAS (Allan and Stevenson, 1981). Loghothetis and Austin 
(1996b) suggested LPS as a vaccine candidate of A. hydrophila as they found 
increased antibody responses against this component in rainbow trout infected 
with live A. hydrophila. Similarly, other surface components of this bacterial 
pathogen, such as OMPs have been widely suggested as attractive targets for 
vaccines due to their involvement in the infection process (Esteve et al., 1994; 
Zhang et al., 2000). Recently, Maji et al. (2006) suggested using a 57 kDa and a 
23 kDa protein found in OMP preparations of A. hydrophila, since they appear to 
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be highly immunogenic when screened with rabbit serum raised against crude 
OMP. 
 
Proteomics combined with Western blot (immunoproteomics) and mass 
spectrometry techniques have been recognised as useful tools for identifying 
proteins of interest for vaccine development. The separation and characterisation 
of complex proteins by 2 dimensional sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (2D SDS-PAGE) has been used to acquire information about the 
expression of proteins in fish bacterial pathogens grown in different culture 
conditions. For example, the OMPs of A. salmonicida, grown in vitro in TSB or 
iron-restricted TSB, and in vivo within chambers implanted in the abdominal cavity 
of Atlantic salmon, Salmo salar have been compared for their differential 
expression (Ebanks et al., 2004). After having obtained information on the 
expression of proteins, 2D SDS-PAGE Western blot allows identification of those 
antigens recognised in the host (Chen et al., 2004). The application of matrix-
assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF 
MS) with 2D SDS-PAGE based techniques is another powerful tool for 
understanding the functions of the proteins (Guerrera and Kleiner, 2005). Overall, 
these techniques can provide crucial information about proteins of interest leading 
to the identification of an effective candidate for vaccine development (Chakravarti 
et al., 2000). For example, recently, potential vaccine candidate proteins were 
identified using immunoproteomics for important human and animal pathogens, 
such as Helicobacter pylori (Krah et al., 2004), Neospora caninum (Shin et al., 
2004), Shigella flexneri (Ying et al., 2005) and Klebsiella pneumoniae (Kurupati et 
al., 2006). 
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Another important factor in vaccine development is the ability to produce sufficient 
quantities of the protective proteins for commercialisation of the vaccine. 
Recombinant DNA technology enables rapid production of large quantities of 
protein in comparison to the traditional method, where purifying proteins from the 
pathogen might yield low quantities as well as involving time consuming processes 
(Munn, 1994; Chakravarti et al. 2000; Potter and Babiuk, 2001; Van den Bergh 
and Arckens, 2005). Recombinant protein vaccines have been reported to have 
conferred protection for a variety of human and animal pathogens (including fish) 
such as Yersinia pestis (Williamson et al., 1995), Ichthyophthirius multifiliis (He et 
al., 1997), rabies virus (Rupprecht et al., 2005), Plasmodium falciparum (Saul et 
al., 2005), and Piscirickettsia salmonis (Wilhelm et al., 2006). 
 
1.7. Aims of the study 
The development of an effective vaccine against A. hydrophila has proven difficult 
due to the heterogenicity of isolates. The main aim of this project was to develop 
an A. hydrophila vaccine that would protect against different strains of A. 
hydrophila isolated from various geographical regions of the world. The different 
specific objectives of the project are summarised below:- 
 
• Classification of different A. hydrophila isolates mainly on the basis of 
virulence using artificial infections in common carp. 
 
• Comparison of protein profiles from different preparations (WC, ECP and 
OMP) of A. hydrophila isolates grown in vitro and in vivo for the identification 
of common and unique proteins. 
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• Identification of the immunogenic proteins of A. hydrophila grown in vitro and 
in vivo in the host (common carp) to determine vaccine candidates. 
 
• Determination of the protection efficacy of the immunogenic proteins 
identified. 
 
• Sequencing of the immunogenic protein and production of recombinant 
proteins. 
 
• Efficacy testing of a recombinant vaccine against different isolates of A. 
hydrophila in common carp. 
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Chapter 2. Characterisation of A. hydrophila: 
Biochemistry, virulence and protein expression 
following culture in vitro and in vivo  
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2.1. Introduction 
Aeromonas hydrophila can be found in a wide range of different environments, 
and is able to adapt, survive and grow at a range of different pH, temperature, salt 
and dissolved oxygen concentrations, and when nutrients are limited (Karem et 
al., 1994; Tsai et al., 1997). The biochemical properties of bacteria are considered 
to be essential for differentiating them phenotypically, and in most cases A. 
hydrophila isolates are consistent with the expected expression of their 
biochemical characteristics (Altwegg et al., 1990; Janda et al., 1996). However, it 
has also been reported that the biochemical characteristics of A. hydrophila can 
be variable and highly temperature dependent (Lallier and Higgins, 1988; Kuijper 
et al., 1989). The majority of A. hydrophila isolates examined by Janda et al. 
(1996) were shown to be able to ferment salicin, utilise DL-lactate and oxidise 
gluconate and very few isolates were able to ferment L-Rhamnose and utilise 
urocanic acid. 
 
This bacterium has the potential to infect humans and other animals, however, not 
all the strains of A. hydrophila are virulent, moreover heterogeneous protein 
profiles are expressed between different virulent strains (Merino et al., 1992; 
Aguilera-Arreola et al., 2005). Nieto and Ellis (1991) concluded that there were 
significant qualitative as well as quantitative differences in the protein components 
of the extracellular products (ECP) of different Aeromonas species and isolates, 
even though they were grown under the same growth conditions. The ECP of A. 
hydrophila is considered to be a major virulent factor for permitting bacterial 
growth within the host and in its development of further infection (Kanai and 
Wakabayashi, 1984). 
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Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) has 
been extremely useful as an analytical tool for the separation and quantification of 
proteins from complex mixtures (O’ Farrell, 1975). Computer analysis of SDS-
PAGE protein profiles of whole cell preparations has been widely used in the 
classification and identification of different species of lactic acid bacteria (Piraino 
et al., 2006). The SDS-PAGE profile of whole cell (WC) preparations of A. 
hydrophila can provide information on the proteins expressed by the bacterium, 
and is a useful tool for studying differences between strains and can be used as a 
diagnostic and epidemiological tool (Haenninen, 1994). 
 
As a technique, 2D SDS-PAGE provides much more information than 1D SDS-
PAGE as it is capable of resolving thousands of proteins in a single procedure 
(O'Farrell, 1975). It has been traditionally used for separating complex mixtures of 
proteins and thereby to identify and characterize individual peptides/proteins 
(Chakravarti et al., 2000; Khouldi et al., 2004). It can also be used to compare 
quantities of proteins in related samples, some of which may have been altered by 
environmental conditions, or to compare mutant and wild type bacteria (Munn, 
1994). Recently, it has been used for identification of potential vaccine candidates 
when applied in conjunction with Western blotting (Chen et al., 2004). 
 
The protein profiles of both the outer membrane protein (OMP) and ECP appear to 
change between isolates or within an isolate when A. hydrophila is cultured under 
different environmental conditions (Merino et al., 1992; Rahman et al., 2001a; 
Esteve and Birbeck, 2004; Imbert and Gancel, 2004). This heterogenicity is of 
particular interest when comparing the growth of the bacterium in vivo and in vitro, 
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since differential up regulation of genes and changes in the surface composition of 
the bacterium has been reported following culture in vitro and in vivo (Rahman and 
Kawai, 2000; Sha et al., 2003). Considerable differences in protein profiles and 
ECP expression between bacteria cultured in vitro and in vivo have also been 
shown for a number of other pathogens, including Streptococcus suis (Quessy et 
al., 1994), Vibrio salmonicida (Colquhoun and Sorum, 1998), A. salmonicida (Ellis 
et al., 1997; Dacanay et al., 2003; Wang et al., 2004), Photobacterium damselae 
subsp. piscicida (Bakopoulos et al., 2004), Staphylococcus aureus (Arbuthnott et 
al., 1992; Allard et al., 2006), Mycobacterium tuberculosis (Akhtar et al., 2006) and 
Francisella tularensis (Twine et al., 2006). 
 
Pansare et al. (1985) reported that certain amino acids, such as alanine and 
arginine, could be used as the sole source for nitrogen to support the growth of A. 
hydrophila in vitro, and suggested that the sarcoplasmic fraction of muscle in fish 
and shellfish is an ideal growth medium for the bacterium in vivo. True antigen 
expression occurs when the bacterium is grown in vivo compared to growth on 
artificial media, in vitro (Garduno et al., 2000). In most cases, A. hydrophila tends 
to produce a capsule in vivo (Mateos and Paniagua, 1995). 
 
Many authors have tried to mimic “near” in vivo conditions for culturing bacteria to 
determine the changes in protein profiles that occur when the bacteria are cultured 
under such conditions. The expression of these differences on bacteria may be 
important to incorporate into the vaccine to produce a protective vaccine. Changes 
in the OMP profiles have been found for a number of major OMPs isolated from 
different strains of A. hydrophila (Aoki and Holland, 1985) and A. salmonicida 
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(Hirst and Ellis, 1994) when cultured under iron-limited conditions. For most 
bacteria, the outer membrane is very important in protection from its host. A 
capsule, for example, helps the pathogen to survive in unfavourable environments, 
such as increased pH and temperature. The outer membrane also plays a 
significant role in virulence, since the outermost surface of the bacterium is in 
direct contact with host cells and immune defences (Ebanks et al., 2005; 
Murakami et al., 2002), and therefore outer membrane components have been 
considered as potentially important vaccine candidates (Vazquez-Juarez et al., 
2003). 
 
The main objective of this chapter was to compare the biochemistry and the 
virulence of 14 isolates of A. hydrophila and then to determine differences 
between WC protein, OMP and ECP preparations of A. hydrophila that had been 
grown in vitro and in vivo. Analysis was performed using one dimensional (1D) 
and two dimensional (2D) SDS-PAGE to examine the profiles between the 
bacteria grown in vitro and in vivo and to identify common proteins between 
bacterial isolates. Changes in the morphology of the bacteria were also 
investigated by electron microscopy. 
 
2.2. Materials and methods 
2.2.1. Biochemical characterisation of the A. hydrophila collection 
Biochemical and growth profiles, Gram staining, and motility tests were performed 
to characterise the A. hydrophila collection held at the Institute of Aquaculture. In 
total, fourteen A. hydrophila isolates from different geographical regions were used 
in this work (Table 2.1). The strains were revived from frozen stocks and 
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maintained on slopes of tryptone soy agar (TSA) (Oxoid, UK). The slopes were 
sub-cultured every six months, and bacteria were regularly sub-cultured on plates 
to check their purity. Gram staining and motility tests were carried out before sub-
culturing onto new slopes. 
 
Table 2.1: A. hydrophila strains used in this study 
 
Isolate Host species Country/date Comments 
T4 Rohu (Labeo rohita) 
Bangladesh 
(1994) 
From an Epizootic 
Ulcerative 
Syndrome (EUS) 
lesion 
98141 
98140 
98139 
Black shark  
(Morulius 
Chrysophekadion) 
Ayuthaya 
Province, 
Thailand 
(1998) 
From a 
Haemorrhagic 
lesion 
Hh Hedgehog (Erinaceus Europaeus) 
Institute of 
Aquaculture, 
Scotland 
- 
Vds Catfish  (Ictulurus puctatus) India 
From an EUS 
lesion 
Catla Catla (Catla catla) India From heart blood 
C24li African catfish,  (Clarias gariepinus) 
Aquatic Animal 
Health 
Research 
Institute, Thailand 
- 
2D20 - 
3D14 - 
2N14 - 
F1d 75 
Frog  
(Rana rugulosa) Asia 
- 
B2/12 unknown Bangladesh - 
Calf unknown 
Institute of 
Aquaculture, 
Scotland 
- 
 
All the above isolates were obtained from Institute of Aquaculture bacterial 
collection. 
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2.2.1.1. Bio-chemical characterisation 
The bio-chemical characteristics of A. hydrophila T4 strain, before and after 
passaging once and twice through fish, and comparison with a type strain from the 
National Collection of Industrial and Marine Bacteria (NCIMB) was performed 
using API 20E (Biomerieux, France) strips, according to the manufacturer’s 
instructions. 
 
2.2.1.2. Gram staining 
Gram staining was performed according to Gram (1884). The composition of the 
reagents used for Gram staining is described in Appendix I. A smear of bacteria 
was placed onto a slide and heat-fixed. Crystal violet was used to stain the smear 
for 1 min, and washed with tap water after pouring off the stain. Gram's iodine was 
then flooded onto the slides and left for 1 min. This was poured off and the smear 
was destained with acetone for 2-3 sec. The slides were washed with water, then 
flooded with safranin for 2 min. The slides were washed with tap water, air dried 
and examined under oil immersion at 100x. 
 
2.2.1.3. Motility test 
A small amount of paraffin wax was placed on four corners of a coverslip and a 
small loopful of sterile saline (0.85 %) was placed into the middle of the coverslip 
(Collins and Patricia, 1976). Bacteria from a fresh culture were resuspended in the 
saline solution. A microscope slide was carefully placed onto the coverslip, taking 
care not to lower the slide onto the suspension, in order to have a hanging drop 
from the coverslip and the motility observed under 40x magnification. 
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2.2.1.4. Standard concentration curve 
A standard concentration curve was prepared for A. hydrophila isolate T4 by using 
viable drop counts technique (Miles and Misra, 1938). The strain was grown 
overnight in tryptic soy broth (TSB) (Oxoid, UK) at 28°C and the pellets harvested 
and washed twice with phosphate buffered saline (PBS) (Appendix I) by 
centrifuging at 1600 × g for 15 min. Pellets were resuspended in PBS and dilutions 
of the bacteria prepared with an absorbance at 610 nm of 0.2, 0.4, 0.8, 1.0, 1.2. 
Dilutions were prepared from all these different concentrations in PBS to give a 
final dilution of 10-6 and 20 µl of this dilution for each absorbance was spotted onto 
six segments of a TSA plate. The plates were incubated overnight at 28°C and an 
average colony forming unit (CFU) calculated for each plate. The number of CFU 
ml–1 was calculated using the following formula, the average number of CFU in a 
segment × 50 × dilution factor (106). A standard concentration curve of optical 
density (OD) at 610 nm vs the average number of CFU ml–1 was then constructed. 
 
2.2.2. Virulence of A. hydrophila in common carp, Cyprinus 
carpio 
This experiment was conducted using the 14 strains of A. hydrophila shown in 
Table 2.1. The bacteria were grown and adjusted to an OD of 1.0 at 610 nm, 
equivalent to 1 × 108 ml-1 CFU, as described in Section 2.2.1.4. From this 
suspension, concentrations of 106 and 104 bacteria ml-1 were prepared. Common 
carp, weighing 30-40 g, were obtained from the indoor fish culture system of 
Research Institute for Fisheries, Aquaculture and Irrigation, Hungary (HAKI). The 
fish were initially anaesthetised for 1 min in a 0.004 % (w/v) benzocaine solution. 
Six fish were used for each of the three bacterial dilutions described above and a 
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total of eighteen fish were used for each bacterial strain. Fish were injected 
intraperitoneally (IP) with 0.1 ml of the bacterial suspension. Each group, injected 
with one of the A. hydrophila isolates, was maintained in individual glass tanks, 
and clipped to identify the different bacterial concentrations injected. The tanks 
were supplied with water, which was passed through a biological recirculatory 
system and ultraviolet (UV) irradiation. The experiment was conducted in a 
temperature controlled indoor aquarium at a water temperature of 20-22°C. The 
fish were monitored three times a day and dead fish removed from the tanks. 
Kidney swabs were taken from dead fish and streaked onto TSA to confirm that 
mortality was due to A. hydrophila. 
 
2.2.3. Culture of A. hydrophila in vitro and in vivo 
The protein profiles of WC, OMP and ECP from bacteria grown in vitro and in vivo 
were examined by 1 and 2D SDS-PAGE. The protein concentration of each 
sample applied to the gels was determined using a protein concentration 
determination kit (Pierce scientific company, Rockford, USA) according to the 
manufacturer’s instructions. 
 
2.2.3.1. Culture of bacteria in vitro 
All 14 strains shown in Table 2.1 were grown in TSB overnight at 28°C for WC and 
OMP preparations, while culture of the bacterium on TSA with a cellophane 
overlay was used to collect the ECP (Liu, 1957). 
 
To prepare WC, the strains of A. hydrophila were grown and the concentration of 
the bacterial suspension adjusted to 1.0 at 610 nm as described in Section 
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2.2.1.4. The bacteria were pelleted by centrifugation at 1600 × g for 10 min and 
the bacteria were then resuspended in sample buffer (Appendix I) at a 
concentration of 1-2 mg ml-1 for SDS-PAGE analysis. 
 
The OMPs from the bacteria were prepared using the method of Osborn et al. 
(1972), with modifications. All 14 strains were grown and harvested, as described 
in Section 2.2.1.4, but the pellets were washed twice with sterile 10 mM Tris-HCl, 
pH 7.8 instead of PBS. The pellets were then resuspended in lysis solution [10 
mM Tris – HCl, 10 mM ethylene diamine tetra acetic acid (EDTA) + 50 µg ml-1 
Phenylmethylsulphonylfluoride (PMSF)] using a volume approximately twice the 
size of the bacterial pellet. The suspension was incubated for 30 min at 45°C and 
then cooled quickly on ice. Two to three volumes of glass beads (150-212 µm) 
were added to the bacteria and vortexed 3 times for 60 sec at 10 sec intervals. 
DNase and RNase were each added at 2 µg ml-1 and incubated 30 min at 20-
22°C. Unbroken cells and debris were removed by centrifuging at 2000 × g for 10 
min. The supernatant containing both OMP and inner membrane protein (IMP) 
were collected and centrifuged at 88,000 × g for 1 h at 4°C to collect the OMP and 
IMP. The supernatant was removed and pellets resuspended in approximately 4 
ml of 1.5 % (v/v) sodium lauryl sarcosinate and vortexed slowly before incubating 
for 30 min at 25°C to solubilise the IMPs (Filip, 1973). The suspension was 
centrifuged at 91,300 × g for 40 min at 4°C to collect the insoluble OMPs. The 
pellet was dissolved and adjusted to a final protein concentration of 1-2 µg µl-1 in 
sample buffer for SDS-PAGE analysis. 
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To prepare the ECP from 4 virulent (T4, 98141, Hh and Vds) and 2 avirulent 
isolates (Catla and C24li), a 5 ml aliquot of bacterial culture, grown overnight as 
described in Section 2.2.1.4, was placed onto Cuprophan sheets (Medicell 
international ltd, UK) [with a 10 kilo Dalton (kDa) molecular weight (MW) cut off], 
which has been placed onto TSA within a large Petri dish (14 cm dia) (Liu, 1957). 
The membrane had first been boiled in 5 mM EDTA, 200 mM sodium bicarbonate, 
and autoclaved before placing on the TSA medium. The Petri dish was incubated 
overnight at 28°C, after which the bacterial culture was harvested from the 
membrane and suspended in sterile PBS. The suspension was centrifuged at 
1600 × g for 15 min to remove the bacteria. The supernatant was collected and 
concentrated using 10, 000 MW cut off spin concentrators (Vivo Science, UK). The 
concentrate was filtered using a 0.45 µm filter, and the protein concentration of the 
filtrate adjusted to 1-2 mg ml-1 in sample buffer for SDS-PAGE analysis. 
 
2.2.3.2. Culture of bacteria in vivo 
Four virulent strains (T4, 98141, Hh and Vds) and 2 avirulent strains (Catla and 
C24li) of A. hydrophila were grown in vivo for five days within dialysis tubing 
placed inside the abdominal cavity of common carp. The virulence of these 
isolates had previously been assessed, as described in Section 2.2.2. 
 
Dialysis tubing with two different MW cut off values, 25 and 100 kDa, obtained 
from Medicell, UK, were used in the study. The tubing was pre-irradiated by the 
manufacturer for sterility, and one end of the tubing came sealed, while the other 
end was closed with a lid after filling the tubing with bacteria suspension. The two 
types of tubing were distinguished from each other by red and blue coloured lids. 
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Bacteria were cultured in TSB overnight at 28°C. The pellets were harvested by 
centrifuging at 1600 × g for 15 min and washed twice with the PBS at 1600 × g for 
15 min. The pellets were resuspended in PBS and the concentration of the 
bacteria adjusted to 1 ×107 bacteria ml-1. Two implants for each molecular weight 
cut off were filled with 2 ml bacteria (T4 isolate) and placed in a tube containing 
TSB to check that the implants were leak-proof before implanting them into the 
fish. 
 
After establishing that the implants did not leak, three tubes were prepared for 
each MW cut off, so that 6 tubes were prepared for each A. hydrophila strain. 
Each tube contained 2 mls of bacterial suspension at a concentration of 1 ×107 
bacteria ml-1. One control tube filled with PBS was also prepared for each MW cut 
off. Preparation of the implants was carried out in a sterile cabinet and care was 
taken during the implantation of the tube to maintain as sterile conditions as 
possible. The operating area was first treated by UV light for 1 h prior to 
performing the surgical procedure, wiped with 70 % alcohol, and then covered with 
sterile aluminium foil. 
 
The fish, obtained from the HAKI aquarium, were approximately 1-1½ kg in 
weight. They were individually transported to the laboratory in a 50 L bucket and 
anaesthetised for 1-2 min in a 0.004 % w/v benzocaine solution. Throughout the 
procedure approximately 1 ml of 0.001 % w/v benzocaine solution was pipetted 
onto the fish’s gills (Colquhoun and Sorum, 1998). The surface of the fish’s 
abdomen was swabbed with 70 % ethanol (v/v), and a 3-4 cm incision was made 
in the abdomen area between the pelvic fin and the anus. The area within the 
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incision was cleared with a sterilised cotton bud in order to avoid damaging the 
internal organs while implanting the dialysis tube into the abdominal cavity of the 
fish. 
 
The dialysis tubing was folded in half and placed carefully into the abdominal 
cavity of the fish in order to avoid any physical injury. The incision was closed with 
4-5 continuous stitches using 910 sutures (Ethicon Ltd, Edinburgh, UK), and a 
disinfectant cum sealant (Orahesive protective powder, Conva tec ltd, UK) was 
then applied to the incision (Figure 2.1). The fish were marked by pectoral and 
ventral fin clipping to identify the strains and the molecular weight of the tubing 
implanted. They were then placed into two round plastic tanks 1 m × 1 m 
(diameter × depth) with aeration, and were swimming normally within 2-3 min of 
returning them to the tank. The fish were frequently observed over a five day 
period before retrieving the tubes from the fish on the fifth day. 
 
To recover the implants, the fish were sacrificed by giving them an overdose of 
anaesthetic and the sutures carefully removed. The tubes were removed and 
placed in sterile tubes before pooling the contents of the respective molecular 
weight cut off tubes for analysis. After pooling the samples, the CFU of the 
suspension was determined, and the purity of the suspension was confirmed by 
streaking it out onto TSA and performing Gram staining on it. The pooled samples 
were briefly stored at 4°C before splitting the bacterial suspension for the different 
analyses to be carried out. Samples from tubes found to be broken in the fish 
abdominal cavity were not used in the analysis. 
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Figure 2.1: Implantation of dialysis tubing containing A. hydrophila for culture of the bacterium in vivo 
(A) Incision, (B) Placing dialysis tubing into the incision, (C) Closing incision by stitching, (D) Covering incision with 
disinfectant cum sealant powder. 
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The WC, OMP, and ECP fractions were prepared from the bacteria for 1D SDS-
PAGE. Only the WC was examined by 2D SDS-PAGE due to the amount of 
sample available. The samples were centrifuged at 1600 × g for 15 min to 
separate the pellets from the ECP. The pellets were washed twice with PBS at 
1600 × g for 15 min and WC and OMP prepared for 1D and 2D SDS-PAGE as 
described in Sections 2.2.3.1 and 2.2.4 below. The ECP was concentrated using 
10, 000 MW cut off spin concentrators (Vivo science, UK) by centrifuging at 2000 
× g for 2 h. It was then filtered through a 0.45 µm filter and prepared for 1D SDS-
PAGE as described in Section 2.2.3.1. 
 
2.2.4. SDS-PAGE 
2.2.4.1. 1D SDS-PAGE 
The samples were boiled for 5 min and centrifuged at 2300 × g for 2 min from 
which 15 µl of sample was loaded into the wells of a 4 % SDS-PAGE stacking gel 
(Appendix I) and run through a 12 % separating gel (Appendix I) according to 
Laemmli (1970). Broad range MW protein markers (Biolabs, UK) were run along 
side the samples to serve as MW references. The gels were run between 45 and 
60 min at 200 V and were then stained overnight in Commassie brilliant blue R-
250 (0.25 % w/v) in 50 % (v/v) methanol and 10 % (v/v) acetic acid and destained 
with 40 % (v/v) methanol and 10 % (v/v) acetic acid. Gels were scanned and the 
MW of bands was determined using TotalLab v2002.03 software program 
(Nonlinear Dynamics Ltd). 
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2.2.4.2. 2D SDS-PAGE 
Whole cell preparations of A. hydrophila grown in vitro and in vivo were analysed 
by 2D SDS-PAGE as recommended by Berkelman and Stenstedt (2002). One ml 
of 1 ×108 ml-1 bacterial suspension was centrifuged at 2300 × g for 10 min and the 
pellet resuspensed in 1 ml lysis solution (9 M urea, 4 % chaps, 40 mM Trisma 
base and 17 mM SDS). Ten µl of nuclease mix (Amersham bioscience) was 
added and vortexed briefly, then left for 30 to 45 min at 20-22°C. Destreak solution 
(Amersham Bioscience) (125 µl) was loaded in to the strip holder channel together 
with 0.6 % of Immobilized pH Gradients (IPG) buffer and 15 µl of sample. A 7 cm 
immobiline drystrip gel (3-10 NL pH range, Amersham Bioscience) was rehydrated 
for 15 h by placing it into a strip holder channel with the gel side facing down 
taking care not to introduce air bubbles. Isoelectic focusing was achieved using 
500 V for 30 min, 1000 V for 30 min and 8000 V for 1 h. The strip was placed in a 
15 ml centrifuge tube containing 10 ml equilibration solution (50 mM Tris HCl (pH 
8.8), 6 M urea, 30 % v/v glycerol, 2 % w/v SDS and 0.002 % w/v bromophenol 
blue) and the strip was equilibrated in the buffer for 20 – 30 min on a rocker. The 
strip was then placed on a 12.5 % SDS-PAGE gel, sealed with agarose sealant 
(0.5 % agarose (w/v) and few grains of bromophenol blue). The gel was subjected 
to 20 mA for 15 min, followed by 40 mA for approximately 90 min and then stained 
with a silver staining kit (Amersham Bioscience), according to the manufacturer’s 
instructions. The spots on the stained gel were analysed using image master 2D 
platinum 0.6 software (Amersham bioscience). 
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2.2.5. Ultra structure of outer membrane 
The difference in the ultrastructure of the outer membrane of bacteria grown in 
vitro and in vivo was examined by transmission electron microscopy (TEM) 
(Hayat, 1986). The bacterial pellets were fixed for 2-4 h in 2.5 % gluteraldehyde in 
100 mM sodium cacodylate buffer (pH 7.2), then centrifuged at 2000 × g for 10 
min and the supernatant removed.  Fresh fixative was added and the pellets were 
gently loosened from the bottom of the centrifuge tube after 30 min using a 
sharpened wooden applicator. After 2 h the pellets were rinsed twice in buffer 
rinse (0.1 M sucrose in 100 mM sodium cacodylate), 5 min each time, in order to 
prevent osmotic shock to the cells. 
 
The pellets were post-fixed in 1 % osmium in sodium cacodylate buffer in a closed 
vial for 1 h, then washed for three times with distilled water for 5 min on each 
wash. The samples were placed in en-bloc in 2 % (v/v) uranyl acetate in 30 % 
acetone and kept in the darkness for 1 h. They were then dehydrated through an 
acetone series: 60 % (v/v) for 20 min, 90 % for 20 min, 100 % for 30 min and 100 
% for 50 min at 20-22°C. The samples were then infiltrated with Spurr’s resin in 1 
acetone: 1 Spurr’s resin for 1 h and in 100 % Spurr’s resin for 2×1 h. The material 
was then embedded in Beem capsules and polymerised for 16 h at 75°C. 
 
All steps except polymerisation and en-bloc, were carried out with continuous 
agitation. Complete processing was carried out in a fume cupboard. Ultra-thin gold 
sections of approximately 90 nm thickness were cut and placed on 200 mesh 
formvar-coated copper grids. Once on the grids, the sections were stained with 4 
% (v/v) uranyl acetate in 50 % (v/v) ethanol for 4 min and 7 min in Reynold's 
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(1963) lead citrate. The grids were finally examined under a TEM (FEI TECNAI G2 
Spirit Bio Twin electron microscopy, Holland). 
 
2.3. Results 
2.3.1. Biochemical characterisation 
Basic biochemical analysis including Gram staining, motility test, and CFU were 
carried out on each A. hydrophila isolate used in the study together with protein 
analysis by 1 and 2D SDS-PAGE. The colonies of A. hydrophila appeared milkish 
white to yellow in colour, and were circular and opaque in shape on TSA plates. 
The bio-chemical characteristics of A. hydrophila (T4 isolate) were similar before 
and after passaging through goldfish (Carassius auratus), and with the reference 
strain obtained from NCIMB, except for some differences in H2S, indole, sorbitol 
and rhamnose production (Table 2.2). 
 
All strains were Gram-negative and had rod shape morphology, but there were 
considerable differences in the lengths of the rod, and chains of rods were found 
with some strains. The morphology seen with each isolate is shown in Table 2.3 
All strains were very active and appeared motile under the microscope. 
 Chapter 2      Page 55 
Table 2.2: Biochemical characterisation of A. hydrophila type strain 1134 
and T4 using API 20E strips 
 
Result 
Biochemical 
test 1134 (NCIMB) 
T4  
(before 
passaging) 
T4 (after 1st 
passaging in 
gold fish) 
T4 (after 2nd 
passaging in 
gold fish) 
O-nitrophenyl-β-D-
galactopyranoside + + + + 
Arginine 
dehydrolysis  + + + + 
Lysine 
decarboxylase  + + + + 
Ornithine 
decarboxylase - - - - 
Citrate utilization  + + + + 
H2S production  - + + - 
Urease 
production  - - - - 
Tryptophane 
deaminase  - - - - 
Indole 
production + + + - 
Acetoin 
production + + + + 
Gelatin 
hydrolysis  + + + + 
Glucose  + + + + 
Mannitol  + + + + 
Inositol  - - - - 
Sorbitol  - - + - 
Rhamnose  + + - - 
Sucrose  + + + + 
Melibiose  - - - - 
Amygdalin  + + + + 
Arabinose  + + + + 
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Table 2.3: Rod morphology of different A. hydrophila strains 
 
Name of strains Small/long rod Chain Presence 
T4 Small × 
98141 Long √ 
Hh Small × 
Vds Long × 
Catla Long √ 
C24li Long × 
2D20 Small × 
3D14 Long √ 
2N14 Long √ 
98140 Long √ 
98139 Long √ 
B2/12 Long × 
F1d75 Long × 
Calf Long × 
 
 
2.3.1.1. Standard concentration curve 
The growth of the A. hydrophila was rapid reaching approximately 1 ×108 colonies 
in 1 ml after 18 h of culture. The standard concentration curve of A. hydrophila is 
shown in Figure 2.2. 
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Figure 2.2: Standard concentration curve for A. hydrophila 
 
 
2.3.2. Virulence of A. hydrophila 
Of the 14 isolates tested, 6 isolates were found to be virulent, while the remainder 
were avirulent causing no mortalities. Mortality only occurred when 1 ×107 fish-1 
was injected into the fish with all six strains described as virulent, while no 
mortalities were recorded at doses of either 1 ×105 or 1 ×103 fish-1. However, 
reddening and moderate swelling of the muscles were noted in all the fish from 
these six groups irrespective of the concentration of bacterial cells injected. 
Clinical signs appeared from the first day after injection with the highest 
concentration of the bacteria used, and after 3 days in the groups of fish injected 
with 1 ×105 and 1 ×103 bacteria ml-1. Mortalities were observed from the first day 
post-injection until the nineth day after injection, and the experiment was stopped 
on Day 15 post-injection. The highest percentage mortality was observed with 
strain B2/12 (66.6 %) and the lowest with strains 98140 and Hh (Figure 2.3). 
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Figure 2.3: Mortalities of Common carp, C. carpio during challenge with 
different isolates of A. hydrophila 
(N=6 fish per group). 
 
2.3.3. Protein profiles of bacteria grown in vitro and in vivo 
Considerable differences were found in the profiles of WC, OMP and ECP from 
the different bacteria grown in vitro and in vivo, when examined by 1 and 2D SDS-
PAGE gel electrophoresis. 
 
2.3.3.1. Protein expression in vitro analysed by 1D SDS-PAGE 
The WC, OMP and ECP preparations of A. hydrophila isolates grown in vitro 
expressed different profiles by SDS-PAGE analysis for each preparation as well 
as each isolate. 
 
Very different protein profiles were obtained with the WC preparations between 
the fourteen strains examined including the number of bands exhibited between 
the different isolates of A. hydrophila (Figure 2.4a). The number of bands 
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observed was greater with isolates 98141, Catla and C24li (lanes 3, 6 and 7) 
compared with the other isolates examined. Three high intensity bands were found 
at 45, 50, 55 kDa with isolate T4 (lane 2), which were not seen with rest of the 
isolates. It was very difficult to place the isolates in groups from the profiles 
obtained. However, 15 bands were found in common with all of the isolates 
compared to 5-10 unique bands found with individual isolates. Major bands in 
common between the fourteen strains were located at around 212, 97, 70, 50, 32 
and 25 kDa. The majority of bands were expressed between 50 and 100 kDa with 
all the strains. Expression of bands with high intensity was also noticed between 
40 and 50 kDa with most of the strains examined. 
 
The OMP profiles showed far less bands than the WC profiles. Between 4 and 6 
bands were observed with each strain between 25 and 66 kDa (Figure 2.4b). A 
major band was seen at approximately 50 kDa with all isolates except 2D20, Calf 
and 2N14 (lanes 8, 15 and 10), with darker bands noted for all the six virulent 
strains (lanes 2, 3, 4, 5, 11 and 13). A common band was also observed at around 
27 kDa with all strains except T4 and 2D20 (lanes 2 and 8). Only the profiles of 
isolates 98140 and 98141 (lanes 3 and 11) looked identical, with no other similar 
pattern observed between strains. 
 
The bands expressed in the ECP preparations of the bacteria were mostly 
between 27 and 70 kDa with all six (4 virulent and 2 avirulent) strains examined 
(Figure 2.4c). A common band was found at 55 kDa with all the isolates, but it was 
weakly expressed with all the avirulent isolates examined. A band at 70 kDa was 
found only in ECP from isolates T4 and Hh (lanes 2 and 4). Bands  at 37,  40,  and  
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Figure 2.4: SDS-PAGE of A. hydrophila grown in vitro, stained with 
Coomassie blue 
(a) Whole cell, (b) Outer membrane protein, (c) Extracellular products. 
Lanes: (1) Standard marker; (2) T4; (3) 98141; (4) Hh; (5) Vds; (6) Catla; (7) 
C24li; (8) 2D20; (9) 3D14; (10) 2N14; (11) 98140; (12) 98139; (13) B2/12; (14) 
F1d75; (15) Calf. ∗ Virulent isolates. 
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50 kDa were noted in all the virulent strains with high intensity at 40 kDa. Two 
weakly expressed bands were also observed below 37 kDa with most of the 
isolates. All the bands were expressed weakly with the avirulent strains compared 
with the virulent strains, but a moderate intensity band was found at 42 kDa in 
both avirulent strains examined. 
 
2.3.3.2. Protein expression in vivo in 1D SDS-PAGE 
The fish with the implants remained alive and healthy over the duration of the 
experiment and their internal organs also looked healthy when examined at the 
time of sacrifice. No growth of A. hydrophila was obtained from kidney swabs 
made from the implanted fish except for one fish implanted with the 98141 isolate 
and one with the Catla isolate as the dialysis tubes were damaged in the 
abdominal cavity of these two fish. Bacteria grown within the implants gave a CFU 
count of 1 ×108 bacteria ml-1 compared to 1 ×107 bacteria ml-1 before implanting 
the bacteria, which was more than a 9 fold increase in bacterial concentration. No 
bacteria growth was obtained from the control implants containing PBS. 
 
Few bands were seen above 90 kDa, while an increase in the number of bands 
was observed below 90 kDa in WC preparations made from the bacteria cultured 
in vivo (Figure 2.5a), compared with the same isolates cultured in vitro (Figure 
2.4a). Isolates grown in vivo expressed a unique band at 58 kDa, however three 
bands were seen in common at around 25, 50, 70 kDa between bacteria grown in 
vitro and grown in vivo within both MW cut off tubes. A faint band at 40 kDa was 
found with all the isolates grown in vitro and in the 100 kDa MW cut off tube, but 
was not   seen  with   bacteria   grown   in  25  kDa  MW  cut  off  tube.  In addition,  
 Chapter 2      Page 62 
 
 
 
Figure 2.5: SDS-PAGE of A. hydrophila grown in vivo, stained with 
Coomassie blue 
(a) Whole cell, (b) Outer membrane protein, (c) Extracellular products. 
1. Profiles of strains from 25 kDa MW cut off dialysis tube. 
2. Profiles of strains from 100 kDa MW cut off dialysis tube. 
Lanes: (1) Standard marker; (2) T4; (3) 98141; (4) Hh; (5) Vds; (6) Catla;        
(7) C24li. ∗ Virulent isolates. 
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another faint band at 43 kDa was present in all the isolates except the Hh isolate 
(lane 4) grown in the 25 kDa MW cut off tube in vivo. Bands were of greater 
intensity at apporoximately 25, 50, 55 and 70 kDa with all virulent strains grown in 
vivo in both MW cut off tubes compared with avirulent strains. 
 
There were no differences between the OMP profiles of bacteria grown in the two 
different MW cut off tubes (Figure 2.5b). Differences were, however, evident in the 
OMP profiles of bacteria cultured in vitro and in vivo. The intensity of the bands 
was less in bacteria grown in vivo compared with in vitro. Common bands were 
seen at 50 and 55 kDa with all isolates grown in both MW cut off tubes in vivo, but 
were only weakly expressed at 55 kDa with Vds & Catla isolates (lane 5 and 6). 
 
Fifteen to twenty bands were observed in the ECP profiles for bacteria grown in 
vivo (Figure 2.5c), however most of the bands seen with isolates grown in vitro 
were also seen in ECP from bacteria grown in vivo. A wide distribution of bands 
was seen in the ECP especially between 25 and 120 kDa in both of the MW cut off 
tubes, however there was little difference in the profiles of ECP recovered from the 
two different tubes. Bands were expressed most strongly at 35, 50, 60 and 80 kDa 
with all isolates grown in both MW cut off tubes. A band at 37 kDa was found with 
all the virulent isolates grown in vitro and in vivo, although it was not found with 
avirulent isolates. A greater number of bands were present in virulent isolates 
compared with avirulent isolates in bacteria grown in both MW cut off tubes. The 
total number of bands in the ECP was relatively low for bacteria cultured in vitro 
compared to when cultured in vivo. 
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2.3.3.3. Protein expression of A. hydrophila grown in vitro and in vivo 
analysed by 2D SDS-PAGE 
 
Further differences were determined in the WC profiles between different isolates 
by 2D SDS-PAGE analysis, both in the apparent molecular mass of the expressed 
proteins and their pI value. The majority of protein spots were found between 30 
and 80 kDa, between pI 4.5 and 8.5 with all of the isolates examined. Most of 
these spots were observed between 43 and 50 kDa, with pI values between 4.5 
and 5.5 with all isolates analysed. The greatest number of spots in common 
between the isolates was found between the isolates T4 and F1d75 with 32 % 
similarity. 
 
The greatest difference in the number of spots expressed between bacteria grown 
in vitro and in vivo was found with isolate 98141, followed by Catla and Vds 
isolates. An average of 37.5 and 40 % fewer spots were seen with the 98141 
isolate grown in vivo in the 25 and 100 kDa MW cut off tubes respectively, 
compared to the same isolate grown in vitro. Around 29 and 36 % fewer spots 
were seen with the Catla isolate and 14 and 16 % fewer with Vds isolate, while a 
similar number of spots were expressed under the different growth conditions for 
isolate T4, Hh and C24li. There was little difference in the number of spots 
between the bacteria grown in vivo within the two different MW cut off tubes. 
Around 9 % of spots were not expressed in the Catla isolate grown in vivo in the 
100 kDa MW cut off tube compare to the 25 kDa MW cut off tube. 
 
The highest percentage of spots in common amongst all 3 growth conditions was 
with the Catla isolate (55.1 %) and the lowest was 29.7 % with 98141 (Table 2.4). 
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A notable number of unique spots were observed for all of the isolates grown in 
vivo, in both MW cut off tubes (Table 2.5). Approximately, 20-25 % of matching 
spots were noted between all the isolates cultured in each of the growth 
conditions. In general, up-regulation of the spots was found to be greater in 
bacteria grown in vivo compared with bacteria grown in vitro (Table 2.6). In 
addition, between the bacteria grown in vivo (Table 2.7), the up-regulation was 
found more in bacteria grown in the 100 kDa MW cut off tube compared to the 25 
kDa MW cut off tube (Figure 2.6). 
 
Table 2.4: No. of spots detected in 2D SDS-PAGE with WC preparations of 
bacteria grown in vitro and in vivo 
 
No. of spots detected 
In vivo A. hydrophila 
isolates In vitro 
25 kDa tube 100 kDa tube 
% common 
spotsa 
No. of 
unique 
spots        
in vivo 
T4 115 113 115 55.1 4 
98141 240 150 145 29.7 5 
Hh 152 147 149 42.8 5 
Vds 122 105 102 46.5 2 
Catla 239 170 154 54.9 4 
C24li 122 118 123 52 9 
 
a % common spots between in vitro and in vivo. 
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Figure 2.6a: 2D SDS-PAGE of A. hydrophila strains grown in vitro 
(1) 2D20, (2) 3D14, (3) 2N14, (4) 98140, (5) 98139, (6) B2/12. 
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Figure 2.6a: 2D SDS-PAGE of A. hydrophila strains grown in vitro 
(7) F1d75, (8) Calf. 
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Figure 2.6b: 2D SDS-PAGE of A. hydrophila strains grown in vitro and in vivo 
(A) Bacteria grown in vitro, (B) Bacteria grown in 25 kDa MW cut off tube in vivo, (C) Bacteria grown in 100 kDa MW cut off tube 
in vivo (1) T4, (2) 98141. 
 up and  down-regulated compared to either in vivo or in vitro.  up and  down regulated compared to bacteria grown in    
vivo in 100 kDa MW cut off tubes.  spots seen only in bacteria grown in vivo. 
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Figure 2.6b: 2D SDS-PAGE of A. hydrophila strains grown in vitro and in vivo 
(A) Bacteria grown in vitro, (B) Bacteria grown in 25 kDa MW cut off tube in vivo, (C) Bacteria grown in 100 kDa MW cut off tube 
in vivo (3) Hh, (4) Vds. 
 up and  down-regulated compared to either in vivo or in vitro.  up and  down regulated compared to bacteria grown in   
vivo in 100 kDa MW cut off tubes.  spots seen only in bacteria grown in vivo. 
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Figure 2.6b: 2D SDS-PAGE of A. hydrophila strains grown in vitro and in vivo 
(A) Bacteria grown in vitro, (B) Bacteria grown in 25 kDa MW cut off tube in vivo, (C) Bacteria grown in 100 kDa MW cut off tube 
in vivo (5) Catla, (6) C24li. 
 up and  down-regulated compared to either in vivo or in vitro.  up and  down regulated compared to bacteria grown in 
vivo in 100 kDa MW cut off tubes.  spots seen only in bacteria grown in vivo. 
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Table 2.5: MW and pl of unique spots seen in 2D SDS-PAGE analysis for 
A. hydrophila strains grown in vivo in both MW cut off tubes compared 
with the same strains grown in vitro 
A. hydrophila 
isolates 
MW pI 
51 5.4 
31 5.9 
30 5.1 
T4 
30 5.8 
77 5.5 
76 5.5 
72 5.1 
72 5.0 
98141 
47 5.4 
61 5.5 
61 5.45 
61 5.4 
49 5.6 
Hh 
48 5.7 
56 5.6 Vds 
28 5.7 
77 5.6 
76 5.5 
54 5.5 
Catla 
27 5.7 
60 5.2 
59 5.9 
59 5.8 
56 6.0 
54 5.5 
37 6.2 
34 5.7 
33 5.6 
C24li 
33 5.5 
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Table 2.6: MW and pl of the most up and down-regulated spots in 2D SDS-
PAGE of A. hydrophila grown either in vitro or in vivo (25 and 100 kDa MW 
cut off tube) 
A. hydrophila   
isolates 
MW pI in vitro in vivo 
  
 57 5.2   
54 5.1     
50 5.15             
T4 
29 5.7   
29 5.15   
31 5.57   
50 5.3   
19 5.9   
22 5.5   
98141 
72 5.0   
47 5.0   
42 5.85   
28 5.6   
35 5.0   
31 4.9   
Hh 
16 5.7   
40 6.0   
69 5.75   
38 5.86   
Vds 
35 5.78   
83 5.0   
64 5.12   
64 5.29   
Catla 
26 6.86   
75 5.45   
69 5.01   
41 5.20   
50 5.49   
41 5.71   
C24li 
30 6.37   
up and  down-regulated spots. 
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Table 2.7: MW and pl of the most up and down-regulated spots in 2D SDS-
PAGE of A. hydrophila grown within the 25 and 100 kDa MW cut off tubes 
in vivo (up-regulated in vivo compared to in vitro) 
 
MW of implants 
A. hydrophila 
isolates 
MW pI 
25 kDa  100 kDa 
33 4.89   
43 5.50   
18 5.29   
T4 
18 5.49   
64 5.33   
58 5.46   
49 5.12   
98141 
47 5.25   
55 4.89   
55 5.33   
46 5.60   
21 4.95   
Hh 
16 5.60   
76 5.55   
71 5.59   Vds 
30 5.73   
26 5.75   
26 6.74   
26 6.16   
Catla 
20 4.90   
70 5.08   
49 5.89   
28 5.55   
C24li 
66 5.70   
 
 up and  down-regulated. 
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2.3.3.4. TEM studies of A. hydrophila cultured in vitro and in vivo 
A difference was observed in the morphology of the bacteria grown in vitro and in 
vivo (Figure 2.7). A distinct gap was seen between the inner and outer membrane 
layers of A. hydrophila cultured in vitro. Whereas, in case of bacteria grown in 
vivo, the presence of an extracellular capsular layer was evident and the 
membranes were more compact compared with the bacteria grown in vitro. 
However, the thickness of the layer did not appear to vary between bacteria grown 
in vitro  and in vivo and between the bacteria grown in the two different tubes in 
vivo, and in most cases the thickness of the outer membrane layer was around 13-
25 nm. 
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Figure 2.7: Transmission electron micrograph of A. hydrophila cultured in 
vitro and in vivo 
(A) Bacteria grown in vitro, (B) Bacteria grown in vivo with 25 kDa cut off tube,   
(C) Bacteria grown in vivo with 100 kDa cut off tube. 
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2.4. Discussion 
Lallier and Higgins (1988) showed all 65 A. hydrophila strains in their study 
isolated from either diseased mammals or healthy and diseased fish, to be 
positive for O-nitrophenyl-β-D-galactopyranoside, arginine dehydrolyase, glucose, 
mannitol and saccharose. They also reported that all these isolates were negative 
for ornithine decarboxylase, H2S, urease and inositol, and other biochemical 
characteristics were variable between the isolates. The biochemical results 
obtained with the API 20E microbial identification kit in this study were in 
agreement with the results of Lallier and Higgins (1988). However, minor 
differences were observed between the NCIMB reference strain and isolate T4, 
and with isolate T4 when it had been passaged once and twice through a goldfish. 
For example, isolate T4 was positive for H2S before and after passaging once 
through a fish, but negative after passaging it a second time through fish. De 
Figueiredo and Plumb (1977) also observed variations in the biochemistry 
between the different isolates of A. hydrophila they screened, but they found these 
differences to be insufficient to separate the isolates into virulent and avirulent 
groups. 
 
Several studies are reported in the literature relating to artificial challenge with 
various doses of A. hydrophila using different isolates in a range of fish species. 
The clinical signs which occurred were all similar at the time of mortality, although 
the time it took for these to appear varied depending on the concentration of A. 
hydrophila used. For example, when catfish (Clarias batrachus) were injected with 
1 ×107 ml-1 A. hydrophila clinical signs became apparent by three days post-
injection, with petechiae and reddening of the abdomen, and similar clinical signs 
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were apparent by Day four post-injection in groups of fish injected with 103, 104, 
105 and 106 ml-1 bacteria by Angka (1990). Similar clinical signs were reported by 
Azad et al. (2001) who observed melanisation followed by reddening and swelling 
at the site of injection in tilapia, Oreochromis mossambicus 1 h post-injection, 
when A. hydrophila was administrated intramuscularly using 107 and 108 CFU  
fish-1. The authors found dermal necrosis and muscular degeneration at 12 h post-
injection, followed by ulceration at Day 2 post-injection. In the present study, in 
which common carp were experimentally challenged with 14 different isolates of A. 
hydrophila, the same clinical signs were observed in fish injected with 1 ×107 ml-1 
the day following injection, and three days post-injection in fish injected with 1 
×103 and 1 ×105 ml-1. Very clear symptoms of infection were seen externally, 
including reddening around the body, erosion of the tail and fins, and swelling and 
ulceration of muscles. 
 
Mortality occurred from the first day post-injection until the nineth day in the 
present study. Six out of the fourteen isolates tested were pathogenic, and 
mortality was greatest in fish injected with 1 ×108 ml-1 CFU. Santos et al. (1988), 
on the other hand, demonstrated that out of the 56 isolates of A. hydrophila they 
tested, 36 (64.3 %) were pathogenic to fingerling rainbow trout, Oncorhynchus 
mykiss using a lethal dose, i.e. 50 % (LD50) between 1 ×104 and 1 ×107 bacteria 
ml-1. Aeromonas hydrophila, injected into European eel, Anuguilla anuguilla by IP 
injection, were 100 % pathogenic at LD50 doses of between 105.4 and 107.5 CFU 
fish-1 depending on the isolates (Esteve et al., 1993). Mortalities began at 18 h 
post-challenge, and ‘red fin disease’ was evident in elvers during the experiment. 
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Similarly, mortalities were seen on Day 1 post-injection in the group injected with 
108 CFU fish-1, and continued up to 8 days post-injection (Azad et al., 2001). 
 
The variation in the mortality caused by different A. hydrophila isolates might be 
due differences in the ECP composition of isolates used for infection. Sirirat et al. 
(1999) found 100 % mortalities in hybrid catfish, (Clarias gariepinus × C. 
macrocephalus) injected with ECP from highly virulent isolates of A. hydrophila 
within 18 h post-injection compared with the same mortality in fish injected with 
ECP from low virulent isolates within 96 h post-injection. Environmental factors, 
such as temperature, have been shown to affect the expression of different toxic 
components of the ECP, such as haemolysin, cytotoxin and enterotoxin of A. 
hydrophila, and the impact of temperature on ECP expression appears to be strain 
dependent (Gonzalez-Serrano et al., 2002). 
 
Researchers have also examined a number of other factors, which could possibly 
influence the infections caused by A. hydrophila in the fish. It was found, for 
example, that viable but non-culturable A. hydrophila (incubated in 0.35 % NaCl 
solution for 50 days) and bacteria cultured for a long time in nutrient broth (i.e. 28 
days) greatly decreased in virulence compared with 1-day-cultured A. hydrophila 
when injected into goldfish (Rahman et al., 2001b). In addition, the virulence of A. 
hydrophila in goldfish was significantly greater at water temperatures of 17°C and 
25°C than that of 10°C and 32°C (Rahman et al., 2001a). The LD50 of bacteria 
delivered by subcutaneous injection in fish held at different temperatures were 
107.06 CFU fish-1 at 10°C, 106.03 CFU fish-1 at 17°C, 106.53 CFU fish-1 at 25°C and 
107.28 CFU fish-1 at 32°C. 
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Pai et al. (1995) found that abraded common carp exposed to A. hydrophila 
experienced no mortality at low stocking densities, but at higher stocking densities, 
mortalities occurred, and these increased with stocking density. Fish without 
abrasions that were exposed to this pathogen showed no mortality, even at 
highest stocking density, and thereby suggested that crowding alone was not 
sufficient to make the fingerlings susceptible to A. hydrophila (Pai et al., 1995). A 
wide variation in mortality (0 to 100 %) among different sub species of rohu, Labeo 
rohita to A. hydrophila was reported and this was attributed to differential 
bactericidal activity in the fish (Sahoo et al., 2004). 
 
It is well known that most bacterial pathogens are able to change their proteins 
and ECP expression under different environmental conditions, and can modulate 
the expression of multiple virulence factors (Griffiths, 1989; Vivas et al., 2005). 
Key factors such as temperature, nutrients, pH, salt, dissolved oxygen, osmolarity 
(Khalil and Mansour, 1997; Tsai et al., 1997; Aguilar et al., 1997; Rahman et al., 
2001a) and modified N2, O2 and CO2 atmospheres (McMahon, 2000) influence 
bacteria growth and expression of their proteins and virulence factors. The 
following authors studied differences between bacteria grown in vitro and in vivo in 
attempt to identify virulence factors. Colquhoun and Sorum (1998) cultured V. 
salmonicida in dialysis tubing implanted into rainbow trout, while Jung (1999) and 
Bakopoulos et al. (2004) cultured P. damselae subsp. piscicida inside dialysis 
tubing implanted into the peritoneal cavity of sea bass, Dicentrarchus labrax. This 
method has also been used in other animals. For example, Morck et al. (1991) 
cultured Pasteurella haemolytica within a chamber implanted in the peritoneal 
cavity of a rabbit, while Davies et al. (1994) implanted P. haemolytica in chambers 
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into the peritoneal cavities of cattle. Similarly, mice were implanted with dialysis 
tubing filled with Yersinia pestis (Ferreira et al., 1998) and A. hydrophila (Sha et 
al., 2003). 
 
In this study, the concentration of the different A. hydrophila suspensions 
recovered from the 25 and the 100 kDa MW cut off tubing implanted into the 
peritoneal cavity of common carp increased approximately 9 to 14 fold compared 
with the concentration used for implantation. Similarly, a 6 to 8 fold increase was 
reported in P. damselae subsp. piscicida, when implanted into seabass, 
irrespective of the pore size of the bags used (2 and 12 kDa MW cut off) 
(Bakopoulos et al., 2004). 
 
The current study identified differences in the protein profiles between A. 
hydrophila grown in vitro and in vivo. Approximately, 15-25 bands were observed 
with all the fourteen A. hydrophila isolates cultured in vivo as well as 5-10 unique 
bands with individual isolates. The number of bands expressed between 90 and 
212 kDa was greater with A. hydrophila cultured in vitro than in vivo. In contrast, 
the number of bands expressed below 90 kDa increased with bacteria grown in 
vivo compared with in vitro. A unique band at 58 kDa was observed with all the 
isolates grown in vivo, however common bands were seen at around 25, 50 and 
70 kDa between all the isolates of A. hydrophila grown in vitro and in vivo. The 
expression of total proteins has been found to be variable for A. hydrophila. Kokka 
et al. (1990) reported at least 30 resolvable proteins using Coomassie blue 
staining of WC protein profiles for eight A. hydrophila isolates (five serogroup 0:11 
and three serogroup 0:22) and two isolates of A. sorbia (one serogroup 0:36 and 
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one rough strain) cultured in vitro. However, among five isolates of serogroup 
0:11, a predominant protein in the MW range of 52 kDa to 54 kDa was consistently 
observed on 10 % SDS-PAGE gels. Variations in the protein expression between 
bacteria grown in two different MW cut off tubing has also been reported for other 
bacteria. For example, a band at approximately 52 kDa was seen in P. damselae 
subsp. piscicida grown in a 300 kDa dialysis bag in seabass, while a band at 45 
kDa was associated with bacteria grown in 25 kDa dialysis bag (Jung, 1999). 
Similar differences also found in the current study, as a faint band at 40 kDa 
observed in bacteria grown within the 100 kDa MW cut off tube was not expressed 
in bacteria grown in the 25 kDa MW cut off tube. 
 
Different environmental conditions used for culturing A. hydrophila, mainly iron 
limited conditions (Aoki and Holland, 1985), and temperature (Merino et al., 1992; 
Rahman et al., 2001a) have been reported to influence the OMP profiles obtained. 
The 14 isolates of A. hydrophila examined in this study had 4 to 6 bands in their 
OMP, which varied considerably from strain to strain. A major band was seen at 
approximately 50 kDa in 11 of the 14 isolates. The OMP profiles of bacteria grown 
in vitro contained more bands than bacteria grown in vivo, as reported by 
Colquhoun and Sorum (1998) for V. salmonicida, and by Rahman and Kawai 
(2000) for A. hydrophila (where bacteria had been recovered from goldfish 
artificially infected with A. hydrophila by IP injection). Although the numbers of 
bands were not the same between bacteria grown in vitro and in vivo, some bands 
with the same molecular weight were found between the two sets of bacteria. 
Some of the weakly expressed bands in the OMP profiles of bacteria grown in 
vitro did not appear in vivo, as seen with V. salmonicida (Colquhoun and Sorum, 
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1998), V. cholerae (Jonson et al., 1989) and Yersinia enterocolitica (Carniel et al., 
1987). 
 
In another study, the OMP profiles of A. hydrophila from different origins contained 
5 or 6 major proteins in each strain, but the profiles were different for each strain, 
although most of these strains had a major band at 36 kDa (Aoki and Holland, 
1985). They found that the heterogenicity of OMPs of different A. hydrophila 
isolates was greater than that of the heterogenicity of various strains of A. 
salmonicida. The OMP prepared from a group of virulent A. hydrophila grown in 
vitro produced very similar electrophoretic profiles on SDS-PAGE, and major 
proteins were observed at 30 kDa and 45 to 55 kDa (Dooley and Trust, 1988). 
When partially purified OMPs were analysed, 2 out of 5 of A. hydrophila 0:11 
serogroups grown in vitro had additional major proteins at 18 and 20 kDa, which 
had not been observed in the analysis of WC preparations of the bacteria (Kokka 
et al., 1990). The OMP profiles of A. hydrophila, A. sorbia and A. caviae cultured 
in vitro showed a common band at 52 kDa on an 11 % discontinuous SDS-PAGE 
(Maruvada et al., 1992). The difference in the OMP expression of bacteria has 
been shown to be affected by number of factors, such as temperature, incubation 
period and nutrients. For example, OMP profiles of different A. hydrophila serotype 
0:34 strains grown at 20°C had a decrease in a 41 kDa band and an increase in a 
24 kDa band compared with bacteria grown at 37°C, although no other major 
differences were observed (Merino et al., 1992). Rocha-de-Souza et al. (2001) 
observed difference in OMP profiles of A. caviae grown at 22°C and 37°C for 48 h 
and 24 h respectively. Growth of 18 isolates of A. salmonicida under iron-restricted 
 Chapter 2  Page 83 
conditions showed four novel OMPs of apparent MW of 70, 72, 77, and  82kDa, 
which were not present in the iron-replete conditions (Hirst and Ellis, 1994)
. 
 
The differences seen in the expression of ECP between bacteria grown in vitro 
and in vivo were extensive. It has already been reported that A. hydophila is able 
to change its ECP expression when grown in different culture medium or at 
different temperatures (Merino et al., 1992; Tsai et al., 1997; Vivas et al., 2004a). 
Differential expression of ECP has been reported for P. damselae subsp. piscicida 
when it was grown in vitro and in vivo (Bakopoulos et al., 2004). It was also 
reported that growth of the pathogen in vivo induced the synthesis of more toxic 
ECPs in comparison with growth in vitro. In this study, the expression of the ECP 
was greater from bacteria cultured in vivo rather than in vitro, and this could be 
due to the bacteria having to obtain nutrients in the in vivo environment, where as 
they are already available in the in vitro environment. Therefore this increase in 
the ECPs of bacteria grown in vivo might act as an additional virulence factors in 
fish. Although, the variation in the expression of the ECP was greater from 
bacteria cultured in vivo compared with in vitro, there was little difference in the 
bands between samples recovered from the different MW cut off dialysis tubes in 
vivo, as also seen for P. damselae subsp. piscicida by Jung (1999). This may 
reflect the availability of similar nutrients and environmental conditions within both 
MW cut off dialysis tubes. 
 
In the work by Imbert and Gancel (2004), where WC preparations were analysed 
by 2D SDS-PAGE, the lower the temperature used to culture A. hydrophila the 
greater the number of new proteins seen (from at least 22 proteins at 20°C to 30 
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at 5°C), and some proteins were over expressed when the bacterium was 
subjected to cold shocks after culturing at 30°C. They also found that most of the 
house keeping proteins was consistently expressed at 30°C and 5°C. 
Approximately 54 protein spots were detected in Commassie blue stained gels of 
A. hydrophila OMP in the work by Chen et al. (2004), and most of the spots were 
in the pl 5.0-8.0 range and had molecular masses from 10-140 kDa. 
 
Ebanks et al. (2004) found a 49 kDa VapA protein (S-layer protein) which is visible 
as multiple isoelectropherotypes in 2D SDS-PAGE profiles of OMP from A. 
salmonicida grown both in implants in abdominal cavity of the Atlantic salmon, 
Salmo salar and under iron-replete conditions in vitro. A similar type of expression 
of spots around 45 to 50 kDa range was also seen in A. hydrophila grown in both 
in vitro and in vivo in this study. Ebanks et al. (2004) also found proteins at 73, 76 
and 85 kDa by 2D SDS-PAGE in the OMPs of the bacterium grown under iron-
restriction as well as grown in vivo. However, these proteins were not present 
when the bacterium was grown under iron-replete conditions in vitro. They 
suggested that iron-restricted growth in vitro is a model to mimic in vivo growth 
conditions as it largely reproduces the same proteins obtained from A. salmonicida 
grown in implants within the peritoneal cavity of salmon, at least with respect to 
the OMPs. In the present study, different A. hydrophila isolates grown in vivo 
appeared to have unique spots mostly between 30 and 80 kDa compared with 
bacteria cultured in vitro. Moreover, 2D SDS-PAGE analysis showed further 
differences in the number of up and down regulated spots in bacteria grown in 
vitro or in vivo compared with 1D SDS-PAGE analysis. The number of bands and 
spots expressed by all the isolates in 1 and 2D SDS-PAGE respectively, was less 
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in bacteria grown in vivo compared to in vitro. However, the intensity of the spots 
was up regulated in bacteria grown in vivo compared to in vitro, and the diversity 
of the expression of the spots has found to be only 20-25 %. 
 
Aeromonas salmonicida grown in media containing yeast extract, peptone, 
glucose and mineral salts, and another media comparising fish viscera produced a 
capsular polysaccharide that was not produced when the bacteria were grown on 
TSA (Merino et al., 1996b). Capsule formation was also evidenced in glucose rich 
medium and in an autolysate of fish viscera for A. hydrophila serogroup 0:34 
strains (Martinez et al., 1995; Aguilar et al., 1999). An extracellular capsular layer, 
however, was not seen either in V. salmonicida grown in implants in the peritoneal 
cavity of the rainbow trout or bacteria isolated from peritoneal fluid of the rainbow 
trout or bacteria grown in vitro (Colquhoun and Sorum, 1998). Repeated sub-
culturing of certain capsular Pasteurella multocida serotype A strains in brain heart 
infusion agar resulted in the capsulated bacterium becoming non-capsulated, with 
an associated loss of virulence (Watt et al., 2003). Wang et al. (2004), on the other 
hand, found novel capsular polysaccharide and lipopolysaccharide O-chain 
polysaccharide from A. salmonicida grown in vivo compared with the bacteria 
grown in vitro. In this study, the capsule was apparent in bacteria grown in vivo. It 
has been suggested that it has an important role in protecting the bacterium from 
the host immune system as it can confer serum resistance (Aguilar et al., 1999). 
 
The differences found in the protein profile analysis during this study suggest that 
the growth conditions experienced by the bacterium, especially the availability of 
nutrients, may play a major role in the up and down-regulation of proteins in A. 
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hydrophila. A number of new proteins and some others with increased expression 
were seen in bacteria grown in vivo and these might be involved in the virulence of 
the bacterium. Such proteins could be mostly surface proteins, which could be 
more easily recognised by the host immune system, and therefore these proteins 
may represent potential vaccine candidates. 
 
In the current study, the difference in the expression of OMP profile bands 
between bacteria grown in vitro and in vivo suggests that different growth 
conditions can modify the OMP profiles of A. hydrophila, as reported previously by 
Rahman and Kawai (2000). Overall, the protein expression in WC and OMP 
preparations of A. hydrophila grown in vivo was reduced compared with bacteria 
grown in vitro, however, proteins between 45 and 50 kDa were observed for both 
in vitro and in vivo cultured bacteria. In contrast, more bands were expressed in 
the ECP for bacteria grown in vivo compared with in vitro. 
 
Collectively, the results of the current study show the difference in the protein 
expression between the bacteria grown in vivo and in vitro. The immunogenicity of 
these proteins in fish was then determined (Chapter 3) to identify potential 
antigens for the development of an A. hydrophila vaccine. 
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3.1. Introduction 
Control of diseases caused by A. hydrophila can be difficult because of the 
existence of antibiotic resistance and the heterogenicity between strains of this 
bacterium (Loghothetis and Austin, 1996a; Janda et al., 1996; Daskalov, 2006). It 
is important to minimise the use of anti-bacterial drugs in fish rearing not only 
because of antibiotic resistance, but also due to the risk of drug residues in fish 
and contamination of the aquatic environment (Rijkers et al., 1980). Suppression 
of the host immune system can also occur following improper use of antibiotics 
and chemicals (Heppell and Davis, 2000; Hu et al., 2005). It has been suggested 
that the use of vaccines in intensive fish culture systems is much more desirable 
for controlling fish diseases than using antibiotics and other therapeutic agents 
(Ellis, 1989; Leong, 1993; Samuel et al., 1996; Lin et al., 1996; Adams and 
Thompson, 2006), and there has been an increase in the use of vaccines since 
the late 1970s (Munn, 1994). 
 
Most commercially available vaccines are bacterins or formalin-inactivated whole 
cell suspensions, for example Aeromonas salmonicida, Vibrio anguillarum, V. 
ordalii, V. salmonicida, and Yersinia ruckeri (Newman, 1993; Munn, 1994; 
Gudding et al., 1999). However, as technologies have progressed and whole cell 
(WC) vaccines have failed to be developed for some pathogens, researchers have 
investigated the potential of different protective components (subunits) of 
pathogens as vaccines (Potter and Babiuk, 2001). These subunit vaccines contain 
only the important components required to induce immunity in the host, and they 
have no ability to infect the host or to replicate in the aquatic environment (Clark 
and Cassidy-Hanley, 2005). 
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The development of a successful vaccine requires antigen identification, analysing 
the efficacy of the protection and finally cost-effective vaccine production 
(Khushiramani et al., 2007a; Chen et al., 2004; Thompson and Adams, 2004). The 
identification of protective antigens has posed a great hurdle in the development of 
an A. hydrophila vaccine due to the diversity of the different strains in this 
bacterium, and at present, no vaccine against this pathogen is commercially 
available (Shotts and Rimler, 1973; McCoy and Pilcher, 1974; Fang et al., 2004; 
Tatner, 1993). The problem of A. hydrophila heterogenicity could be overcome if 
common antigens between strains, which induce protection, could be identified 
(Stevenson, 1988; Fang et al., 2004). Thus, it has been suggested that a 
component of A. hydrophila, which is immunognenic and will cross-protect against 
all isolates could be a possible vaccine candidate against this pathogen rather 
than using live, attenuated or inactivated bacterial WC vaccines (Dooley et al., 
1988; Leung et al., 1997; Rahman and Kawai, 2000). Some of the surface proteins 
of A. hydrophila are thought to be important in protection against this pathogen 
(Karunasagar and Karunasagar, 1996), mainly O-antigens (Dooley et al., 1985), 
lipopolysaccharide (LPS) (Loghothetis and Austin, 1994), S-layers (Leung et al., 
1997) and outer membrane proteins (Rahman and Kawai, 2000). 
 
The ability to produce a specific immune response, including cellular and humoral 
responses, is characteristic of the vertebrate immune system and has been 
demonstrated in numerous fish species (Pilstrom et al., 2005; Lund et al., 2006). 
Production of specific antibodies against bacterial pathogens is dependent on the 
characteristics of the pathogen as well as the immune system of the host (Lund et 
al., 1991 and 2006; Stromsheim et al., 1994). These antibodies could aid in the 
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identification of antigens for the production of vaccines (Hirst and Ellis, 1994; Ellis, 
1999; LaFrentz et al., 2003). Immunological methods such as enzyme linked 
immunosorbent assay (ELISA) and Western blot are useful for identifying 
immunogenic antigens of a bacterium in the sera of fish which have survived an 
infection by the same bacterium (Merino et al., 1993; Sendra et al., 1997). 
Although it could possible to identify various immunogenic antigens for a 
bacterium, a particular immunogenic antigen needs to be protective against a wide 
range of strains in order to be an effective vaccine candidate (Hirst and Ellis, 1994; 
Makela, 2000). The protection of the target antigen for vaccine development can 
be evaluated by vaccination as well as passive immunisation of fish and 
subsequently challenging them with live pathogen (Azad et al., 1999; Irie et al., 
2005). 
 
The main aim of this Chapter was to identify potential vaccine antigens for A. 
hydrophila. Common carp (Cyprinus carpio) were infected with 6 isolates of A. 
hydrophila and sera collected from these fish. The titre values of antibodies 
elicited were measured by ELISA, and the antibodies were screened against WC, 
outer membrane protein (OMP) and extracellular product (ECP) preparations of 14 
different isolates of A. hydrophila, by Western blot to identify any common 
antigens. The protective immunity elicited by a common antigen (50 kilo Dalton 
(kDa) protein) of A. hydrophila was then evaluated by vaccination and passive 
immunisation. This protein was electro-eluted from a sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) gel containing proteins of A. 
hydrophila T4 isolate, and this was subsequently used to immunise fish. Levels of 
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protection to this protein were assessed by artificially challenging the fish with A. 
hydrophila. 
 
3.2. Materials and methods 
3.2.1. Antibody response of common carp to A. hydrophila 
Four virulent strains; T4, 98141, Hh, Vds and two avirulent strains; Catla and C24li 
of A. hydrophila (described in Section 2.3.2) were used to determine the antibody 
response of common carp to A. hydrophila. Common carp (average weight 30 g) 
were obtained from Research Institute for Fisheries, Aquaculture and Irrigation, 
Hungary (HAKI) freshwater aquarium and maintained in 6 separate glass tanks. 
The fish were anesthetized with benzocaine, as described in Section 2.2.2, and 
injected intraperitoneally (IP) with 0.1 ml PBS containing 1 ×106 viable A. 
hydrophila. Each strain was injected into 24 fish and an additional 24 fish were 
injected with phosphate buffered saline (PBS) to serve as controls. After injection, 
the fish were placed back into a glass tank aquarium supplied with recirculating 
water that had been passed through a sedimentation tank, drum filter, biofilter and 
ultraviolet (UV) radiation. The temperature of the tank water was maintained at 20 
± 1°C throughout the experiment. The fish were observed regularly for any 
changes in behaviour. Blood samples were taken 3, 9, 12 and 21 days post-
injection. Fish were scarified with an overdose of anesthestic before taking the 
blood samples. Pre-injection bleeds were also taken from six fish just prior to 
injection. The blood was collected and stored overnight at 4°C and the serum 
collected the next day by centrifuging at 2000 × g for 5 min. The serum was stored 
at –20°C until further analysis. 
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3.2.2. Polyclonal antibody production against A. hydrophila in 
rabbits 
Strain T4 was used to raise polyclonal rabbit serum against A. hydrophila. The 
bacterium was grown in tryptone soy broth (TSB) overnight and harvested, as 
described in Section 2.2.1.4. The cells were adjusted to a concentration of 1 ×108 
ml-1 in PBS and were heat-killed by incubating in a water bath at 60°C for 1 h. The 
effectiveness of heat killing was determined by looking for growth on tryptone soy 
agar (TSA) (Schneider and Rheinheimer, 1988). After confirmation that there were 
no live bacteria in the suspension, it was emulsified with Hunter’s Titermax 
adjuvant (Cytrx, Georgia, USA) in equal volume. About 1ml of blood (pre-immune) 
was collected from the ear vein of a female New Zealand White rabbit (Charles 
River UK Ltd.), and then the rabbit was injected with 0.4 ml of the bacterial 
suspension subcutaneously into four sites using a 21g needle. Booster injections 
were given once a month for a three month period. Test bleeds were collected 2 
weeks after each injection and stored overnight at 4°C. The blood was centrifuged 
at 2000 × g for 5 min and the serum collected and stored at -20°C for analysis. 
The antibody titre of the serum and the antigens recognised by the serum were 
analysed by ELISA and Western blot, respectively, for each serum sample. The 
fourth and final immunisation was carried out with the same amount of the antigen 
diluted in PBS and administrated by an intravenous injection into the ear vein. The 
animal was bled after 10 days by cardiac puncture after anaesthesia with 
pentobarbitonesodium (Sagatal) 60mg ml-1 using a dose of 0.5 ml kg-1 
bodyweight. Serum was prepared as described above and stored at -20 °C for 
further analysis. 
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3.2.3. Enzyme linked immunosorbent assay 
An indirect ELISA was used to measure the antibody titre in serum samples from 
both fish and rabbit according to Adams and Thompson (1990). A 96 well micro 
titre ELISA plate (ImmulonTM, Dynatech) was coated with 0.05 % (w/v) poly-L-
lysine in coating buffer (Appendix I), 50 µl well-1 for 60 min at 20-22°C. The plate 
was washed twice with low salt wash buffer (LSWB) (Appendix 1), and a 
suspension of A. hydrophila (corresponding isolates used for raising serum) with a 
concentration of 1 ×108 ml-1 was added to the plate at 100 µl well-1. The plate was 
incubated overnight at 4°C, after which the bacterial cells were fixed to the bottom 
of the well using 50 µl well-1 of 0.05 % (v/v) gluteraldehyde in PBS incubating for 
20 min at 20-22°C. The plate was washed three times with LSWB. The plate was 
coated with 250 µl well-1 3 % (w/v) of casein (skimmed milk) (Marvel, UK) in H2O, 
and incubated for 2 h at 20-22°C. The plate was washed three times with LSWB. 
The remainder of the procedure was slightly different depending on whether fish or 
rabbit serum was being used. 
 
For the fish serum, two fold dilutions of the serum from 1/8-1/512 were made in 
antibody buffer (Appendix 1) and 100 µl well-1 was added to the ELISA plate. The 
serum from the control fish was added to the last row as a negative control. The 
plate was incubated overnight at 4°C, after which the plate was washed 5 times 
with high salt wash buffer (HSWB) (Appendix 1), incubating for 5 min on last wash. 
Anti-common carp and crussian carp (Carassius auratus) monoclonal antibodies 
(MAbs, Aquatic Diagnostics Ltd., Stirling, UK) were used to detect common carp 
and goldfish (C. auratus) IgM, respectively following the manufacture’s 
instructions. The plate was incubated for 2 h, and then washed with HSWB as 
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described above. Goat anti-mouse IgG-HRP (Sigma, Missouri, USA) diluted 
1/1000 in conjugate buffer (Appendix I) was added to the plate at 100 µl well-1, 
and incubated for 1 h at 20-22°C. The plate was again washed with HSWB as 
described above and 100 µl well-1 chromogen in substrate buffer (Appendix I) was 
added to the wells. This was incubated for 10 min at 20-22°C and the reaction 
stopped with 50 µl of 2 M H2SO4 well-1. Finally, the plate was read in an ELISA 
plate reader (Dynex technologies, UK) and the results were compared between 
control and sample wells. Values three times higher than the negative control 
value were considered positive. The positive values at the lowest dilution were 
considered as a titre value for the serum examined. 
 
For the rabbit serum samples, 100 µL well-1 of serum was added at 10 fold 
dilutions (1 ×10-1 to 1 ×108) made in antibody buffer.  Then PBS was added to the 
last row at 100 µl well-1 as a negative control. The plate was incubated for 1h at 
20-22°C, before washing with 5 washes of HSWB, incubating for 5 min on the last 
wash. Goat anti-rabbit immunoglobulin conjugated to Horseradish Peroxidase 
(IgG-HRP) (Sigma, Missouri, USA) diluted 1/1000 in conjugate buffer was then 
added at 100 µl well-1 and incubated for 1h at 20-22°C. The plate was washed 
again with HSWB as described above. The rest of the procedure was the same as 
that used for the fish serum above.  
 
3.2.4. Western blot 
Western blot analysis was performed using rabbit and fish anti-sera to identify 
which A. hydrophila antigens were recognised by the antibodies, using the method 
outlined by Wiens et al. (1990) with modifications. All the corresponding SDS-
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PAGE gels for the Western blots reported in this Chapter can be found in   
Chapter 2. 
 
3.2.4.1. Western blot using common carp antibody 
Western blot analysis was carried out for all 14 isolates of A. hydrophila (described 
in Table 2.1) grown in vitro using pooled common carp serum raised against six 
isolates of A. hydrophila strains (T4, 98141, Hh, Vds, Catla and C24li). Different 
preparations of the bacterium (i.e. WC, OMP and ECP) prepared from these 6 
isolates of A. hydrophila grown either in vitro or in vivo were screened in the 
Western blot with each of the 6 anti-sera raised against different isolates of A. 
hydrophila. 
 
The bacterial preparations above described were run on a 12 % SDS-PAGE gel, 
as described in the Section, 2.2.4.1 using rainbow molecular weight (MW) marker 
(Amersham Biosciences, UK) as a reference. The gels were equilibrated in the 
transblot buffer (Appendix 1) and transferred on to nitrocellulose membranes 
according to the manufacture’s instructions. The transfer was made using 60 V for 
1 h. The nitrocellulose membranes were removed from the transfer apparatus and 
placed in 2 % (w/v) casein for 1 h at 20-22°C to block non-specific binding sites on 
the membranes. The membranes were washed three times with Tris buffered 
saline containing 0.1 % (v/v) Tween-20 (TTBS) (Appendix 1) for 5 min on each 
wash. After washing, the membranes were incubated overnight in the common 
carp anti-serum diluted 1/10 in Tris buffered saline (TBS) (Appendix 1). 
Membranes were washed with TTBS as described, before incubating the 
membranes with an anti-carp IgM monoclonal antibody (Aquatic Diagnostics Ltd, 
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Stirling, UK) for 2 h. The membranes were again washed with TTBS as described, 
before incubating with anti-mouse IgG-HRP (Sigma, Missouri, USA) for 1 h. They 
were then washed three times as described, including a fourth rinse of 1 min with 
TBS. The blots were developed by adding chromogen and substrate solution (2 ml 
of 4-chloro-naphthol solution (Appendix I) with 10 mls of PBS and 10 µl of H2O2) 
and incubating at 20-22°C until bands were observed. The reaction was stopped 
by soaking the membranes in distilled water for 10 min. The MW of bands was 
determined using the rainbow molecular weight markers in TotalLab v2002.03 
software (Nonlinear Dynamics Ltd). 
 
3.2.4.2. 2D SDS-PAGE Western blot using common carp antibody 
The antigenic profile of WC preparation of isolate T4 grown in vitro was screened 
using 2D SDS-PAGE Western blotting with anti-serum (raised for T4 isolate) from 
common carp. The 2D SDS-PAGE and Western blotting procedures were 
performed as described in Sections 2.2.4.2 and 3.2.4.1, respectively. 
 
3.2.4.3. Western blot using rabbit antibody 
All 14 isolates of A. hydrophila described in the Table 2.1 were analysed by 
Western blotting using the rabbit antibody. The procedure described in Section 
3.2.4.1 was followed until blocking non-specific binding sites with casein. The 
membrane was then washed three times with TTBS for 5 min on each wash. It 
was placed in the anti-A. hydrophila rabbit serum 1/100 dilution in TBS and 
incubated for 1 h at 20-22°C. It was washed again as described above and then 
incubated in anti-rabbit IgG-HRP (Sigma, Missouri, USA) using a 1/100 dilution at 
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20-22°C for 1 h.
 
The remaining of the procedure was the same as outlined in 
Section 3.2.4.1. 
 
3.2.5. Assessing the levels of protection of a 50 kDa protein in 
goldfish against A. hydrophila challenge 
3.2.5.1. Preparation of the antigen 
The 50 kDa protein was eluted from 12 % SDS-PAGE profiles of A. hydrophila T4 
strain. WC preparations of the bacterium were prepared as described in Section 
2.2.3.1. An SDS-PAGE gel (16 × 18 cm size) was prepared as outlined in Section 
2.2.4.1, and 100 µl of sample was loaded in to each well except the first and the 
last well, to which were added 20 µl of rainbow MW markers. The gels were run 
for between 5 and 6 h in a Hoefer SE 600 apparatus at 250 V with 130 mA. On 
completing the electrophoresis, the first two lanes of the gel were sliced off and 
stained and destained for 30 min each as described in Section 2.2.4.1. After 
confirming the location of the 50 kDa band, it was excised from the unstained gel 
and was finely chopped into small pieces. These were placed in elution tubes 
(Ambersham Bioscience) containing 300 µl of SDS-PAGE reservoir buffer 
(Appendix I). The tubes were filled with the gel and a blotting paper disk 
(Ambersham Bioscience) followed by a porous polyethylene plug (Ambersham 
Bioscience) placed on top of the gel. The tip of the tube was cut and placed into a 
1.5 ml centrifuge tube containing 300 µL of 4x SDS-PAGE reservoir buffer. The 
tubes were then placed into an electroeluter (Hoefer, San Francisco, USA) and 
subjected to 50 V at 0.5 mA and a reverse run at 50 V for 5 sec at the end. The 
eluted protein was collected and the reservoir buffer was removed from the 
samples by applying a buffer change with PBS using a 10,000 MW cut-off spin 
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concentrator (Vivo Science, UK) at 2000 × g for 90 min. The concentration of 
protein was determined as described in Section 2.2.3. SDS-PAGE and Western 
blot were performed with the eluted protein to confirm the presence of the 50 kDa 
protein in the elutant prior to using the antigen in the immunisation trials. 
 
3.2.5.2. Determination of the LD50 of A. hydrophila T4 isolate in 
goldfish 
Aeromonas hydrophila isolate T4 was randomly chosen for this study from one of 
the virulent isolates described in the Chapter 2. It was passaged twice through 
goldfish to check the virulence of the isolate before using it for the challenge. One 
fish weighing 30 g was injected with 0.1 ml of 1 ×108 ml-1 of bacteria. Three days 
after injection, the fish was sacrificed overdosing with benzocaine (0.01 % w/v) 
and the kidney was sampled by streaking a loopful of the organ onto TSA. The 
next day, colonies of T4 were identified morphologically, bio-chemically and using 
SDS-PAGE profiles. The isolate was re-cultured in TSB and injected into another 
goldfish. The next day, the fish was found dead and samples were taken from its 
kidney and streaked onto TSA. Colonies which grew were identified as A. 
hydrophila as described above, and this isolate was used for challenging both 
vaccinated and passively immunised fish. 
 
Determination of the LD50 of A. hydrophila T4 isolate in goldfish was carried out 
using three groups of fish with 4 fish per group. One group was injected with 0.1 
ml of 1 ×108 bacterium, the second group with 0.1 ml of 1 ×107 bacterium and the 
third group with 0.1 ml of 5 ×107 bacterium ml-1. The fourth group of fish (2 fish) 
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were injected with 0.1 ml of 2.5 ×107 bacterium ml-1. All the fish which survived 
were sacrificed at the end of the experiment and sampled as described above. 
 
3.2.5.3. Immunisation of goldfish with the electro-eluted 50kDa protein 
For preliminary vaccination, four goldfish weighing around 30-40g were injected IP 
with 200 µL of suspension having 12.3 µg of 50 kDa protein in 60 µL of PBS and 
140 µL of montanide adjuvant. Another four fish were also injected with PBS to 
serve as controls. All the fish were challenged with A. hydrophila 31 days post-
vaccination and sacrificed 21 days after challenge as described above. Samples 
were taken from their kidneys as previously described. The relative percentage 
survival (RPS) was calculated using the following formula (Ellis, 1988). 
 
                 % vaccinated mortality 
RPS= 1-                                        × 100 
         % control mortality 
 
 
 
3.2.5.4. Passive immunisation of goldfish with anti-50kDa protein 
serum raised in goldfish 
Two goldfish weighing 30-40 g were injected IP with 200 µL of antigen (i.e. 12.3 
µg 50 kDa protein) emulsified with Freund’s complete adjuvant (FCA). Thirty four 
days later, both fish were re-vaccinated with the same suspension as described 
above except Freund’s incomplete adjuvant was used in place of FCA. Seventeen 
days after the booster injection, blood was collected from one fish after sacrificing 
it as described above, while the other fish died 2 weeks after the booster injection. 
The anti-serum was collected from the blood as described in the Section 3.2.2 and 
an ELISA performed before using it for passive immunisation to establish its titre. 
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Three goldfish weighing between 30-40 g were immunised by IP injection with 0.1 
ml of goldfish sera raised against the 50 kDa protein electro-eluted from A. 
hydrophila in Section 3.2.5.3, and 3 fish were injected with control serum collected 
from non-vaccinated goldfish. After 24 h all the fish were challenged with 0.1 ml of 
2.5 ×107 ml-1 A. hydrophila T4 isolate in PBS by IP injection, but on the opposite 
side to the site where they had been injected with the antiserum (LaFrentz et al., 
2003). Kidney samples from fish which died during the experiment and surviving 
fish at Day 21 post-challenge were streaked on TSA to confirm specific mortality. 
 
3.3. Results 
3.3.1. Antibody response of common carp infected with different 
isolates of A. hydrophila 
3.3.1.1. Antibody response of common carp infected with                     
A. hydrophila 
The antibody levels increased after Day 9 and a positive response was observed 
on Day 12 post-infection with all the isolates, except for isolate 98141. By Day 21 
post-infection, this response had increased further for 3 of the isolates, with the 
highest antibody response recorded against isolate T4 followed by isolates C24li 
and Vds (Figure 3.1). In case of the Catla and Hh isolates, the antibody response 
began to fall after Day 12, while very little antibody response was observed 
against isolate 98141. 
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Figure 3.1: Antibody response of common carp against different isolates 
of A. hydrophila determined by ELISA expressed as an absorbance at   
450 nm 
All sera were diluted 1:512 and ELISA conditions are outlined in section 3.2.3. 
 
3.3.1.2. Western blot analysis of common carp serum 
The WC preparations of A. hydrophila isolates grown in vitro, screened with the 
anti-sera from infected common carp by Western blotting, exhibited a distribution 
of bands between 20 and 160 kDa (Figure 3.2). Carp antibodies bound to antigens 
ranging from 30-50 kDa for 3 of the virulent isolates, T4, Hh and B2/12. One band 
was observed at approximately 75 kDa except for isolates 2D20, 98140, 98141 
and 98139, while another band was located at around 50 kDa except for isolate 
2D20. Only one band could be observed with isolate 2D20 at around 33 kDa, 
whereas the greatest number of bands was observed with the Calf isolate. 
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Figure 3.2: Western blot analysis of different whole cell preparations of     
A. hydrophila against pooled serum from common carp infected with 6 
different A. hydrophila isolates 
Lanes: (1) Standard marker; (2) T4; (3) 98141; (4) Hh; (5) Vds; (6) Catla; (7) 
C24li; (8) 2D20; (9) 3D14; (10) 2N14; (11) 98140; (12) 98139; (13) B2/12; (14) 
F1d75; (15) Calf. 
The corresponding SDS-PAGE gel for this blot is shown in Chapter 2 (Figure 
2.4). ∗ Virulent isolates. 
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The antibody response against WC, OMP and ECP preparations of A. hydrophila 
grown in vitro and in vivo, showed similar profiles among isolates T4, 98141 and 
Hh with a little variation between them (Figure 3.3). With all the virulent isolates 
(T4, Hh, 98141 and Vds), a band was evident at around 50 kDa in WC and OMP 
preparations with bacteria grown both in vitro and in vivo. This band was also 
present in ECP preparations from bacteria cultured in vitro but not in vivo. The 
ECP preparations from all the virulent isolates grown in both MW cut off tubes 
exhibited 1-4 bands between 52 and 100 kDa. 
 
A weakly stained band was also seen at 75 kDa and 32 kDa with the WC and ECP 
preparations, respectively, with isolate T4 grown in vitro. Isolate 98141 exhibited a 
band at 130 kDa with WC preparation and bands at 35 and 27 kDa with OMP 
preparations. Two bands at 40 and 20 kDa were seen in the ECP preparations of 
bacteria grown in vitro. Another virulent isolate, Hh, exhibited a band at 43 kDa in 
ECP preparations of bacteria grown in vitro. In the case of isolate Vds, expression 
of bands were very similar between 30 and 100 kDa with WC preparations from 
bacteria grown in vitro and in vivo. The OMP preparations from isolate Vds grown 
in vitro showed 6 bands between 25 and 50 kDa. 
 
No bands were identified in the ECP preparations of the profiles of the avirulent 
isolates (Catla, C24li) cultured in vitro. The WC preparations from both avirulent 
isolates grown in vitro and in vivo showed a band at 92 kDa. A band at 50 kDa 
was observed in WC and OMP preparations of isolate Catla grown in vitro, while a 
band at 37 kDa was only seen with OMP preparations from the bacteria grown in 
vitro. A  weekly stained  band  at 92  kDa was  seen  with ECP  from  isolate  Catla 
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Figure 3.3: Western blot analysis of different preparations of 6                  
A. hydrophila isolates screened with serum raised against corresponding 
A. hydrophila isolates in common carp  
(A) T4, (B) 98141, (C) Hh, (D) Vds, (E) Catla, (F) C24li. 
Lanes: (1) Standard marker; (2) WC in vitro; (3) WC in vivo 25 kDa; (4) WC in 
vivo 100 kDa; (5) OMP in vitro; (6) OMP in vivo 25 kDa; (7) OMP in vivo 100 
kDa; (8) ECP in vitro; (9) ECP in vivo 25 kDa; (10) ECP in vivo 100 kDa. 
The corresponding SDS-PAGE gels for these blots are shown in Chapter 2 
(Section 2.3.3). 
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grown in both 25 and 100 kDa MW cut off tube. Another weakly stained band at 
75kDa was only seen in ECP from the bacteria cultured in the 25 kDa MW cut off 
tube. A band at around 50 kDa was seen in both WC and OMP preparations from 
isolate C24li grown in vitro and in vivo. Six bands were seen between 35 and 100 
kDa with ECP preparations from bacteria grown in both MW cut off tubes but the 
bands were weakly stained in the case of bacteria grown in the 100 MW cut off 
tube. WC and OMP preparations from isolate C24li cultured in vitro exhibited a 
band at 35 kDa. 
 
3.3.1.3. 2D SDS-PAGE Western blot 
The 2D Western blot for A. hydrophila T4 isolate using the antibody raised against 
the isolate in common carp expressed three spots at approximately 50 kDa with pI 
values between 5 and 5.7 (Figure 3.4). 
 
3.3.2. Response of rabbit antibody against A. hydrophila 
The end-point titre of the rabbit anti-A. hydrophila serum was 1 ×10-7 as 
determined by ELISA. In Western blot, different banding profiles were exhibited 
with all 14 isolates used, using antibodies raised against heat-killed A. hydrophila 
(T4 isolate) in rabbit. A strong response was seen in the region between 15 to 75 
kDa with all the isolates (Figure 3.5). Similar results were seen for the virulent 
isolates (T4, 98141, Hh, Vds, B2/12) analysed, except 98140 and the same result 
was also reproduced for the two avirulent isolates, 98139 and F1d75. Five major 
bands were seen at around 26, 28, 37, 50 and 75 kDa in seven of the isolates. 
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Figure 3.4: 2D Western blot analysis of whole cell preparation of A. 
hydrophila T4 isolate screened with antibody from common carp infected 
with A. hydrophila T4 isolate 
The corresponding SDS-PAGE gel for this blot is shown in Chapter 2 (Figure 
2.6). 
 
 
Figure 3.5: Western blot analysis of different whole cell preparation of     
A. hydrophila against rabbit anti-A. hydrophila serum 
Lane: (1) Standard marker; (2) T4; (3) 98141; (4) Hh; (5) Vds; (6) Catla; (7) 
C24li; (8) 2D20; (9) 3D14; (10) 2N14; (11) 98140; (12) 98139; (13) B2/12; (14) 
F1d75; (15) Calf. 
The corresponding SDS-PAGE gel for this blot is shown in Chapter 2 (Figure 
2.4). ∗ Virulent isolates. 
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3.3.3. Vaccination and Passive immunisation of goldfish with an 
electro-eluted 50 kDa protein from A. hydrophila 
Aeromonas hydrophila strain T4, which had been maintained in the laboratory was 
of low virulence as fish did not die when injected with 0.1 ml of the bacterium IP at 
a concentration of 1 ×108 ml-1. However, after the first passage, the strain 
appeared to have increased its virulence as fish died the day after re-injection into 
goldfish at the same concentration of bacteria. The LD50 for 0.1 ml of A. hydrophila 
isolate T4 was determined to be 2.5 ×107 ml-1 for goldfish weighing around 30-40g 
and this dose was subsequently used in the challenges performed in goldfish. 
 
In the vaccination experiment, two control and one vaccinated fish died due to 
unknown causes before challenging them with A. hydrophila isolate T4. The two 
fish remaining in the control group died on Day one and Day 4 post-challenge 
(Figure 3.6). One fish from the vaccinated group was also sacrificed one week 
post-challenge as it was suffering from a severe lesion and A. hydrophila was 
isolated from swabs taken from the lesion and kidney of the sacrificed fish. The 
remaining two fish in the vaccinated group were healthy and sacrificed at the end 
of the experiment, at 21 days post-challenge. All kidney swabs taken from dead 
fish were positive for A. hydrophila while the samples taken from two vaccinated 
fish at the end of experiment were negative. Though the numbers of fish used in 
the experiment were low, the RPS value was 66.7 %. 
 
The fish serum raised against the 50 kDa protein of A. hydrophila used to 
passively immunise fish, had a titre of 1/16. In the trial with this serum, one fish 
from the  control  group  died  two  days  post-infection  and  the presence of A. 
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hydrophila in its kidney was confirmed using an API 20E strip. No other fish died 
and no kidneys were positive for the bacteria when remaining fish were sampled 
at the end of the trial on Day 21. 
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Figure 3.6: Cumulative percentage of goldfish mortality in preliminary 
vaccination trial 
 
 
3.4. Discussion 
It is difficult to prevent outbreaks of diseases caused by A. hydrophila due to the 
heterogenicity of isolates (i.e. it has been difficult to develop a successful vaccine) 
and there is increasing resistance of the bacterium to a wide range of antibiotics 
(Janda et al., 1996; Dixon et al., 1990; Daskalov, 2006). Use of antibiotics has 
been reported to stop the growth of favourable bacterial communities in 
aquaculture systems, leading to deterioration of systems, as well as an 
accumulation of antibiotic residues in fish tissues (Kulp and Borden, 1942; Martin, 
1973; Van Muiswinkel et al., 1985; Ellis, 1988; Ilhan et al., 2006). Considering the 
disadvantages of using antibiotics discussed in Chapter 1, immunoprophylaxsis is 
a safe method for preventing diseases in aquaculture rather than treating fish with 
antibiotics (Samuel et al., 1996). A number of vaccine preparations containing 
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different components of A. hydrophila have been tried in an attempt to protect fish 
from diseases caused by this bacterium (Baba et al., 1988b; Loghothetis and 
Austin, 1994; Rahman and Kawai, 2000; Perez et al., 2002; Vivas et al., 2004a; 
Rodrigues et al., 2006). However, no commercial vaccine is yet available for A. 
hydrophila (Fang et al., 2004). This may be because of insufficient ability to meet 
the efficacy, safety or cost effectiveness required for the vaccine preparations 
which have been tried to date (Clark and Cassidy-Hanley, 2005). 
 
In this study, common carp were infected with A. hydrophila and the anti-sera 
produced were used to identify immunogenic components of the bacterium using 
Western blotting. The different A. hydrophila isolates examined elicited a variety of 
responses in common carp, as determined by ELISA. An increase in antibody 
response against A. hydrophila was seen after Day 9 post-infection for all the 
isolates except one isolate (98141). Antibody response peaked on Day 12 post-
infection for two isolates (Hh and Catla) and was high on Day 21 post-infection for 
three isolates (T4, Vds and C24li). Authors have observed that the immune 
responses against A. hydrophila are variable according to the nature of isolates 
and fish species used for the infection (Loghothetis and Austin, 1996a; Sahoo et 
al., 2004). For example, tilapia (Oreochomis aureus) artificially infected with A. 
hydrophila exhibited an increase in antibody response from 48 h, and a maximum 
titre (1:512) was observed by Day 30 post-infection (Prieto et al., 1992). A similar 
titre was observed on Day 21 post-infection for all the isolates in the current study. 
Moreover, the antibody response of common carp did not show any differentiation 
between virulent and avirulent isolates of A. hydrophila in the ELISA. This may be 
due to differences in the ability of the immune system of the host to respond to 
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foreign agents. However, variation in individual immune responses against a 
specific isolate of A. hydrophila was seen to differ in rainbow trout, Oncorhynchus 
mykiss, as not all the fish developed the same levels of antibody response against 
a specific isolate (Loghothetis and Austin, 1996a). 
 
Choosing the protective antigen(s) is an important basic step in establishing a 
suitable vaccine (Potter and Babiuk, 2001). The host immune response plays a 
vital role in the identification of antigens for producing effective vaccines (Ellis, 
1999). In this study, Western blot analysis using the anti-sera produced on Day 21 
post-infection, against different strains of A. hydrophila, showed differences in the 
profiles between the isolates. However, when pooled sera (from common carp 
infected with 6 different isolates) were used to examine the response against the 
14 isolates of A. hydrophila (described in Table 2.1), a band at around 50 kDa was 
observed in all the isolates grown in vitro, except for isolate 2D20. Moreover, 
bands from 30-50 kDa were stained in the profiles of 3 of the virulent isolates, T4, 
Hh and B2/12 grown in vitro. The response seen with the fish serum in Western 
blotting against samples prepared from bacteria grown in vitro and in vivo was 
variable. However, the response seen against the virulent strains was quite 
similar. A band at around 50 kDa was seen with all the preparations (WC, OMP, 
ECP) from the virulent isolates grown both in vitro and in vivo compared with 
avirulent isolates, with the exception of the ECP from bacteria grown in vivo, which 
did not contain the band. 
 
The 2D Western blot analysis is useful to identify all of the immunogenic 
components of a pathogen for diagnostic and vaccine production, as 2D SDS-
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PAGE can separate even very complex mixtures of proteins to allow easier 
identification of individual proteins by Western blot (Klade, 2002; Chen et al., 
2004). The 2D Western blot analysis of A. hydrophila (T4 isolate) WC revealed 3 
spots at approximately 50 kDa between 5 and 5.7 pl range when serum raised 
against T4 isolates was used. Spots in this particular region were darkly stained 
with all the isolates in 2D SDS-PAGE (Figure 2.6) suggesting that these spots 
contain particularly immunogenic proteins. 
 
The results of the 1D and 2D Western blot analysis suggest that a molecule at 
approximately 50 kDa (ranging between 47 and 51 kDa) might be one of the major 
immunogenic components of A. hydrophila. Although the molecule varies in size 
with isolate and type of preparations, for the purpose of this thesis we will refer to 
this as the 50 kDa molecule. This similar 50 kDa protein of A. hydrophila has 
already been reported by number of authors to be a major virulence surface factor 
(Dooley and Trust, 1988; Janda and Duffey, 1988; Ascencio et al., 1991b and 
1998; Sendra et al., 1997). 
 
Antibodies raised against A. hydrophila (heat-killed T4 isolate) in rabbits were also 
analysed. The heavily stained band observed at 50 kDa with most of the isolates 
against pooled common carp antibody was found to be weakly stained with rabbit 
antibody. This indicates a difference in the host response, which, might be due to 
the fact that heat-killed cells were used in rabbits to elicit the antibody response, 
while live cells were used in fish. Other researchers have reported that the 50 kDa 
protein is recognised by antibodies raised against heat-killed A. hydrophila in 
rabbits (Sendra et al., 1997). 
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Other components of A. hydrophila have also been reported as immunogenic 
when screened with antibodies from different sources by Western blotting. For 
example, antibodies raised in rainbow trout against live and killed A. hydrophila by 
immersion, injection or oral administration, reacted with formalised cells and LPS 
of the bacterium, and to a lesser extent with exopolysacchride, flagella, S-layer 
protein and a haemolytic component in the ECP of A. hydrophila (Loghothetis and 
Austin, 1994). The same authors (1996b) also suggested that the LPS of A. 
hydrophila was the major antigenic component of WCs, as strong agglutination of 
formalised and live cells of A. hydrophila was seen with serum from rainbow trout 
compared with extremely weak agglutination with boiled and LPS deficient A. 
hydrophila. Antibodies raised against formalin killed A. hydrophila in rabbit showed 
a response to LPS in Western blot and also showed that O polysaccharide was 
the immunodominant region of the LPS molecule (Dooley et al., 1986). 
 
Researchers have used direct immunisation as well as passive immunisation as a 
tool to evaluate the immune response and protection produced by a specific 
antigen/pathogen. For instance, carp, C. carpio injected IP with formalin killed A. 
hydrophila showed an increased agglutinating antibody titre one week after 
immunisation, and the peak response ranging from 1:2,048 to 8192 were 
observed 4 weeks after immunisation (Kusuda et al., 1987). A specific immune 
response in catfish, Clarias gariepinus at 4 weeks post-immunisation with 
formalin-killed A. hydrophila was significantly greater than that measured in control 
catfish (Yin et al., 1997). Indian major carp, rohu and mrigal (Cirrhinus. mrigala) 
had  a   detectable   antibody  response  against  all  components  of  a  polyvalent  
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vaccine (composed of whole cell and ECP of A. hydrophila) on Day 7 after primary 
immunisation, which peaked at 14 days post-immunisation (Chandran et al., 
2002b). A significant increase in antibody response in common carp against A. 
salmonicida was also observed at Day 14 post-immunisation when the fish were 
immunised with liposomes containing antigens of the bacteria (Irie et al., 2005). 
 
In vaccine development, fish immunised with various pathogens have been shown 
to elicit different levels of protection following challenge with the corresponding 
pathogens. It has been reported, for example, that an RPS value of 86.6 % was 
obtained in trout immunised with formalin-treated V. anguillarum for one month 
before challenging them with bacteria (Akhlaghi, 1999). The author observed that 
fish passively immunised with serum against formalin killed V. anguillarum raised 
either in trout, sheep and rabbits appeared only weakly protected by the fish 
serum (RPS of 40.0 %) compared with either the sheep or the rabbit serum (RPS 
of 93.3 and 86.6 %, respectively). In another trial, tilapia, O. niloticus which were 
challenged with Streptococcus iniae after immunising them with live bacteria had 
an 18 % cumulative mortality, while only a 0 and 3.3 % cumulative mortality was 
seen in fish passively immunised with serum raised against live or heat inactivated 
bacteria respectively (Shelby et al., 2002). Tilapia, vaccinated with formalin-treated 
S. agalactiae showed 40 % mortality when challenged with the bacteria compared 
with 60 % mortality in the control group (Pasnik et al., 2006). These authors also 
noted significantly less mortality (P < 0.0001) in the passively immunised group 
using fish serum raised against S. agalactiae compared with the control group 
after challenging them with the bacterium. 
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In the current study, the 50 kDa protein of A. hydrophila was considered to be the 
most immunogenic protein which is present in most isolates. The 50 kDa protein 
conferred protection in goldfish against A. hydrophila in the direct immunisation 
trial, however, the results of passive immunisation trial are inconclusive due to low 
mortality after challenge. The titre of the fish serum raised against the electro-
eluted 50 kDa protein was also very low 1/16. Although both trials were carried out 
with a limited number of fish, the protection seen in goldfish against A. hydrophila 
in direct immunisation trial suggests that the 50 kDa protein may be a suitable 
vaccine candidate against this bacterium. 
 
To conclude, the antibody responses in common carp following A. hydrophila 
infection were evaluated, and the anti-sera collected was used to identify common 
antigens between isolates to be used as possible vaccine candidates. The results 
suggested that a 50 kDa protein was the most common immunogenic antigen on 
the isolates. This particular protein was expressed by all the virulent isolates, in 
the WC and OMP preparations from bacteria grown both in vitro and in vivo. This 
molecule only appeared to be present in the ECP of bacteria grown in vitro, but 
not in vivo. Moreover, no apparent difference was seen in the response between 
bacteria grown in 25 and 100 kDa MW cut off tubes except with the ECP 
preparations. The efficacy of this 50 kDa protein in goldfish following vaccination 
and experimental challenge against A. hydrophila suggests that this protein may 
indeed be a protective vaccine candidate. 
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4.1. Introduction 
Vaccination of humans and other animals induces specific immunity to assist in 
the elimination of microbes, neutralisation of microbial toxins and prevention of 
further microbial invasion (Minichiello, 2002). Recently, the expression of proteins 
in recombinant systems has become a widely used technique for vaccine 
production in mammals (Andersen and Krummen, 2002; Jenny et al., 2003). This 
method enables rapid production of large quantities of specific protein (He et al., 
1997). Researchers are using recombinant DNA technology to develop protein 
vaccines for the aquaculture industry because it provides a means to produce 
sufficient quantities of the immunoprotective vaccine antigen inexpensively (Leong 
et al., 1997; Wilhelm et al., 2006). Such vaccines have enormous potential in the 
aquaculture industry as they are safe and efficient compared with live or 
attenuated vaccines (Clark and Cassidy-Hanley, 2005). They also provide an 
alternative approach to traditional formalin-killed whole cell (WC) vaccines that are 
not always efficacious. 
 
Recombinant protein production involves a series of stages including DNA 
amplification, expression in host cells, purification and confirmation of protein 
immunogenicity in the host (Murthy et al., 2004). Quality and yield of recombinant 
protein are dependent on the protein gene sequence, the vector, host cell and 
culture conditions used (Stevens, 2000). The primary microbial host for producing 
recombinant therapeutic proteins has been Escherichia coli, although many 
alternative organisms and expression systems are now being used (Baneyx, 1999; 
Swartz, 2001). The use of affinity tags (e.g. histidine tags) simplifies the 
purification of the recombinant fusion proteins (Nygren et al., 1994). 
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Sequencing, identification and characterisation of the protein can be carried out 
either by matrix-assisted laser desorption ionisation time-of-flight mass 
spectrometry (MALDI-TOF MS) (Wang et al., 2003) or N-terminal sequencing 
(Prasad et al., 2005). The MALDI-TOF MS is a superior method to identify all 
kinds of proteins between 1 and 300 kilo Dalton (kDa) with high accuracy and 
sensitivity (Bonk and Humeny, 2001). This method comprises digestion of the 
target protein, typically by trypsin and the resulting peptides are mass analysed 
and these data are compared with those held in a sequence database (Egelhofer 
et al., 2002). Reverse translation of the sequence identified protein generates the 
sequence of the gene responsible for encoding the protein, which in turn facilitates 
primer design for DNA amplification. 
 
Recombinant proteins have been used as vaccine candidates for a variety of fish 
pathogens, for example, the recombinant immobilization antigen of 
Ichthyophthirius multifiliis protected goldfish (Carassius auratus) against the 
parasite (He et al., 1997). A recombinant protein from Piscirickettsia salmonis has 
been shown to elicit protection against salmonid rickettsial septicaemia (SRS), in 
coho salmon (Oncorhynchus kisutch) (Kuzyk et al., 2001). Recombinant protein 
vaccines are, however, not always successful with regard to protection. Maurice et 
al. (2004) found increased antibody titres in goldfish immunised with recombinant 
A-layer proteins of A. salmonicida entrapped in alginate beads, however, 
vaccinated fish did not show any resistance to the bacterium. This was also the 
case for an 85a (31 kDa) recombinant protein antigen of Mycobacterium marinum 
as no protection was observed in striped bass, Morone saxatilis, when fish were 
challenged with the bacterium 70 days post-vaccination (Pasnik et al., 2003). 
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The aim of the present Chapter was to to identify the 50 kDa protein of A. 
hydrophila which exhibited immunogenic and protective properties in Chapter 3. 
Following sequencing by MALDI-TOF MS, production of a recombinant 50 kDa 
protein was planned to ensure a sufficient quantity of protein for large scale 
vaccination efficacy testing. A vaccination trial was designed using the 
recombinant protein in common carp (Cyprinus carpio) to assess firstly the level of 
protection elicited by this recombinant protein, and secondly to see, if the antigen 
cross-protected against different isolates of A. hydrophila. 
 
4.2. Materials and methods 
4.2.1. Identification of the 50 kDa protein of A. hydrophila by 
peptide mass fingerprinting 
A whole cell preparation of A. hydrophila T4 isolate in Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer was prepared as 
described in Section 2.2.3.1 and sent to University of Dundee, Scotland, UK for 
sequencing and identification of the 50 kDa protein by MALDI-TOF MS. Samples 
were in-gel reductively alkylated prior to staining with colloidal Coomassie blue, 
then digested in 0.1 % of n-octyl glucoside/20mM ammonium bicarbonate plus 
12.5 µg ml-1 trypsin, and the sample (1.5 µl) was spotted from the extract (30 µl) 
after adding an equal volume of acetonitrile for performing MALDI-TOF MS 
analysis. 
 
4.2.2. Recombinant 50 kDa protein production 
The protective nature of the 50 kDa protein from A. hydrophila was previously 
confirmed in goldfish using a small number of fish (Chapter 3). It was, therefore, of 
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interest to confirm this protection in a large scale trial using common carp. Thus 
recombinant protein was produced in order to have a sufficient quantity of protein 
for a large scale vaccination trial. All the recombinant protein work was conducted 
at the Genomic Laboratory, Tokyo University of Marine Sciences and Technology, 
Japan. 
 
4.2.2.1. DNA extraction from A. hydrophila T4 isolate 
Aeromonas hydrophila T4 isolate was grown overnight as described in Section 
2.2.1.4, after which it was transferred to 1.5 ml centrifuge tubes and centrifuged at 
5000 × g for 5 min at 4°C. The pellet was resuspended in 567 µl Tris 
ethylenediaminetetraacetic acid (EDTA) (TE) buffer (10 mM Tris-Cl and 1 mM 
EDTA, pH 8), 30 µl of 10 % (w/v) SDS and 3 µl of 20 mg ml-1 proteinase K. The 
bacteria were thoroughly mixed and incubated for 1 h at 37°C before adding 100 µl 
of 5 M NaCl and was again thoroughly mixing, after which, 80 µl 
cetyltrimethylammonium bromide (CTAB) in NaCl solution (10 % v/v CTAB in 0.7 
M NaCl) was added, mixed and incubated for 10 min at 65°C. DNA was extracted 
from the sample with an equal volume (780 µl) of chloroform: isoamyl alcohol 
(24:1 ratio). The tube was inverted a couple of times and centrifuged at 5000 × g 
for 5 min at 4°C. The aqueous phase was transferred to a fresh tube and extracted 
with phenol: chloroform: isoamyl alcohol (25:24:1 ratio). The contents of the tube 
was thoroughly mixed and centrifuged at 5000 × g for 10 min at 20-22°C. The 
aqueous phase was transferred to a fresh tube, and the DNA precipitated with an 
equal volume of isopropanol and the contents of the tube were thoroughly mixed 
by inverting the tube a couple of times and centrifuged at 5000 × g for 10 min at 
4°C. The precipitate was washed with 70 % ethanol by centrifuging at 5000 × g for 
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10 min at 4°C. The supernatant was removed and the pellet briefly dried at 20-
22°C for 10 min. The pellets were resuspended in 100 µl TE buffer and stored at -
20°C until used. 
 
4.2.2.2. Polymerase chain reaction (PCR) of A. hydrophila 50 kDa 
protein gene 
Specific primers were designed to amplify the full length of the 50 kDa protein 
gene based on the sequence data for S-layer gene of A. hydrophila published by 
Thomas and Trust (1995a). Restriction sites Nco I and Bgl II were added to the 
forward and reverse primers respectively (Figure 4.1) to assist its cloning into the 
expression vector pQE 60 (Appendix II). The PCR mixture (Appendix II) was 
prepared for 40 µl reactions and each reaction included 32 cycles using the 
following conditions; preheating to 95°C/5 min; denaturation for 95°C during 30 
sec; annealing at 55°C/30 sec; elongation at 72°C/1min and a final elongation step 
at 72°C/5 min. 
 
 
 
                                          Nco I   Forward primer sequence   
 
 
 
       Reverse primer sequence   Bgl II              
 
Figure 4.1: Primers and restriction enzymes used for amplification of the 
50 kDa protein gene 
 
          5’ ccatgggagttaatctggacactggtgc 3’ 
3’ gacttgtggtacttgcgtaagtctaga 5’ 
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4.2.2.3. Preparation of PCR products for transformation into E. coli 
The PCR products were run on a 1 % agarose gel for 30 min at 100V. The target 
bands were identified by ultraviolet (UV) light and were cut from the gel using a 
scalpel and chopped into small pieces. The DNA were extracted from the gel 
using a DNA purification kit from Amersham Bio-Science. Digestion of the PCR 
products and the pQE 60 vector (Qiagen) were carried out overnight at 37°C with a 
digestion mixture described in Appendix II. Both pQE 60 vectors and PCR 
products were purified after the digestion process as described above. The ligation 
was attained by mixing 2 µl of vector with 8 µl of PCR products and adding 10 µl 
ligation high (Cosmo Bio Co Ltd, Tokyo) before incubating it overnight at 16°C. 
 
4.2.2.4. Transformation of vectors carrying 50 kDa protein gene into   
E. coli 
Escherichia coli, M15 (Quiagen, Tokyo, Japan) was used for transforming pQE 60 
vectors carrying the amplified 50 kDa protein gene of A. hydrophila. Initially, 100 µl 
of cells were thawed from storage at -70°C. The pQE 60 vectors were added to the 
cells and incubated for 30 min on ice. The mixture was given a heat shock at 45°C 
for 45 sec before adding 800 µl of SOC medium (Sigma) and incubating at 37°C 
for 1 h with vigorous shaking. The cells were centrifuged at 2000 × g for 3 min and 
resuspended in 100 µl 2x yeast tryptone broth (2xYT). The cell suspension was 
transferred (spread plate) onto Luria Bertani (LB) agar plates containing ampicillin 
and kanamycin. The plate was incubated overnight at 37°C and approximately 10 
colonies plated from the LB-agar plate and transferred to a fresh LB-agar plate. 
The fresh plate was incubated for approximately 4 h at 37°C, and then PCR was 
performed on colonies taken from the plate using colony PCR mixture (Appendix 
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II) to confirm the presence of the 50 kDa protein gene insert in the bacterial 
colonies. The PCR conditions described in Section 4.1.2.2 were applied using E. 
coli colonies having recombinant pQE60 as the template to the PCR carried out 
here. 
 
4.2.2.5. Expression of the recombinant 50 kDa protein in E. coli 
The clones containing the 50 kDa protein gene insert identified by PCR, were 
inoculated into LB broth containing ampicillin (100 µg ml-1) and kanamycin (25 µg 
ml-1), and incubated overnight at 37°C. The expression of the recombinant protein 
was achieved by adding 1mM isopropyl-β-thiogalactoside (IPTG) to the medium 
and incubating for 4 h. The E. coli cells were harvested and total proteins of IPTG 
induced and non-induced recombinant bacteria were separated on a 12 % SDS-
PAGE and subjected to Western blot as outlined in Sections 2.2.4.1 and 3.2.4.2. 
After electroblotting onto a nitrocellulose membrane (ATTO Co., Tokyo, Japan), 
the membranes were blocked as outlined in Section 3.2.4 and incubated with an 
anti-histidine-tag antibody (Amersham Biosciences Buckinghamshire, UK) diluted 
1:6000 in TBS for 1 h. As a second antibody, mouse anti-rabbit conjugated to IgG-
alkaline phosphatase (Promega, Madison WI, U.S.A) was used at a concentration 
of 1:7500 and incubated for 1 h. The reaction was developed using the 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP-NBT) alkaline 
phosphatase substrate (1 tablet dissolved in 10 ml of double distilled water, 
Sigma-Aldrich Co, St Louis MO, U.S.A). 
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4.2.2.6. Large scale production of recombinant 50 kDa protein 
Positive clones were cultured in 50 ml of LB broth with antibiotics, ampicillin (100 
µg ml-1) and kanamycin (25 µg ml-1) overnight at 37°C with vigorous shaking. This 
culture was transferred to 1 L fresh LB broth and cultured at 37°C with vigorous 
shaking. The absorbance of the culture broth at 600nm was measured every hour 
until it reached 0.6, after which, the culture was induced to express the 
recombinant proteins by adding 1 mM IPTG. Bacterial growth was stopped exactly 
4 h after inducement and the bacterial pellets were harvested at 4000 × g for 30 
min at 4°C. The pellets were resuspended in phosphate buffered saline (PBS) and 
stored at -80°C. 
 
The bacterial pellet was subjected to 3 rounds of freeze-thawing before 
resuspending in sterile PBS and sonicating 60 times at 150 Watts for 20 sec with 
10 sec intervals. After sonication, the soluble (native protein) and insoluble 
materials (inclusion bodies) were separated by centrifugation at 4000xg for 30 min 
at 4°C. Inclusion bodies were solubilised in 250 ml denaturing solution (8 M urea, 
0.1 % (w/v) SDS and 100 mM Tris-HCl) with 10 mM imidazole, while imidazole 
was added to the supernatant at final concentration of 10 mM. Inclusion bodies 
and the denaturing solution mentioned above were mixed together and 20 ml of 
nickel beads (Ni Sepharose 6 fast flow, Amersham bioscience) was added to bind 
the target proteins. Both pellet and supernatant were placed on ice and shaken 
overnight. 
 
A column (XK 16/20 empty lab scale column, Amersham Bio-Science) was filled 
with beads and washed three times with 20 mM washing buffer (Imidazole 20 mM, 
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NaH2PO4 50 mM and NaCl 300 mM) pH 8. The proteins were eluted from the 
beads using elution buffer (Imidazole 250 mM, NaH2Po4 50 mM and NaCl 300 
mM) pH 8.5 and collected in fractions, the OD of which were measured at 280 nm. 
Fractions containing proteins were pooled together before concentrating using a 
Millipore membrane (10,000 MW cut off, Amicon), and dialysed overnight in sterile 
PBS using seamless cellulose tubing (12,000 MW cut off, Union Carbidge 
Corporation, Tokyo). The protein concentration of the suspension was measured 
using a Pierce protein determination kit and the protein was stored at -20°C until 
further use. SDS-PAGE described in Section 2.2.4.1 and Western blot described 
in Section 3.2.4.2 were performed with serum raised in common carp against A. 
hydrophila isolate T4 to confirm the immunogenicity of the recombinant 50 kDa 
protein. 
 
4.2.3. Sequencing of the A. hydrophila T4 isolate 50 kDa protein 
gene 
The 50 kDa protein gene of A. hydrophila isolate T4 was sequenced at the 
Genomic Laboratory, Tokyo University of Marine Sciences and Technology with 
primers (Figure 4.1) to compare the 50 kDa protein genome with A. hydrophila 
isolate TF7 S-layer protein genome reported by Thomas and Trust (1995a). 
 
4.2.4. Vaccination of common carp with recombinant 50 kDa 
protein 
4.2.4.1. Standardising the A. hydrophila challenge 
The six virulent isolates (T4, 98140, 98141, Hh, B2/12 and Vds) described in 
Chapter 2, were passaged twice through common carp (30-40g). Bacterial 
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suspensions of these strains were prepared at a concentration of 1 ×108 bacteria 
ml-1, as described in Section 2.2.1.4, and 0.1 ml of these were injected 
intraperitoneally (IP) into two fish for each strain. Samples were taken from the 
kidney of dead fish 24 h post-injection, and streaked onto tryptone soy agar (TSA) 
plates which were incubated overnight at 28°C. Colonies on the plate were 
confirmed as A. hydrophila as described in Section 2.2.1. The bacteria were 
repassaged through fish using a bacterial suspension for each isolate at 5 ×107 
bacteria ml-1 and 0.1 ml injected as described above. 
 
After passaging the bacteria through the fish, the LD50 was determined for the six 
isolates in common carp (30-40 g). Initially, three doses of bacteria were selected; 
2 ×107, 5 ×107 and 2.5 ×107 bacteria ml-1. The fish were injected IP with 0.1 ml of 
these suspensions and placed in a separate glass tank for each strain. The fish 
were maintained in a recirculatory water system with aeration. The concentrations 
of bacteria were modified and injected to a fresh group of fish until obtaining LD50 
values for all the isolates. 
 
4.2.4.2. Vaccination 
Recombinant 50 kDa protein of A. hydrophila diluted in PBS was mixed with 
montanide adjuvant (Schering-Plough Aquaculture, Saffron Walden, UK) at a ratio 
of 30:70 (v/v) to give a final antigen concentration of 300 µg ml-1. Buffer (PBS) 
mixed with the adjuvant was also prepared at the same ratio as the antigen to 
serve as a negative control. Mixing was achieved by vortexing until the antigen 
was emulsified, and this was stored overnight at 4°C to ensure that the antigen did 
not separate from the adjuvant. 
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One hundred and fifty common carp (30-40 g) were vaccinated by IP injection with 
0.1 ml of the vaccine preparation, and another 150 fish were injected with the PBS 
adjuvant mixture. The right side pectoral fins of control fish were clipped for 
identification. All the fish were maintained for 35 days in 1 × 1 m (Diameter × 
depth) tanks with recirculating water before challenging them with six different 
isolates of A. hydrophila. 
 
4.2.4.3. Challenge studies 
Each of the six virulent isolates described in Section 5.2.1 were used to challenge 
vaccinated fish. Twenty vaccinated and 20 control fish were injected IP with each 
strain after anesthetising them as described in Section 2.2.2. The concentrations 
of the bacteria used in the challenge were 1 ×108, 2 ×107, 2 ×107, 5 ×107, 7.5 ×106 
and 2 ×107 bacteria ml-1 for T4, 98140, 98141, Hh, B2/12 and Vds respectively. All 
40 fish within each group were placed in separate glass tank (90 cm length × 47 
cm height × 40 cm depth) with aeration and recirculating water. The fish were 
maintained for 16 days post-challenge and dead fish were removed 3 times a day. 
Samples from the kidney of dead fish and also from surviving fish at the end of the 
experiment on Day 16 post-challenge were streaked onto TSA plates. Six 
surviving fish (3 vaccinated and 3 control fish) per bacterial strain were sacrificed 
with an overdose of benzocaine (0.01 % w/v) and their kidneys sampled. 
 
4.2.4.4. Statistical analysis 
The results obtained were analysed statistically using Chi-square test for survival, 
comparing the mortality of vaccinated fish with the control group fish after 
challenging with bacteria. 
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4.3. Results 
4.3.1. Peptide Mass Fingerprinting of the 50 kDa protein from A. 
hydrophila 
Sequencing of 50 kDa protein of A. hydrophila isolate T4 was carried out by 
MALDI-TOF MS and the spectrum of peptide profiles obtained can be seen in 
Figure 4.2. After matching the peptide mass fingerprint with that obtained by 
Thomas and Trust (1995a), the protein was identified as a 47.6 kDa S-layer 
protein. The whole amino acid and genomic sequence of the S-layer protein of A. 
hydrophila reported by these authors were obtained from the National Centre for 
Biotechnology Information (NCBI) database (Figure 4.3). 
 
 
 
Figure 4.2: MALDI-TOF MS spectrum showing the peptide profiles of 50 
kDa band 
 
799.0 1441.8 2084.6 2727.4 3370.2 4013.0
Mass (m/z)
4.1E+4
0
10
20
30
40
50
60
70
80
90
100
%
 
In
te
n
s
ity
4700 Reflector Spec #1 MC=>BC=>NF0.7[BP = 1876.0, 41167]
18
75
.
97
97
83
2.
32
07
12
33
.
58
56
88
0.
46
62
17
25
.
00
10
15
44
.
88
33
11
79
.
65
91
89
2.
49
44
20
65
.
11
79
14
00
.
73
02
10
23
.
55
24
22
05
.
14
16
11
20
.
60
24
12
43
.
74
96
14
59
.
83
31
16
05
.
88
66
16
91
.
83
76
23
90
.
23
58
13
35
.
71
31
22
73
.
15
06
18
63
.
91
48
28
56
.
30
20
82
4.
45
35
19
57
.
99
33
15
20
.
77
03
95
7.
44
38
11
84
.
62
26
35
55
.
87
43
25
50
.
22
75
30
02
.
37
57
26
09
.
31
20
32
15
.
47
92
24
49
.
10
86
31
53
.
43
99
38
15
.
83
76
37
15
.
63
35
38
81
.
29
44
29
38
.
31
62
33
81
.
57
23
27
33
.
36
55
 Chapter 4  Page 128 
 
Figure 4.3: Nucleic and amino acid sequences of A. hydrophila S-layer 
protein 
Signal peptide sequences are highlighted (Nucleic acid in green and amino acid 
in yellow). 
 
NCBI accession number – AAA67043 (Thomas and Trust, 1995a). 
 
 
 
 
 
1       atgattctaatgaaaaagacactgattgcactggccgttgctggtctgagctttaacgctgctgcagttaatctggacactggtgctggc 
1            M     I    L    M     K     K      T      L     I    A      L     A      V    A    G     L     S      F   N     A     A     A     V    N    L      D      T    G     A    G 
91     gtttctaagtttgctagcgaaatcaaagttgatggcgcggcaggtactaccttgggtaccgcagccggtgctgctatgaatgcagtgagc 
 31         V   S    K      F   A     S      E      I      K     V    D     G     A      A      G     T     T      L    G     T     A      A      G     A     A    M    N    A       V    S 
181   aagctgggtttctctatttctaccggtaacaagcgttacattcgttacgatgtaactggtggttcactggctggtgtcgctgttgcggac 
    61      K      L     G     F    S     I    S    T      G     N     K      R    Y     I     R    Y     D    V     T     G    G      S     L    A     G     V     A     V    A      D 
271    ttgaccttggttggtggtactcctgttgctgtagttgcagctgatagctcctttgttatctctcagaccgccgctgatggtagctttgtg 
     91      L     T     L    V    G     G     T     P     V    A    V     V   A     A     D     S      S     F   V    I     S    Q      T      A      A    D     G     S      F    V 
361   atcgttgaagttgttgctaagaaagacatccctgctgatgcagtgatgacctccaaagccgatggtcgtgtgaacgttaagacaaaaaat 
   121     I      V    E      V    V   A     K      K     D      I     P     A     D    A      V      M   T     S      K     A      D     G    R      V    N      V    K     T      K     N 
451    ggcgtagctatcagctatcgcctgttcgagactgctctggatgccgttgctaacgatccagctaagaccctggccaaggcaaatggtcaa 
   151      G      V     A     I      S     Y    R      L     F     E     T     A     L     D     A     V    A     N     D     P     A     K      T      L     A     K      A      N    G     Q 
541    ctgctgactttctccccagctatcctcgccaaagttgagaagaagggttctgccgacaagatcgacgtgaccgagtcttccatgaagttt 
   181      L      L     T    F    S     P      A     I      L     A     K     V     E      K      K     G     S    A      D     K      I      D      V    T      E       S    S     M    K     F 
631    gttaccaatgcgaatgttaaagctactgataccatcctgggtcaagtaagcatcactgcagacgtaaacactcttttggctaacggtact 
   211      V    T      N   A       N     V   K     A     T    D     T       I      L     G    Q     V     S       I     T     A      D     V     N     T     L   L    A     N     G     T 
721    cccgtggctgctaccagtgatattctgaatgcaagcaaactggttgttaatggtgatttctctgcaggtgcagtagacgccgataacaaa 
   241      P      V     A     A     T      S     D     I    L      N    A     S       K     L     V   V    N    G      D    F    S   A      G     A      V     D     A      D     N     K 
811    ctggttctgggtaccgtcaagctgaatgctgccaatgctactaaagttgaagccgcgaaagctgagctggctgtggcagatgcaggtatt 
   271      L     V    L     G     T      V     K     L      N    A     A     N    A     T     K     V    E      A     A       K     A     E      L      A    V     A      D    A     G      I 
 901   ggtgcagcagctccagcaggtaacatcagctactttgttggtggcaaagctcctatcgctccgcaggctgtaactgctactttcgttccg 
    301     G     A      A     A     P       A     G     N      I     S      Y     F   V    G     G      K     A     P     I     A     P       Q     A     V    T     A     T     F    V   P 
 991   gttgtaaaagctggttatgagttggctgatgtaaatctgggcgaaattggtgtgctgaacaaaaatggttccaccaaagaagctaacctg 
     331    V    V     K     A     G    Y    E      L    A     D     V    N     L    G       E      I     G     V     L     N      K     N    G     S     T      K      E    A      N     L 
1081  gtgctggctccagatacctcttacaccaacctggtgcgtatctccaacacctccaacatcgctggtaagttctttgtgactgcttatgct 
     361     V      L    A     P      D    T      S    Y     T      N     L     V     R      I     S     N     T     S      N     I     A      G     K     F    F   V     T     A    Y   A 
1171  gatgatggtaagtctgtaagcttcgcactgtctgatgttgctggtcagccggctgttctggaagctggcgcctccaccaagcagatgaaa 
      391    D     D    G      K     S    V     S      F    A      L     S    D     V   A     G     Q      P      A     V    L     E      A     G     A     S      T      K     Q      M    K 
1261  gtggctgatatctatgctgctgcccaagccaaaggtctggctctgactggtgacaagaaactgcgtctgaaagttgaaggtgaagtggct 
      421    V     A     D     I     Y    A     A    A     Q      A      K     G     L     A     L     T     G     D      K     K     L     R      L    K     V    E      G      E      V    A  
1351  tccctgagcctgcagaactacaccgtctccaaagacggtaacgctctgaacaccatgaacgcattctaa 
      451    S      L     S      L     Q      N    Y     T      V    S      K     D     G     N      A     L     N     T      M    N     A      F   * 
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4.3.1.1. Sequence of the S-layer protein gene isolated from A. 
hydrophila T4 isolate 
The isolated gene encoding the S-layer protein from A. hydrophila T4 isolate 
differed by six bases from the published nucleotide sequence of the S-layer 
protein from A. hydrophila TF7 isolate (Thomas and Trust, 1995a), see Figure 4.4 
and Table 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Sequence of amplified gene encoding the S-layer protein from 
A. hydrophila T4 isolate 
Bases different to that genome reported for the S-layer protein of A. hydrophila 
isolate TF7 by Thomas and Trust (1995a) have been highlighted. 
 
Gene encoding S-layer protein from A. hydrophila T4 isolate was amplified as 
outlined in Section 4.2.2.2. 
 
 
 
 
 
 
 
 
 
 
1       atgattctaatgaaaaagacactgattgcactggccgttgctggtctgagctttaacgctgctgcagttaatctggacactggtgctggt 
91     gtttctaagtttgctagcgaaatcaaagttgatggcgcggcaggtactaccttgggtaccgcagccggtgctgctatgaatgcagtgagc 
181   aagctgggtttctctatttctaccggtaacaagcgttacattcgttacgatgtaactggtggttcactggctggtgtcgctgttgcggac 
271   ttgaccttggttggtggtactcctgttgctgtagttgcagctgatagctcctttgttatctctcagaccgccgctgatggtagctttgtg 
361   atcgttgaagttgttgctaagaaagacatccctgctgatgcagtgatgacctccaaagccgatggtcgtgtgaacgttaagaacaaaaat 
451   ggcgtagctatcagctatcgcctgttcgagactgctctggatgccgttgctaacgatccagctaagaccctggccaaggcaaatggtcaa 
541   ctgctgactttctccccagctatcctcgccaaagttgagaagaagggttctgccgacaagatcgacgtgaccgagtcttccatgaagttt 
631   gttaccaatgcgaatgttaaagctactgataccatcctgggtcaagtaagcatcactgcagacgtaaacactcttttggctaacggtact 
721   cccgtggctgctaccagtgatattctgaatgcaagcaaactggttgttaatggtgatttctctgcaggtgcagtagacgccgataacaaa 
811   ctggttctgggtaccgtcaagctgaatgctgccaatgctactaaagttgaagccgcgaaagctgagctggctgtggcagatgcaggtatt 
901   ggtgcagcagctccagcaggtaacatcagctactttgttggtggcaaagctcctatcgctccgcagtctgtaactgctactttcgttccg 
991   gttgtaaaagctggttatgagttggctgatgtaaatctgggcgaaattggtgtgctgaacaaaaatggttccaccaaagaagctaacctg 
1081 gtgctggctccagatacctcttacaccaacctggtgcgtatctccaacacctccaacatcgctggtaagttctttgtgactgcttatgct 
1171 gatgatggtaagtctgtaagcttcgcactgtctgatgttgctggtcagccggctgttctggacgctggcgcctccaccacgcagatgaaa 
1261 gtggctgatatctatgctgctgcccaagccaaaggtctggctctgactggtgacaagaaactgcgtctgaaagttgaaggtgaagtggct 
1351 tccctgagcctgcagaactacaccgtctccaaagacggtaacgctctgaacaccatgaacgcattctaa 
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Table 4.1: The consequences of the nucleotide/amino acid changes 
between sequence of A. hydrophila TF7 and T4 isolates 
 
Nucleotide position 
TF7 published sequence 
(Nucleotide/amino acid) 
Amplified T4 sequence 
(Nucleotide/amino acid) 
90 ggc/G ggt/G 
442/3 aca/T aac/N 
967 gct/A tct/S 
1233 gaa/E gac/D 
1249 aag/K acg/T 
 
 
4.3.2. Production of a recombinant protein for the S-layer of        
A. hydrophila isolate T4 
The production of a 1353 bp PCR product suggested that the specific amplification 
of the gene encoding S-layer protein from A. hydrophila T4 isolate was successful 
(Figure 4.5). The digestion of the purified 1353 bp fragment and the pQE60 vector 
by enzymes Nco I and Bgl II, and ligation of the digested genomic DNA within the 
pQE-60 vector was confirmed from the band obtained at around 4.8 kb on the 1 % 
agrose gel shown in Figure 4.5 (Lane 4). 
 
 
 
 
 
 
 
 
 Chapter 4  Page 131 
 
 
 
 
 
 
Figure 4.5: Amplification of the S-layer gene of A. hydrophila isolate T4 
shown on a 1 % agrose gel 
Lanes: (1) Standard marker; (2) S-layer protein gene; (3) purified S-layer 
protein gene; (4) pQE60 vector carrying S-layer protein gene. 
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After transformation of vectors into E. coli cells, the presence of the pQE60 having 
1353 bp fragment constructs were confirmed by PCR. The SDS-PAGE analysis of 
E. coli transformed with pQE60 having 1353 bp fragment constructs indicated the 
presence of an abundant protein of molecular mass 45.5 kDa (Figure 4.6a). The 
protein also gave a positive reaction in Western blot against an anti-histidine 
antibody (Figure 4.6b). 
 
4.3.2.1. Large scale production of S-layer recombinant protein 
The concentration of bacteria in the culture media was 0.65 at OD600 before IPTG 
induction. A final yield of 15 mg of purified protein was recovered from the nickel 
bead-packed column from 1 litre culture. The SDS-PAGE analysis revealed the 
elution step yielded a 45.5 kDa protein (Figure 4.7a). Western blotting using serum 
raised against the WC A. hydrophila T4 isolate in common carp (Figure 4.7b) 
exhibited a cross reaction with this overexpressed His-tagged protein. 
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            A                                        B   
Figure 4.6: Expression of S-layer protein of A. hydrophila with E. coli WC 
protein 
(A) 12 % SDS-PAGE stained with Coomassie blue, (B) Western blot of protein 
using an anti-histidine tag antibodies. 
Lanes: (1) Standard protein marker; (2) WC preparation of recombinant E. coli 
without IPTG induction; (3) WC preparation of recombinant E. coli with IPTG 
induction showing S-layer protein. 
 
             
             A                                                  B 
 Figure 4.7: Recombinant S-layer protein of A. hydrophila purified from    
E. coli 
(A) 12 % SDS-PAGE stained with Coomassie blue (B) Western blot against 
anti-A. hydrophila T4 isolate antibody from carp. Lanes: (1) Standard protein 
marker; (2) WC protein of A. hydrophila; (3 & 4) protein separated from 
insoluble fractions of recombinant E. coli; (5 & 6) protein separated from soluble 
fractions of recombinant E. coli. 
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4.3.3. Efficacy of recombinant S-layer protein against                   
A. hydrophila in common carp 
4.3.3.1. Standardisation of the challenge of common carp with            
A. hydrophila 
All six strains T4, 98140, 98141, Hh, B2/12 and Vds were passaged two times 
through common carp and the bacteria were successfully recovered from both 
passages. During the first passage, no mortalities occurred in any of the groups of 
fish, while most fish died upon repassaging the bacterium a second time with all 
strains except T4. The values obtained in the preliminary challenge experiment in 
which the LD50 dose for each strain was determined are given in Table 4.1. The 
highest LD50 value of 1 ×108 bacteria ml-1 was obtained with isolate T4, while the 
lowest dose (7.5 ×106 bacteria ml-1) was found with isolate B2/12. An LD50 value of 
2 ×107 bacteria ml-1 was found with isolates 98140, 98141 and Vds. 
 
Table 4.1: The LD50 values of A. hydrophila strains for common carp 
 
Strains of          
A. hydrophila 
LD50 Value 
(bacteria ml-1)  
T4 1 ×108 
Hh 5 ×107 
98140 2 ×107 
98141 2 ×107 
Vds 2 ×107 
B2/12 7.5 ×106 
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4.3.3.2. Vaccination of common carp with recombinant S-layer protein 
of A. hydrophila 
Some mortalities (10 %) occurred in both the vaccinated and control groups of fish 
following injection, which then stabilised the next day and no more mortalities 
occurred prior to challenging the fish with A. hydrophila. In fish challenged with 
isolate T4, 75 % of control and 10 % of vaccinated fish died. A high percentage of 
mortalities were recorded in control fish challenged with isolate T4 compared with 
fish challenged with the other isolates of A. hydrophila. Fifteen percent of the 
control group died by the first day post-challenge and 25 % had died by Day 2 
post-challenge. The levels of mortality decreased to 10 % by Day 3 post-challenge 
and thereafter it varied between 5 and 10 % until the mortalities stopped by Day 8 
post-challenge. The mortality in the vaccinated group was 5 % on Day 1 post-
challenge and another 5 % had died by Day 5 (Figure 4.8a). A relatively high           
relative percentage survival (RPS) value (87 %) was found with isolate T4 
compared with other isolates (Table 4.2). 
 
Mortality of 5 % was noted in the control group challenged with isolate Hh on Day 
1 post-challenge. However, the mortality increased to 20 % by Day 2, 15 % 
occurred on Day 5 and 10 % on Day 6. The remainder of mortalities (i.e. 15 %) 
were distributed over the period after Day 7. In the vaccinated group, 5 % of 
mortalities were recorded on the first and third day post-challenge (Figure 4.8b). 
The second highest RPS value (85 %) in the trial was observed with this isolate. 
 
Fifty percentage mortality was seen with the control group challenged with isolate 
98140. Thirty percent died in the control group during the first two days post-
challenge and remainder died over the  course  of  the  experiment  (16 days post- 
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Figure 4.8: Cumulative percentage mortality of carp vaccinated with 
recombinant S-layer protein and challenged with A. hydrophila isolates 
(A) T4, (B) Hh, (C) 98140, (D) 98141, (E) Vds, (F) B2/12. 
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challenge). Five percent mortality was recorded in the vaccinated group during the 
first two days post-challenge, and no further mortalities occurred in this group 
leading to an 80 % RPS value for this isolate (Figure 4.8c). 
 
In the control group challenged with isolate 98141, 25 % of mortality occurred over 
the first two days of the experiment and thereafter 15 % mortalities occurred. The 
mortality with the vaccinated group was similar to that of the mortality recorded 
with vaccinated group challenged with isolate 98140 (Figure 4.8d). An RPS value 
of 75 % was recorded with this isolate. 
 
The control group challenged with isolate Vds experienced a 10 % mortality on 
Day 1, Day 2 and Day 5 post-challenge, while 5 % mortalities occurred on the third 
and sixth day post-challenge (Figure 4.8e). A total of 15 % mortality occurred in 
the vaccinated group distributed over Day 2, 3 and 5 post-challenge. The RPS 
value with this isolate was 62.5 %. 
 
Percentage mortality in the control group rose to 30 % during the first two days 
after challenging the fish with isolate B2/12. Another 15 % mortality occurred in 
this group over the remainder of the experiment. The highest percentage mortality 
amongst vaccinated fish was recorded in the group challenged with B2/12. Ten 
percent mortality was observed in this group on the next day post-challenge and   
5 % of mortality occurred on the second day and the third day post-challenge 
(Figure 4.8f). The RPS value was low (56 %) with this isolate compared to other 
isolates. 
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Table 4.2: Percentage mortality and relative percentage survival of carp 
vaccinated with recombinant S-layer protein of A. hydrophila and then 
challenged against the bacteria 35 days post-vaccination 
 
Total mortality (%) 
Strain of             
A. hydrophila Vaccinated 
fish 
Control  
fish 
Relative 
percentage 
survival (%) 
P-value 
(Chi-square 
test) 
T4 10 75 87 0.000 
Hh 10 65 85 0.000 
98140 10 50 80 0.006 
98141 10 40 75 0.028 
Vds 15 40 62.5 0.077 
B2/12 20 45 56 0.091 
 
All the fish that died during the experiment showed the presence of A. hydrophila 
in their kidneys, determined from swabs plated onto TSA. In contrast, A. 
hydrophila was not cultured from kidney swabs taken from the surviving fish 
except very few colonies from one fish in the vaccinated group challenged with 
isolate 98140 and one fish in the control group challenged with isolate 98141, 
when the experiment was completed. Statistical analysis revealed that survival 
against isolates T4, 98140, 98141 and Hh were significant in vaccinated fish 
compared to control fish, while levels of survival were not statistically significant for 
isolates B2/12 and Vds (Table 4.2). 
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4.4. Discussion 
Different preparations of vaccines against A. hydrophila have been used including 
sonicated preparations (Thune and Plumb, 1982), heat or formalin-inactivated 
bacterial extracts (Koval, 1988), live cells (Loghothetis and Austin, 1994) and heat-
killed cells (Tafalla et al., 1999). For example, Rohu (Labeo rohita) and mrigal 
(Cirrhinus mrigala) carp immunised with pooled WC of three A. hydrophila isolates 
had RPS values of around 53.5 % and 35 % respectively, when challenged 
against three A. hydrophila isolates together (Chandran et al., 2002a). They found 
RPS values of 48 % and 38 % with rohu and mrigal respectively, when fish were 
challenged with three pooled A. hydrophila isolates after immunisation with pooled 
ECP from those isolates. Azad et al., (2000b) observed RPS values of 82-100 % 
in common carp immunised with an A. hydrophila biofilm (heat inactivated) 
vaccine, while an RPS value of 76-81 % was seen in fish immunised with heat 
inactivated free-cell suspension of A. hydrophila. An RPS value of 90.8-100 % was 
obtained with three batches of catfish, Clarias batrachus vaccinated with heat 
inactivated A. hydrophila biofilm and challenged with same A. hydrophila isolate 
compared with RPS values of 28.8-42.1 % for fish immunised with heat inactivated 
free cell suspension of A. hydrophila (Nayak et al., 2004b). Although these 
attempts seem promising, the level of protection has only been investigated 
against one or a few isolates, and the vaccines do not appear to have been 
evaluated against a range of isolates to establish if they cross-protect against a 
range of A. hydrophila isolates. 
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Recently, attention has focused on recombinant protein vaccine production. This 
technique has a number of advantages over using the WC or separate 
components from a pathogen as vaccines. These protein vaccines are 
inexpensive, safe and mostly efficacious compared with the traditional vaccines 
(Clark and Cassidy-Hanley, 2005). One of the other major advantages is that this 
method of preparation avoids unwanted antigens from the pathogen in the vaccine 
compared to traditional vaccines (WC) where inclusion of all antigens may lead to 
suppression of the host immune system by some antigen. For example, some of 
the surface proteins (p22 and p57) of Renibacterium salmoninarum have been 
found to suppress the immune system of fish, and therefore, the WC preparations 
of this bacterium may not be used as vaccines (Fredriksen et al., 1997). 
Recombinant protein vaccines, on the other hand, can induce a specific immunity 
against the particular antigen used, which could protect the host efficiently during 
infection (Potter and Babiuk, 2001). These vaccines have been developed for a 
variety of human and animal pathogens, for example, mice immunised with a 
recombinant Salmonella typhimurium aroA vaccine that secretes the naturally 
secreted 30 kDa protein of Mycobacterium bovis conferred protection against M. 
tuberculosis (Hess et al., 2000). Protective immune response against piscine 
nodavirus was observed with sevenband grouper, Epinephelus septemfasciatus 
vaccinated by recombinant 42 kDa protein of the virus (Tanaka et al., 2001). A 
mixture of recombinant proteins containing two heat shock proteins and one 
flagella protein of Piscirickettsia salmonis protected Atlantic salmon and exhibited 
a RPS value of 95 % when fish were challenged with the bacterium (Wilhelm et 
al., 2006). 
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In this study, a recombinant S-layer protein of A. hydrophila was produced to 
confirm the protection efficacy of this protein in common carp against different 
isolates of A. hydrophila. The low quantity of protein eluted from SDS-PAGE gels 
was a major constraint for efficacy testing, and preliminary efficacy trials had to be 
conducted on very small numbers of fish as discussed in Chapter 3. A larger 
number of fish was vaccinated with recombinant S-layer protein of A. hydrophila in 
this Chapter to establish if this protein conferred protection. Vaccinated fish were 
then challenged with a range of different A. hydrophila isolates to confirm if the 
protein could cross-protect between the isolates. 
 
The protein (S-layer) identified by MALDI-TOF MS is the outermost component of 
the cell envelope of bacteria and such structures are widely distributed throughout 
the prokaryotic kingdom. The S-layer proteins are composed of regularly arranged 
protein or glycoprotein monomers, which self-assemble into a precise 
supramolecular structure enclosing the bacterial cell (Koval, 1988; Thomas and 
Trust, 1995a). The unit cell dimension of the S-layer is approximately 12 nm in A. 
hydrophila (Murray et al., 1988). The S-layer often tends to be lost during 
prolonged cultivation of the bacterium in the laboratory (Sleytr and Messner, 1983 
and 1988). 
 
Six bases were found to be different in the gene encoding S-layer protein from A. 
hydrophila T4 isolate compared with the S-layer genome sequence of isolate TF7 
reported by Thomas and Trust (1995a). This in turn could result with changes in 4 
amino acids in the S-layer protein of A. hydrophila isolate T4 compared with S-
layer amino acid sequence reported for isolate TF7. However, this needs to be 
further characterised by nucleotide sequencing of the amplified gene encoding S-
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layer protein from A. hydrophila T4 isolate and peptide mass fingerprinting of the 
overexpressed protein. These chracterisation might resolve whether the sequence 
substitutions are the result of isolate variation or due to mis-incorporation of 
nucleotides by Taq polymerase during amplification. Such changes of amino acids 
in a particular gene are reported to be involved in modifications of some 
funcational proterties of the gene (Tran et al., 2000). For example, an amino-acid 
substitution (from Gly in the wild type to Asp in the mutant) in pufL gene of purble 
bacteria, Rubrivivax gelatinosus coding for the L subunit of the reaction centre 
conferred resistant to an herbicide, terbutryn (Ouchane et al., 1995). Simlarly, an 
increased senstivity to oxidative stress was found with a spirochetal bacterium, 
Borrelia burgdorferi when a single nucleotide substituion, converting an arginine to 
a lysine was observed with a mutated strain compared with a parent strain (Seshu 
et al., 2004). Alterations in the amino acid sequence of a secreated protein (dense 
granule antigens) between strains of a parasite, Toxoplasma gondii plays an 
important role in both pathogenicity and anitgenicity (Fazaeli et al., 2000). 
 
As with the natural S-layer protein isolated from A. hydrophila, the recombinant S-
layer protein proved reactive in Western blot analysis against anti-A. hydrophila T4 
common carp serum. Although it took some time to establish a recombinant S-
layer protein, especially due to the standardisation of primers, PCR conditions, 
ligation and transformation, this method is more convenient and effective than the 
electro-elution of the S-layer protein from SDS-PAGE gels as a source of protein 
for vaccination studies. The recombinant protein was uncontaminated and the 
expression was consistently reproduced. Problems were encountered, however, 
during the development process, mainly in primer design with the selective 
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restriction enzymes used and vector transformation into competent cells. Initially, 
various sets of primers with different restriction enzymes; Eco RI and Nde I were 
investigated. These primers were lengthy with six histidine tag, stop codon, 
restriction enzyme (Nde I) and 4 ‘T’ bases in the reverse primer 
(tgtggtacttgcgtaaggtagtagtagtagtagtaattgtatactttt), while restriction enzyme and 
another 4 ‘T’ bases were present in the forward primer 
(ttttcatatggttaatctggacactggtgc). Initial attempts to clone the 1353 bp fragment 
encoding the S-layer protein from A. hydrophila T4 isolate was unsuccessful due 
to the ineffective ligation of the amplified S-layer gene using these primers and ‘T’ 
vectors. Finally, these problems were resolved as the effective ligation of the 
amplified gene and the pQE 60 vector was attained when the primers with 
restriction enzymes mentioned in the Figure 4.1 were used for the amplification of 
S-layer gene. Transformation of the pQE 60 vector carrying the amplified S-layer 
gene into competent cells was also successful after using these primers for the S-
layer gene amplification. 
 
Variations in the degree of virulence was observed between different isolates of A. 
hydrophila during determination of the LD50 values in the virulence study carried 
out in Chapter 2. Causes for variation in virulence of different A. hydrophila 
isolates has been previously explained by Santos et al. (1988), Zhang et al. (2000) 
and Sirirat et al. (1999). The authors found a wide variation in the gene expression 
of different A. hydrophila isolates, which in turn lead to different expression of 
virulent factors, such as extracellular products (ECP) and surface proteins. In this 
study, the lowest virulence was seen with isolate T4 and the highest virulence with 
isolate B2/12. High mortality rate was observed both in vaccinated and control 
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group within two days post-challenge compared with the mortality from Day 3 
post-challenge as described in Figure 4.8. This result suggests that artificial 
challenge with A. hydrophila could result in sudden mortality of fish due to toxic 
shock (Allan and Stevenson, 1981; Chakraborty et al., 1984; Khalil and Mansour, 
1997; Perez et al., 2002). Such a pattern of mortalities may not occur during a 
natural infection, and efficacy testing of the recombinant S-layer protein vaccine 
produced in this Chapter may therefore perform better against natural infection. 
The protection elicited by the S-layer protein in vaccinated fish indicates a 
potential role for this protein in the virulence of A. hydrophila. 
 
The pathogenicity of A. hydrophila is mostly due to surface properties and 
extracellular enzymes (Nord et al., 1975; Larsen and Jensen, 1977; Dooley and 
Trust, 1988; Santos et al., 1988; Favre et al., 1993; Thomas and Trust, 1995a and 
b). The virulence of the S-layer protein of A. hydrophila has previously been 
reported by Dooley et al. (1986), Sakata and Shimojo (1991) and Thomas and 
Trust (1995a and b). As a major surface protein, the S-layer (with a molecular 
weight of 52 kDa) has been associated with isolates of A. hydrophila with high 
levels of virulence (Dooley et al., 1985). It is a predominant cell surface protein 
seen in the SDS-PAGE profiles of WC lysates and outer membrane fractions of A. 
hydrophila (Murray et al., 1988). The S-layer of A. hydrophila has the ability to bind 
to host proteins such as fibronectin, laminin and vitronectin, as well as providing 
resistance to serum killing and protease digestion (Noonan and Trust, 1997). 
 
This S-layer protein has been studied in various bacteria because of its role as 
one of the major virulence factors in bacteria, and helps the bacterium to evade 
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the host’s immune system (Thompson, 2002). Moreover, being on the outermost 
layer of the bacterium, the S-layer protein has more possibility of interacting 
readily with the host than any other protein components of the bacterium (Koval, 
1988; Thomas and Trust, 1995a). This property could be one reason why the S-
layer protein appears to be more immunogenic than other proteins in the 
bacterium. A number of authors have studied the S-layer protein in Aeromonas, 
mainly examining its virulence and its evasion of the host’s immune system. For 
example, Kokka et al. (1992) found that A. hydrophila strains belonging to the 
serogroup O:11 had an S-layer protein, and suggested that the S-layers may 
provide protection for bacteria in their natural environment or may provide a 
selective advantage in the ability of bacterium to cause infection. The presence of 
S-layer protein among highly virulent strains of A. hydrophila had also been 
confirmed by Thomas and Trust (1995a and b). Diseases in humans and animals 
(particularly fish) caused by A. hydrophila, possessing S-layers are often 
associated with invasive systemic infection (Janda et al., 1994a). 
 
Virulence characteristics of other Aeromonas species have also been reported as 
being associated with surface layers of the bacterium, for example those playing a 
role in binding with iron-containing proteins of the host (Ascencio et al., 1992). The 
S-layer of A. salmonicida had been shown to be a prerequisite for virulence, by 
increasing hydrophobicity and enhancing macrophage association to efficiently 
adhere, enter, and survive within macrophages (Garduno et al., 2000). The S-
layer of A. salmonicida physically protects the cell against bacteriophages, 
proteases, as well as immune and non-immune complement and is required for 
macrophage infiltration and resistance (Kay and Trust, 1991). Chang et al. (1992) 
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showed that resistance of A. salmonicida to complement-mediated lysis was 
acquired by having an S-layer in conjunction with lipopolysaccharide (LPS). Kay 
and Trust (1991) confirmed that mutants containing a disorganized S-layer are 
avirulent and are able to confer significant protection to salmonids when applied 
by immersion exposure. Our studies indicate that the S-layer protein antigen of A. 
hydrophila appears to have conferred protection against the different isolates of A. 
hydrophila tested, although the RPS values of carp did vary between the different 
challenge isolates. 
 
No mortalities occurred in any of the groups of fish after Day 11 post-challenge in 
the vaccination trial described in this Chapter. Moreover, no colonies of A. 
hydrophila grew from the kidney swabs taken from surviving fish at the end of 
experiment except for two fish. This suggests that most of the surviving fish in the 
control group had cleared the bacterium through their own immune response, as 
fish can produce an antibody response against different components of bacterium 
and clear the bacteria in blood circulatory system within seven days post-infection 
(Leung and Stevenson, 1988b; Chandran et al., 2002b). 
 
Recombinant outer membrane proteins (OMPs) have been tested as possible 
vaccine antigens for A. hydrophila. Fang et al. (2004) showed significant 
protection against two isolates of A. hydrophila in blue gourami, Trichogaster 
trichopterus (75 and 87.5 % RPS) immunised with a recombinant 43 kDa OMP. 
More recently, a recombinant OMP (37 kDa) of A. hydrophila was produced and 
was shown to be immunogenic in rohu carp (Khushiramani et al., 2007a). Fish 
vaccinated with this recombinant OMP showed a RPS value of 57 after 
 Chapter 4  Page 147 
challenging the fish with a virulent A. hydrophila isolate (Khushiramani et al., 
2007b). Cross-protection against a range of A. hydrophila isolates was not 
reported. The protection obtained in the present study, by the recombinant S-layer 
protein antigen against 6 different isolates of A. hydrophila, suggests that it may 
be a suitable vaccine against a range of A. hydrophila isolates. 
 
In summary, the results from this Chapter suggest that the S-layer protein of A. 
hydrophila may be important in inducing specific antibodies that confer protection 
in common carp against a variety of different virulent isolates of A. hydrophila. The 
S-layer protein was also shown to protect against an A. hydrophila challenge in 
goldfish in Chapter 3. The protection obtained in goldfish and common carp 
against A. hydrophila suggests that the recombinant S-layer protein of A. 
hydrophila might protect different species of fish from infection by this pathogen in 
aquaculture systems. 
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Aeromonas hydrophila is an important fish pathogen (Merino et al., 1995; Rahman 
and Kawai, 2000; Vivas et al., 2005) that has been reported to cause a wide range 
of diseases in fish and shellfish (Tanasomwang and Saitanu, 1979; Karunasagar 
et al., 1989; Borrel et al., 1998; Nielsen et al., 2001) in the aquatic environment. 
Farmers have found it difficult to treat A. hydrophila infections in fish due to the 
resistance of this pathogen to a number of antibiotics (Shariff, 1998; Dixon et al., 
1990; Vivekanandhan et al., 2002). Thus, researchers have been trying to develop 
a vaccine to protect fish against diseases caused by A. hydrophila, but this has 
proven difficult mainly because of the heterogenicity of the pathogen (Lamers et 
al., 1985; Baba et al., 1988b; Leung et al., 1997; Rahman and Kawai, 2000). 
 
A variety of approaches have been used to try to develop an effective vaccine 
against A. hydrophila. Various preparations of A. hydrophila, such as whole cell 
(WC) (killed, live and live attenuated), extracellular products (ECP), outer 
membrane protein (OMP) and lipopolysaccharide (LPS) have been found to be 
protective. In most studies the efficacy of the vaccine was performed using only 
one isolate (homologous strains) and it is not known if these vaccines will cross-
protect against other isolates (Baba et al., 1988b; Leung et al., 1997; Hernanz et 
al., 1998; Azad et al., 1999; Rahman and Kawai, 2000; Nayak et al., 2004). 
Among the vaccines evaluated, the highest relative percentage survival (RPS) of 
100 % was found with an inactivated biofilm vaccine for the bacterium (Azad et al., 
1999; Nayak et al., 2004). Only a few studies have addressed the issue of cross-
protection. For example, protection against two isolates of A. hydrophila was 
reported in fish immunised with a plasmid-free A. hydrophila mutant (Majumdar et 
al., 2006), while Fang et al. (2000) found protection against two heterologous 
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isolates in gourami (Trichogaster trichopterus) vaccinated with OMP (43 kDa) of A. 
hydrophila. Generally, the levels of protection against a range of isolates have not 
been evaluated despite the antigenic diversity of A. hydrophila being highlighted 
as a major problem for developing a successful vaccine (Karunasagar et al., 1991; 
Loghothetis and Austin, 1996a; Rahman and Kawai, 2000). In addition, from the 
work conducted by Baba et al. (1988b) it appears that antigenic components may 
be denatured in A. hydrophila when vaccines are used as inactivated WC 
preparations. They found increased and long lasting protection in fish immunised 
with LPS of A. hydrophila in comparison to protection achieved in fish immunised 
with formalin inactivated WC vaccine. Most of the vaccines (discussed earlier in 
this paragraph) have been developed on an experimental scale and have not 
been field-tested for commercialisation, possibly due to the fact that licensing 
vaccines is a long and complicated process, also requiring field trials or it may not 
be cost effective to produce a commercial vaccine. However, Chandran et al. 
(2000a) investigated the protection efficacy of a polyvalent vaccine containing 
inactivated WC and ECP of A. hydrophila in the field using two species of Indian 
major carp (rohu, Labeo rohita and Mrigal, Cirrhinus mrigala) but the vaccine failed 
to protect the fish upon artificially challenging them with the bacterium. Therefore, 
in the present study the approach of using immunoproteomic techniques was used 
to identify a common protective antigen between A. hydrophila isolates (cultured in 
vitro and in vivo) in order to develop an effective vaccine against the pathogen. 
Recombinant protein production technology was then utilised to produce sufficient 
quantities of the immunogenic protein to carry out vaccine efficacy trials, using a 
variety of A. hydrophila isolates to challenge the fish. 
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Electrophoresis (1 and 2 dimensional sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis, SDS-PAGE) was used in the current study to determine WC, 
OMP and ECP profiles of different isolates of A. hydrophila grown in vitro and in 
vivo. Generating reproducible 2D gels was difficult initially and it took considerable 
time to attain gel consistency before accurate analysis of the protein profiles could 
be made. Moreover, the presence of streaking in the 2D gels affected the position 
of spots and clarity of the gels. The 2D gels were repeated several times using a 
variety of modifications for sample preparation to eliminate this streaking problem. 
This was eventually eliminated by incubating the bacterial samples with DNAse 
and RNAse while preparing the samples for 2D SDS-PAGE (Berkelman and 
Stenstedt, 2002). The use of silver staining was very effective in staining the 2D 
SDS-PAGE gels, and made visualising the smaller spots easier. Similarly, the 
software for 1 and 2D gel analysis was extremely effective for differentiating the 
location of the bands and spots expressed. The 2D SDS-PAGE was more 
informative than the 1D SDS-PAGE with reference to up and down-regulation of 
proteins from bacteria cultured in vitro and in vivo, as this method separated the 
proteins with respective to their pI and MW, while 1D analysis is based on MW 
only. 
 
Up and down-regulation or expression of unique proteins in vivo has been 
reported for a variety of bacterial pathogens affecting fish, such as A. salmonicida, 
Vibrio salmonicida and Photobacterium damselae subsp. piscicida, when these 
were cultured in dialysis bags implanted within the peritoneal cavity of different fish 
(Jung, 1999; Colquhoun and Sorum, 1998; Dacanay et al., 2003; Wang et al., 
2004; Ebanks et al., 2004; Bakopoulos et al., 2004). Such up-regulated or unique 
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proteins expressed by the pathogen in vivo (in the host) have been reported to be 
associated with virulence (e.g. A. salmonicida) (Ebanks et al., 2004). In some 
cases, the growth of bacteria in vivo has been imitated in vitro by using iron-
restricted culture medium (obtained by adding the iron-chelator (e.g. 2,2’-dipyridyl) 
to the medium), glucose rich medium, as well as autolysate of fish viscera 
medium. Such modified in vitro systems have been used to investigate changes in 
bacterial expression (e.g. A. hydrophila, A. salmonicida and Edwardsiella tarda) to 
try to identify molecules that may be useful for vaccine development (Aoki and 
Holland, 1985; Hirst and Ellis, 1994; Martinez et al., 1995; Aguilar et al.,1999). For 
example, the antigens expressed by A. salmonicida grown under iron-restricted 
culture conditions have been shown to be immunogenic and protective (Ellis et al., 
1997). In the current study, a selection of virulent and avirulent isolates of A. 
hydrophila were cultured in vitro and in vivo to investigate the up and down-
regulation of proteins for the identification of potential common antigens for 
vaccine development. Virulent isolates of A. hydrophila cultured in vivo expressed 
bands of increased intensity at 70, 55, 50 and 25 kDa in the 1D SDS-PAGE with 
WC preparations, while unique bands at 58 and 55 kDa for WC and OMP 
preparations, respectively, were observed for all the isolates cultured in vivo. 
Analysis of WC preparations of A. hydrophila by 2D SDS-PAGE showed a number 
of unique and up-regulated spots in the bacteria grown in vivo, mostly between 30 
and 80 kDa with pI values ranging from 5.0-6.0 (Table 2.5 and 2.6). 
 
Differences in the formation of bacterial capsules have also been reported 
between bacteria cultured in vitro and in vivo. Bacterial capsules may promote the 
adherence of the bacterium to different surfaces to facilitate colonisation (Roberts, 
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1996). It was reported that such capsule formation in A. hydrophila can confer 
serum resistance, and thus it can protect the bacterium from the defence 
mechanisms of the host (Aguilar et al., 1999). Capsular expression has been seen 
in A. hydrophila recovered from artificially infected trout (Mateos and Paniagua, 
1995). In addition, culture environments mimicking growth conditions in vivo (i.e. 
yeast extract peptone glucose mineral salts medium and autolysate of fish viscera 
medium) have also been shown to induce the formation of such capsules in A. 
hydrophila and A. salmonicida (Merino et al., 1996b; Aguilar et al., 1999). Capsule 
formation was also seen in the present study with A. hydrophila grown in vivo 
compared with bacteria grown in vitro. 
 
Antibodies raised against bacteria are useful tools to assist in the identification of 
potential vaccine antigens. Researchers have explored a wide range of 
approaches using antibodies to determine vaccine candidates for A. hydrophila. 
For example, agglutination, immunodiffusion and immunoelectrophoresis assays 
were used to screen different components of A. hydrophila (lipopolysaccharide 
(LPS), exopolysaccharide, flagella, S-layer protein and haemolytic components of 
ECP) using antibodies raised against inactivated and live bacteria in rabbits and 
trout, respectively, to identify immunogenic components (Loghothetis and Austin, 
1994 and 1996b). Antibodies have also been raised against inactivated A. 
hydrophila in rabbits and used to screen LPS and OMP from A. hydrophila by 
Western blot (Dooley et al., 1986; Sendra et al., 1997). In another approach, 
different OMP fractions were screened using enzyme linked immunosorbent assay 
(ELISA) with antibodies raised against crude OMP of A. hydrophila in rabbits in 
search of immunogenic antigens (Maji et al., 2006). Jung (1999) suggested raising 
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antibodies against live bacteria in the host (fish) and using these to screen 
bacteria cultured in vivo to accurately identify potential protective antigens. This 
was in contrast to using inactivated bacteria for raising the antibodies and then 
using these to screen bacteria grown in vitro. The author also highlighted that 
potential immunogenic antigens may not be recognised by the antibodies raised 
against live bacteria in fish if the bacteria used for screening had been grown in 
vitro (i.e. the appropriate antigen may not be expressed in vitro). Therefore, in the 
present study, antibodies were raised against different live isolates of A. 
hydrophila in common carp (Cyprinus carpio), in order to acquire host antibodies 
against the proteins which are expressed in vivo. These were then utilised to 
identify potential protective antigens of A. hydrophila using various preparations 
(WC, OMP and ECP) of different A. hydrophila isolates grown in vitro and in vivo. 
A common protein of molecular mass 50 kDa was found to be expressed in the 
bacteria grown under two growth conditions when the preparations were screened 
with the antibodies raised against the corresponding isolates in common carp 
(Chapter 3). Similarly, a common protein of molecular mass 50 kDa was also 
found in most WC preparations of virulent and avirulent isolates (14 isolates) 
cultured in vitro when screened with pooled sera raised against six different 
isolates (4 virulent and 2 avirulent). This 50 kDa protein was identified as the S-
layer protein of A. hydrophila. The 2D Western blot performed with a WC 
preparation of isolate T4 provided additional information on the expression of the 
antigens recognised by the fish sera. There appears to be post-translational 
modification (addition of other biochemical functional groups such as acetate, 
phosphate, various lipids and carbohydrates with proteins) of the S-layer protein, 
since three spots were found very close together at 50 kDa but with slightly 
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different pI values (Figure 3.4). Although such modifications can change the 
chemical nature of proteins all three spots did react with the fish anti-sera 
suggesting that the immunogenic region of the S-layer protein was conserved. 
Thomas and Trust (1995a) showed post-translational modification of the A. 
hydrophila S-layer protein due to phosphorylation (addition of a phosphate (PO4) 
group to S-layer protein), and reported that this process can result in a change in 
pI values as well as the MW of the S-layer protein. It has been reported that post-
translational modification of expressed bacterial proteins might alter function of the 
protein in relation to its virulence (Cozzone et al., 2004). For example, a 
Helicobacter pylori protein (Cag A), causing gastric carcinoma in humans is 
reported to be more virulent following post-translational modification (by 
phosphorylation) (Higashi et al., 2002). 
 
Direct and passive immunisation have been used by a number of researchers to 
determine the protection elicited by different bacterial vaccines in fish (Kusuda et 
al., 1987; Yin et al., 1997; Irie et al., 2005; Akhlaghi, 1999; Shelby et al., 2002). 
For direct immunisation, various types of antigens were used such as killed, 
attenuated and live A. hydrophila, and different components (OMP and LPS) 
(Baba et al., 1988b; Leung et al., 1997; Rahman and Kawai, 2000; Chandran et 
al., 2002a; Vivas et al., 2004b; Nayak et al. 2004b). In passive immunisation, anti-
sera against a variety of pathogens, raised in different animals such as fish, sheep 
and rabbits have been used (Akhlaghi, 1999; Shelby et al., 2002; Pasnik et al., 
2006). In the present study, goldfish were vaccinated (preliminary trials) with the 
50 kDa protein from A. hydrophila (electro-eluted from the SDS-PAGE gel) and 
then challenged with one of the most virulent isolate (T4) to assess protection prior 
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to up-scaling investigations with this protein (Chapter 3). Similarly, fish were also 
passively immunised with goldfish serum raised against 50 kDa protein of A. 
hydrophila and then challenged to test protection efficacy. The 50 kDa protein 
appeared to confer protection in goldfish in these small-scale studies. The RPS 
value was 67 % in the vaccination trial, while the results of the passive 
immunisation trial were inconclusive due to the small number of fish used and the 
fact that only 33 % mortality occurred in the control group, however no mortalities 
occurred in the passively immunised fish. 
 
The antigen used for vaccination and for raising the serum for passive 
immunisation trial (i.e. 50 kDa protein) was prepared by electro-elution from the 
WC SDS-PAGE of A. hydrophila (T4 isolate). Although it was possible to elute 
sufficient amounts of protein from the gel for a small trial, it was a very laborious 
process as a number of gels had to be run to harvest enough protein (100 µg). 
The protection achieved in the goldfish immunisation experiment suggests that the 
antigen identified in the present study (50 kDa) elicits a protective antibody 
response. The Western blot results indicate that using live bacteria for raising the 
antibodies in fish might be a more valuable approach rather than using killed or 
inactivated bacteria, when identification of protective vaccine candidates are 
sought. This is in agreement with Jung (1999). 
 
It has been shown that matrix-assisted laser desorption ionisation time-of-flight 
mass spectrometry (MALDI-TOF MS) is a powerful tool to identify proteins within a 
short time compared with the traditional approaches such as nucleic acid 
sequencing (Chen et al., 2004; Ying et al., 2005). This technology was used in the 
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current study to confirm that 50 kDa protein was the S-layer protein of A. 
hydrophila. The S-layer protein has been reported to be a major virulence factor of 
A. hydrophila as discussed in Chapter 1, while it is also found to be an important 
virulence factor for many other bacteria such as Clostridium botulinum, A. 
salmonicida, Campylobacter fetus subsp. fetus, C. rectus and Mycobacterium 
bovis (Boulanger et al., 1977; Messner and Sleytr, 1992). It assists pathogens in 
evading host immune responses and provides resistance to serum killing and 
protease digestion in Aeromonas and Campylobacter species (Noonan and Trust, 
1997; Thompson, 2002). 
 
Localisation of the S-layer protein on the surface of the bacterium and its 
contribution in infection could be one reason why this molecule elicited protection 
against A. hydrophila in goldfish. The surface components of bacteria can be 
recognised by the fish immune system soon after infection occurs and thus the 
fish could elicit antibodies to encounter the pathogen. Although, it has been 
reported that bacterial S-layer proteins are lost during culture in vitro, work done 
with Wolinella recta (a human Gram-negative bacterial pathogen) suggests that it 
may not be completely lost (Borinski and Holt, 1990). They found that the S-layer 
proteins were missing or faintly stained in both 1 and 2D SDS-PAGE with the 
isolate passaged in vitro a number of times compared with the isolate passaged 
several times in vitro. In the current study, the S-layer proteins appeared to be up-
regulated in bacteria grown in vivo compared with bacteria cultured in vitro 
(Figures 2.4, 2.5 and 2.6b). The down-regulation of the S-layer protein of A. 
hydrophila cultured in vitro and post-translational modification of the S-layer 
protein may be important factors involved in both heterogenicity and pathogenicity. 
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Recombinant DNA technology is considered to be a useful tool in speeding up the 
development of vaccines and the drug discovery process for animals and fish 
(Munn, 1994; Chakravarti et al. 2000; Potter and Babiuk, 2001). It has several 
advantages compared with the production of traditional vaccines, as discussed in 
Chapter 4, including large yields of a consistent protein in a short period of time, 
low production cost, safety and efficacy. However, incorrect protein folding 
(denatured protein), low expression of proteins due to problems with efficiency of 
promoters in plasmids, and the translational efficiency of E. coli mRNAs are some 
times encountered during recombinant protein production (De Bernardez Clark, 
1998; Baneyx, 1999). In the current study, the gene encoding S-layer protein was 
cloned and overexpressed and was found to react with the antibodies raised 
against live A. hydrophila in the Western blot (Figure 4.7). However, there were 
difficulties with the primer design for DNA amplification, the restriction enzymes 
used for ligating vectors with the S-layer protein genes and transforming the 
vectors into competent cells. These factors were overcome after designing 
suitable primers and using different restriction enzymes; the modifications adapted 
during the process were discussed in Chapter 4. 
 
Recombinant protein vaccines have been shown to protect humans and other 
animals (including fish) from a variety of pathogens, including bacteria, 
Mycobacterium tuberculosis (Skeiky, et al., 2004), parasites (Plasmodium 
falciparum) (Saul et al., 2005) and virus e.g. infectious pancreatic necrosis virus 
(IPNV) (Aquabirnavirus sp.) (Biering et al., 2005). Recombinant protein vaccines 
have also been developed for different other virus of the Rhabdoviridae family in 
fish, such as infectious hematopoietic necrosis virus (IHNV), viral haemorrhagic 
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septicaemia virus (VHSV) and spring viraemia of carp virus (SVCV) but these 
have not yet been commercialised due to limited protection (Noonan et al., 1995; 
Cain et al., 1999). The recombinant protein vaccine for IPNV is commercially 
available in Norway and Chile (Biering et al., 2005). Licensing vaccines for 
commercial use, on the other hand, is a problem globally due to the number of 
regulations to be followed in aspects of safety, purity, potency, efficacy, handling, 
storing and administration of the vaccines (Sethi et al., 1997; Midtlyng, 2005). 
Important control measures such as limitation on the use raw materials/chemicals 
for culturing bacteria and methods for production of recombinant proteins, 
including removal of antibiotic resistance genes in the expression vector, and 
bacteria are also a constraint for licensing recombinant protein vaccines (Personal 
communication, Prof. Patrick Smith, Schering-Plough Aquaculture, UK). In the 
current study, the recombinant S-layer protein conferred protection in common 
carp against all six virulent isolates examined with the RPS values ranging from 56 
to 87 % between the different isolates of A. hydrophila. Protection was considered 
significant only for isolates T4, 98140, 98141 and Hh compared with Vds and 
B2/12. Isolate B2/12 was the most virulent strain used although the levels of 
virulence of other isolates are not consistent compared to each other between 
virulence and LD50 determination trials (Tables 4.1 and 4.2 and Figure 2.3). The 
variation in protection obtained suggests that there might be a need for a second 
antigen to be added to the vaccine for increasing the vaccine’s efficacy and 
improve cross-protection against isolates such as Vds and B2/12. For example, 
OMPs (43 and 37 kDa) and LPS of A. hydrophila could possibly be selected as 
additional antigens as these components have been shown to be immunogenic 
and protective in various investigations reported in the literature (Baba et al., 
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1988b; Loghothetis and Austin 1996b; Fang et al., 2004; Khushiramani et al., 
2007a and 2007b). Despite the variation in protection between challenge isolates, 
the recombinant S-layer protein vaccine may be a useful tool to help manage the 
disease problem in the aquaculture industry caused by A. hydrophila as the 
natural infection could be less severe compared to artificial challenge. However, 
further trials in the field using this recombinant S-layer protein vaccine are required 
to examine the accurate performance of the vaccine. Challenge against a larger 
number of isolates is essential to investigate cross-protection of the vaccine prior 
to commercialising the vaccine. In addition, the antibiotic resistance gene from the 
plasmid used in the current study needs to be eliminated before expressing the 
proteins for commercialisation. 
 
Problems with the development of successful traditional WC vaccines against A. 
hydrophila could be due to the expression of inappropriate antigens on bacteria 
grown in vitro. These antigens may not be represented on the bacteria, in vivo, 
during infection and thus protection is poor or not effective against a wide range of 
isolates. Although the S-layer protein appears to be present in A. hydrophila grown 
in vitro and in vivo it does appear to be up-regulated in vivo. The conformation of 
the S-layer protein may also be important for attaining protection. However, further 
work is required to fully evaluate the role of the S-layer protein in conferring 
protection. 
 
In conclusion, the results from the present study suggest that it is potentially 
achievable to develop a commercial vaccine against A. hydrophila which will 
overcome the issues of the heterogenicity of the bacterium. It may be possible to 
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improve the vaccine by adding additional antigens to the formulation. The 
aquaculture industry desperately needs such a product to manage this devastating 
disease problem. 
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Appendix I. Buffers and reagents 
Phosphate buffered saline (pH 7.2) 
NaH2PO42H2O (5.6 mM)    0.876 g 
Na2HPO42H2O (14.4 mM)    2.56 g 
NaCl (0.15 M)     8.77 g 
Distilled water      1000 ml 
 
Reagents used for Gram’s staining 
Crystal violet solution 
Crystal violet      2 g 
95 % ethanol      20 ml 
Ammonium oxalate     0.5 g 
Distilled water     80 ml 
 
Iodine Solution 
Iodine       1 g 
Potassium iodide     2 g 
Distilled water     300 ml 
 
Safranine Solution 
Safranine      0.25 g 
95 % ethonal      10 ml 
Distilled water      90 ml 
 
Alcohol / Acetone mixture 
Ethanol       950 ml 
Acetone      50 ml 
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Buffers used for Electrophoresis 
Sample buffer (2 X) 
Tris-Hcl (0.5 M, pH 6.8)    2.5 ml 
Glycerol (1 M)     2.0 ml 
SDS (10 % w/v = 0.35 M)    4.0 ml 
Dithiothreitol (0.2 M)    0.31 g 
Bromophenol blue     2.0 mg 
Distilled water      to 10 ml 
Stored at -20°C 
 
Reservoir buffer for 1D SDS-PAGE (5 X, pH 8.3) 
Tris base (123 mM)     7.5 g 
Glycine (0.96 M)     36 g 
SDS (17 mM)     2.5 g 
Distilled water      500 ml 
 
Reservoir buffer for 2D SDS-PAGE (5 X, pH 8.3) 
Tris base(125 mM)     7.575 g 
Glycine (1 M)     37.5 g 
SDS (17 mM)     2.5 g 
Distilled water      to 500 ml 
Filter the buffer through 0.45 µm filter  
 
Separating gel buffer (pH 8.7) 
Tris base (1.5 M)     91 g 
SDS (0.4 %,13.8 mM)    2 g 
Distilled water     500 ml 
Stored at -4°C 
  
Stacking gel buffer (pH 6.8) 
Tris base (0.5 M)     6.05 g 
SDS (0.4 %, 13.8 mM)    0.4 g 
Distilled water     100 ml 
Stored at -4°C 
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Separating gel (12 %) 
Separating gel buffer    24.90 % 
Distilled water     34.85 % 
Acrylamide (30 % w/v)    39.83 % 
(29 % acrylamide + 1 % bis acrylamide) 
N,N,N,N-tetramethylethylenediamine 
TEMED (1 M)     0.075 % 
Ammonium persulphate (10 % = 438 mM) 0.35 % 
 
Stacking gel (4 %) 
Stacking gel buffer     25 % 
Distilled water     61 % 
Acrylamide (30 % w/v)    13.4 % 
(29 % acrylamide + 1 % bis acrylamide) 
TEMED (1 M)     0.10 % 
Ammonium persulphate (10 % = 438 mM) 0.05 % 
 
Buffers used for ELISA 
Coating buffer (pH 9.6) 
Na2Co3 (15 mM)     1.59 g 
NaHCo3 (38.9 mM)     2.93 g 
 
Low salt wash buffer (10 X, pH 7.3) 
Trisma base (0.2 M)    24.2 g 
Nacl (3.8 M)      222.2 g 
Tween20      5 ml 
Distilled water      1000 ml 
 
High salt wash buffer (10 X, pH 7.7) 
Trisma base (0.2 M)    24.2 g 
Nacl (5 M)      292.2 g 
Tween20      10 ml 
Distilled water      1000 ml 
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Antibody buffer 
BSA         1 g 
PBS       100 ml 
 
Conjugate buffer 
BSA         1 g 
Low salt wash buffer (1 X)    100 ml 
 
Substrate buffer (pH 5.4) 
0.1 M Citric acid     21 g 
0.1 M Sodium acetate    8.2 g 
Distilled water     1000 ml 
Stored at -4°C 
 
Chromogen solution 
3’3’5’5’-Tetramethylbenidine  
dihydrochloride (42 mM)    0.07896 g 
Acetic acid:distilled water (1:2)   6 ml 
Stored at -4°C 
 
Chromogen in substrate buffer 
Substrate buffer     15 ml 
Chromogen solution    150 µl 
H2O2       5 µl 
 
Buffers used for Western blot 
Transblot buffer (pH 8.3) 
Glycine (192 mM)     14.4 g 
Tris base (25 mM)     3.03 g 
Methanol      200 ml 
Distilled water     800 ml 
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Tris buffered saline (pH 7.5) 
Tris base (0.02 M)     2.42 g 
NaCl (0.5 M)      29.24 g 
Distilled water      1000 ml 
 
Tris buffered saline with Tween  
Tween 20      1 ml 
Tris buffered saline     1000 ml 
 
Substrate solution (10 X) 
4-chloro-naphthol     0.15 g 
Methanol      50 ml 
Stored in the dark at -20°C 
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Appendix II. Mixtures and vector used for 
recombinant protein production 
PCR mixture (40 µl volume with 32 cycles) 
Genomic DNA        3 µl 
Primer forward        1.0 µl 
Primer reverse         1.0 µl 
dNTP          5 µl 
10 x buffer         4 µl 
Taq DNA polymerase      0.5 µl 
Double distilled water     24.5 µl 
Colony PCR mixture (10.5 µl volume with 32 cycles) 
 Small pinch of colony 
 Primer forward     0.2 µl 
 Primer reverse     0.2 µl 
 dNTP       1 µl  
10 x buffer      1 µl 
 Taq DNA polymerase    0.1 µl 
 Double distilled water    8 µl 
PCR products digestion mixture 
 Purified PCR products     10 µl 
 10 x buffer (H)      1 µl 
 Nco I enzyme      0.5 µl 
 Bgl II enzyme      0.5 µl 
 Double distilled water     8 µl 
Vector digestion mixture 
 pQE 60 vector     2 µl  
 10 x buffer (H)     1 µl 
 Nco I enzyme     0.5 µl 
 Bgl II enzyme     0.5 µl 
 Double distilled water    8 µl 
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Map of the expression vector pQE 60 
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Appendix III. Publications and presentations from 
the project 
Poobalane S., Thompson K.D., Diab A., Ardo L., Jeney G., Smith P. and Adams 
A. Protein expression by Aeromonas hydrophila during growth in vitro and in vivo. 
Microbial pathogenesis (Submitted). 
 
Poobalane S. Aeromonas hydrophila vaccine development using 
immunoproteomics. Oral presentation, Departmental seminar, 29.11.2006, 
Institute of Aquaculture, University of Stirling, Scotland, UK. 
 
Poobalane S., Thompson K. D., Jeney G., Jeney Z. and Adams A. Antigenic 
analysis of different strains of Aeromonas hydrophila grown in vitro and in vivo. 
Oral presentation, European Association of Fish Pathologist 12th International 
conference, 11-16 September 2005, Copenhagen, Denmark. Book of Abstracts p. 
88. 
 
Poobalane S., Thompson K. D. and Adams A. Proteomic and immunological 
analysis of A. hydrophila for vaccine production. Orals presentation, Scottish fish 
immunology research centre seminar day, 14.06.2005, Institute of Aquaculture, 
University of Stirling, Scotland, UK. 
